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Treating addictive behaviours in alcohol and drug populations in real-world settings carries a 
range of issues: standardised treatment approaches have been criticised for their complexity and 
inaccessibility, their failure to retain clients over the course of therapy, and their inability to 
address the range of coexisting difficulties present. The development of transdiagnostic third 
wave therapies has recently emerged as an alternative to traditional approaches. One such 
therapeutic approach is Acceptance and Commitment Therapy (ACT). ACT has proven to be 
effective in the treatment of several mental illnesses such as anxiety disorders, mood disorders, 
psychotic symptoms, and personality disorders; it has been found to be effective with medical 
issues such as chronic pain, cancer, epilepsy, and weight loss; and, importantly, it has been 
applied across a variety of challenging conditions and evidence of its effectiveness in treatment 
of addictive behaviours is promising and growing. The current study aims to examine the 
effectiveness of a manualised ACT-based group treatment programme applied in a real-world 
Alcohol and Other Drug (AOD) community setting. It was hypothesised that ACT would lead 
to reductions in alcohol use, substance use and cravings, and common co-occurring 
symptomology such as anxiety and stress. It was also hypothesised that there would be an 
increase in mood management skills and mindfulness tendencies. Findings suggest ACT is a 
promising approach to treating AOD communities as it is well-regarded by clients and it elicits 
a reduction in several substance use behaviours; however, several outcomes were not 
statistically significant for many of the comparisons which is likely due to the study being 
underpowered. In addition, most coexisting problems reduced by post-group and improvements 
to mood management were evident. However, a rebound effect was found at the three-month 
follow-up in which the mood management skills reduced, and coexisting stress and anxiety 
increased. Mindfulness tendencies demonstrated an accumulative effect and showed significant 
increases by follow-up. These results, although not statistically significant, still provide support 
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for future development and implementation of transdiagnostic approaches such as ACT, 
particularly in AOD services that commonly deal with dual diagnosis.  
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attending the groups and your effort in making this research possible (i.e. filling out several 
questionnaires several times!). There was laughter and there were tears and I thank you for 
showing up anyway. Your courage to be vulnerable and sit with your discomfort in a group 
that started out as strangers is a major credit to your strength and motivation in the ever-
evolving journey you are all on. My hope is that the skills learnt in the group continue to ease 
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The story of how this research project came to be 
Substance Use Disorders (SUDs) have always fascinated and interested me. Through my 
master’s degree I sought to understand the neuro-psycho-pharmacological explanations of 
addiction via animal models in the laboratory. This provided the foundation of understanding 
the brain mechanisms in the development of addictions. While intensely fascinating, I felt my 
main calling was to work with people. So, I moved from the laboratory setting to the clinical 
face to face setting and began working as an AOD Counsellor. Throughout my work as an AOD 
counsellor the overwhelming presentation of people with coexisting mental health and 
addiction problems was starkly evident. I noted an obvious gap in treatments targeting the 
underlying processes evident in both presenting issues. I believe that the prevalence of 
comorbid problems will continue to rise, and treatment approaches need to be able to address 
both problems effectively and services (mental health and addiction) need to work together for 
the benefit of their clients.  
Therefore, when I was accepted into the Wellington Doctoral Clinical Psychology 
Programme, I sought to further research addictions alongside coexisting mental health 
problems. However, there were no research supervisors who had experience or interest in SUDs 
in Wellington. I put the call out to several potential supervisors and asked fellow students if 
they knew of any staff members within the Massey University’s three campuses that conducted 
addiction-based research. This proved to be fruitful as a fellow pre-first year doctoral student 
gave me the name of Dr Shane Harvey from the Palmerston North campus who was running 
group treatment programmes that targeted AOD problems, amongst other issues, in the NZ 
army. In December 2014 I made my first contact with Dr Shane Harvey to foreshadow my 
interest in SUDs and asked if he had any projects I could be a part of and if he was willing to 
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be my supervisor for my doctoral research. Although there was no specific project developed, 
Shane explained he had an agreement with the Palmerston North AOD Service to develop and 
run research into ACT group therapy or to evaluate the existing group therapy already 
established at the AOD service. Contact with the principal psychologist, Guy Breakwell, at the 
Palmerston North AOD service in early January 2015 consolidated the project and he became 
the co-supervisor for my doctoral research. Dr Simon Bennett joined the project as my 
Wellington Campus Supervisor. From this point, the basis for the current research was 
developed. The NZ Army Wellbeing Course written and facilitated by Dr Shane Harvey and 
Doug Dickson was used as a starting point to begin research and development of ACT group 
treatment programme for the AOD service.  
The specific research design varied throughout the project. There was a preference for 
the ACT group treatment programme study to include active comparison groups as well as 
control groups. Through an established relationship with another District Health Board (DHB), 
an addiction service that was already running therapy groups was approached to gather data for 
a comparison group. Several meetings planning the implementation of the same measures 
across groups were had whereby the ACT group treatment programme was going to be 
compared to a CBT group for anxiety within the context of an addiction service. The 
comparison group ran twice in 2016. Comparative measures were collected. Unfortunately, due 
to attrition rates and missing assessment points (mainly for mid-group assessment phase), the 
data were not able to be utilised, leaving no comparison group design for the ACT group 
research project. Another group that had originally planned to be compared to the ACT group 
was the Mindfulness Based Relapse Prevention Group run by the Palmerston North AOD 
Service. However, due to unforeseen circumstances the Mindfulness Based Relapse Prevention 
Group could not be continued in 2016, leaving no viable alternatives for comparison groups. 
From an ethical perspective the AOD service and researchers were uncomfortable with the 
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addition of waitlist or control groups that would result in clients not being able to access 
treatment as soon as possible. Therefore, the current research design was revised and resulted 
in a repeated measure design across four assessment phases. This was considered the best and 
most efficient way to present the effectiveness of the ACT group treatment programme with 
participants from the AOD service in Palmerston North, New Zealand.  
To add to the current study’s publishable quality an additional study that would 
complement the ACT group treatment programme was discussed. At the beginning of this 
journey a meta-analysis investigating ACT applied to SUDs had not been conducted and was 
initially planned as study one. The ACT group manual development and delivery and analysis 
following as the main study. However, at the end of 2015 Lee, An, Levin, and Twohig published 
their preliminary meta-analysis of ACT for SUDs (Lee et al., 2015). While there were 
limitations and future directions that the current research could have continued, this additional 
study was deemed as unfeasible within the short timeframe of two years to complete the 
doctoral research.  
Thus, all efforts were used to research and develop a manual for ACT-based group 
treatment applied to SUDs. The effects of addiction are wide reaching; people from all cultures 
and backgrounds are not immune to developing addiction. Creating a group treatment 
programme that targets not only their addiction but also fosters skills that could help them with 
their related mental health concerns proved to be a very rewarding and worthwhile project that 
continues to reap benefits for the community. The success and popularity of the ACT group 
treatment programme developed from the current study has resulted in clients and staff at the 
AOD service continuing to implement the intervention outside of this research. I would 
anticipate that this is the next step towards such integrative and transdiagnostic approaches 
becoming the standardised treatment for coexisting problems in New Zealand.   
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Group facilitator: “What has your substance use (addiction) cost you in your life?” 
Group participants: “my friends and family…I lost them all. I became so unreliable 
and unpleasant to be around” … “I ‘can’t work’ because substances are ‘more 
important’ … “I stopped having a social life… Too embarrassed to drink in public” … 
“My children hated seeing me drink, worried about my actions”  
– Anonymised quotes, ACT Group  
For many, addiction to substances, including alcohol, begins as a way to manage emotions. 
Substances can be used to enhance positive feelings such as euphoria or avoid negative 
emotions such as stress. As these quotes illustrate, the pursuit to control emotions is costly. 
These people report pursuing substances to the extent that their friends and family were 
abandoned, and they became unreliable and unpleasant to their loved ones, yet reliable to the 
substance. They struggled to focus on work yet could focus on where and when they will 
source their next drink or use. Undesirable and uncomfortable emotions and experiences were 
strongly avoided, and these were actively removed from their own thoughts, 
feelings/emotions, and bodily sensations (which also includes withdrawal symptoms from the 
substances). In this pursuit of pleasurable experiences, or in many cases, the pursuit of 
avoiding discomfort, the initial relief sought from the substance often led to the violation of 
personal values and actions.  
Many therapeutic approaches have been developed to treat substance addiction, but 
this remains one of the hardest disorders to treat. Treatment effectiveness is variable, with 
Alcohol and Other Drug (AOD) problems and high relapse rates and comorbidity a service 
reality (Drake, Mueser, Brunette, & McHugo, 2004; Dutra, Stathopoulou, Basden, Leyro, 




Powers, & Otto, 2008; Prendergast, Podus, Finney, Greenwell, & Roll, 2006). Therefore, 
transdiagnostic therapies that aim to target common underlying psychological processes are 
called for in attempts to improve treatment efficacy with oft-complex cases comorbid with 
other disorders. A common theme amongst emerging transdiagnostic therapies is the 
emphasis on value violation and experiential avoidance as contributory underlying 
mechanisms for a range of psychopathology, including substance use disorders (SUDs), 
anxiety disorders, and mood disorders (Hayes, Strosahl, Luoma, Smith, & Wilson, 2004). 
This is because a common coping approach thought to underlie all these coexisting conditions 
is an individual attempting to control aversive emotions and experiences, with self-medication 
seen as one such control strategy. This thesis explores the use of an emerging therapy, 
Acceptance and Commitment Therapy (ACT), with people who struggle with alcohol and 
other drugs as well as comorbid problems.  
ACT is a transdiagnostic therapeutic approach that at a fundamental level most 
psychological disorders are the product of experiential avoidance or fusion to unhelpful 
thoughts. Transdiagnostic therapies target core underlying psychological processes that 
precipitate and perpetuate many mental health disorders, including SUDs. Therefore, ACT is 
positioned to effectively target SUDs where common triggers such as anxiety and mood 
problems can also be simultaneously treated. Hence, this literature review provides the ground 
work for why such coexisting problems with SUDs warrant investigation and why ACT is an 
important therapy to consider when addressing alcohol and other drug (AOD) problems 
comorbid with mental health problems. To do this, the current chapter is divided into four 
sections. Section one presents the background information on the prevalence and problems, 
including coexisting mental health conditions, associated with SUDs in New Zealand (NZ) 
and overseas. Section two provides an overview of the history of development of ACT and a 
summary of the research on ACT for various health conditions. Section three dissects the 




literature on ACT specifically applied to addictions (SUDs), and lastly, section four outlines 
the rationale for the current study.  
 
  




SECTION ONE: Defining the Problem – A Global and Local Profile of Substance Use 
Disorders 
Definitions and Terminology  
The word addiction originates from the root word “addico”, a Latin term used to describe the 
action or occurrence of “giving over”, where one feels devoted to something (Alexander & 
Schweighofer, 1988, p. 151). While there have been many debates and various definitions of 
addiction over several decades, even centuries, addiction, in the context of using substances 
such as alcohol and drugs has been depicted since the early 19th century. This development 
saw the inclusion of descriptive and diagnostic terms such as substance dependence, 
substance abuse, tolerance, and withdrawal symptoms (Alexander & Schweighofer, 1988; 
Sussman & Sussman, 2011). Addiction in the Diagnostic and Statistical Manual of Mental 
Disorders, from DSM I to DSM 5, has seen various changes to terminology, where the word 
addiction is rarely used. For the purposes of the current study, an important overview 
outlining the changes to the diagnostic criteria for a substance use disorder is briefly 
presented.  
The relatively recent release of the Diagnostic and Statistical Manual of Mental 
Disorders Fifth Edition (DSM-5) (American Psychiatric Association (APA), 2013) has seen 
changes in the identification of substance-related and addictive disorders. Instead of 
distinguishing between abuse and dependence as required in the Diagnostic and Statistical 
Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) (APA, 2006), the 
DSM-5 now uses the overarching term substance use disorder (SUD) on a continuum from 
mild to severe (APA, 2013). The DSM-5 presents ten different classes of substances: alcohol, 
caffeine, cannabis, hallucinogens, inhalants, opioids, anxiolytics, stimulants, tobacco, and 
other (or unknown) substances. The specific substance, or the primary substance, one uses is 
used to label the substance disorder, for example, alcohol use disorder or opioid use disorder. 




Furthermore, each substance can be diagnosed as substance use disorders (SUDs) or 
substance-induced disorders (SIDs). Substance-induced refers to intoxication, withdrawal, and 
other substance or medication induced mental disorders (i.e. substance-induced psychosis). 
The term addiction has been removed and the addition of drug cravings and elimination of 
legal problems has been implemented produce to the same overall criteria for each substance 
(APA, 2013). Table 1 presents the overarching criteria across all substance classifications for 
a diagnosis of a SUD and is adapted from the DSM-5 (APA, 2013). 
  




Table 1.  
Summary of DSM-5 Diagnostic Criteria for Substance Use Disorders. 
 Impaired control 
1:  The person takes substance in larger amounts or over a longer period than was originally intended. 
2:  
 
The person may express a persistent desire to cut down or regulate substance use and may report 
multiple unsuccessful efforts to decrease or discontinue use. 
3: The person may spend a great deal of time obtaining the substance, using the substance, 
recovering from its effects. (In severe cases daily activities revolve around the substance). 
4: Craving is manifested by an intense desire or urge for the drug that may occur at any time but is 
more likely when in an environment where the drug was previously obtained or used. (Classical 
conditioning, activation of specific reward structures in the brain, can be a sign of impending 
relapse, best to query urges/cravings). 
 Social impairment 
5: Recurrent substance use may result in a failure to fulfil major role obligations at work, school, or 
home.  
6: The person may continue substance use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the substance.  
7: Important social, occupational, or recreational activities may be given up or reduced because of 





8: Recurrent substance use in situations in which it is physically hazardous. 
9: The person may continue to use the substance despite knowing persistent or recurrent physical or 




10: Tolerance is signalled by requiring a markedly increased dose of the substance to achieve the 
desired effect or a markedly reduced effect when the usual dose is consumed.  
11: Withdrawal syndrome that occurs when blood or tissue concentration of a substance decline in 
an individual who had maintained prolonged heavy use of the substance. Each substance has its 
own set of withdrawal features.  
Note: The criteria above is generalised to fit all substances rather than specific substances that the DSM-5 outlines 
such as Alcohol Use Disorder (pg. 491, APA, 2013).  
The DSM-5 severity continuum identifies a mild SUD by the presence of at least two 
or three symptoms, whereas four or five symptoms are needed for a moderate diagnosis. A 
severe SUD is endorsed by the presence of six or more criteria as listed above (APA, 2013).  
  




Global Prevalence and Costs of Substance Use Disorders  
The worldwide costs of SUDs are not limited to the costs of health care and law enforcement 
to social harm. Social harm includes the social, economic, psychological, and environmental 
effects SUDs have on society. In 2008 the World Health Organisation (WHO) reported 125 
million people worldwide suffer from some form of alcohol use disorder. Of those affected by 
alcohol use disorders 40.5% were diagnosed as moderate or severe. The global prevalence1 rate 
for a drug use disorder was 11.8%. Worldwide reports among SUDs found that men were nearly 
seven times more likely than females to have an alcohol or drug use disorder (World Health 
Organization, 2008). The Global Burden of Diseases (GBD), Injuries, and Risk Factors study 
conducted in 2010 reported an increase of 37.6% between 1990 (the first GBD study conducted) 
and 2010 for the burden due to mental health disorders and SUDs, in combination increases in 
alcohol, opioids, and cocaine use were also identified during this period (Whiteford et al., 
2013). These statistics were further broken down, in which mental health disorders and SUDs 
(20 types included) accounted for 189.9 million disability-adjusted life years (DALYS) and 
were the leading cause of years lived with disability (YLDs) (Whiteford et al., 2013).  
Specific substances, excluding alcohol and tobacco, that had the highest burden 
worldwide were opioids and amphetamines, with the United States of America (USA), United 
Kingdom (UK), Russia, and Australia reported the highest rates of burden due to overall 
substance use (Degenhardt et al., 2013). Years of life lost to premature mortality (YLLs) due to 
SUDs accounted for 81.1% of the 8.6 million reported for both mental health disorders and 
SUDs (Whiteford et al., 2013). Further data from the GBD study analysed by Charlson, Baxter, 
Due, Degenhardt, Whiteford, and Vos (2015) reported 110, 000 deaths were estimated to be 
directly attributed to alcohol as 110 000, with alcohol as the underlying cause of death 
                                                          
1 Prevalence is defined as an epidemiological measure of how commonly a disease or condition occurs in a 
population at a particular point in time. It is often reported as number of cases per 100 000 of the population (Le 
& Boen, 1995) 




significantly increasing to over 5 million for the year of 2010. Illicit drug use related deaths 
were estimated at over 700 000 in which most deaths were due specifically to opioids (Charlson 
et al., 2015). This summary of the worldwide impact of SUDs provides brief detail of the extent 
and costs of such problems. Although the data presented here reflect mostly health related costs 
and premature deaths due to substance use, they do not encompass the costs of the justice 
system, which further presents a strain on countries and communities globally. Continued 
research into prevention and interventions for such relevant and significant problems is clearly 
warranted.  
Local Prevalence and Costs of Substance Use Disorders  
Global findings were reflected in the 2006 NZ Mental Health Survey (Te Rau Hinengaro) where 
the scale of the impact of mental health disorders and SUDs was evident. The survey reported 
that 39.5% of the NZ population met criteria for a DSM-IV-TR disorder (including SUDs) with 
a lifetime prevalence of 46.6% and a 12-month prevalence of 20.7%. The lifetime prevalence 
for any SUD was 12.3% and the 12-month prevalence was 3.5%. The same global sex 
differences were reported in NZ findings, where males had higher prevalence rates for SUDs 
compared to females (5.0% and 2.2% respectively, see Table 2). Further to this, 22% of those 
suffering from SUDs were young (16-24 years), Māori men. These statistics shed light on who, 
in NZ, is experiencing SUDs, and highlights the ongoing SUD issue for NZ, which in turn 
impacts on the types of prevention and interventions provided and tailored towards people with 
SUDs in NZ (Oakley-Browne, Wells, Scott, & McGee, 2006; Wells, Oakley-Browne, Scott, 
McGee, Baxter, & Kokaua, 2006). These figures alone provide a reason to conduct research 
that addresses these problems that are so commonly seen in NZ, and to develop a treatment 
programme that can help men and women from all walks of life.  
 
 




Table 2.  
Lifetime Prevalence of Substance Use Disorders among Adults in New Zealand.  














































Note: Data taken from the 2006 New Zealand Health Survey collected between 2003-2004 with 12 992 
completed interview utilising DSM-IV-TR criteria for substance use disorders (73.3% response rate) (Oakley-
Browne et al., 2006).  
Another poignant issue, demonstrated in the global and local data, is the rate of 
comorbidity of mental health problems and SUDs. The prevalence of coexisting problems 
further supports the development of treatment programmes that address multiple problems 
many New Zealanders struggle with simultaneously. The NZ Mental Health Survey identified 
37% of the population experiencing two or more disorders, mental health and physical health 
(12-month prevalence).  People who reported lower education levels and lower 
socioeconomical status were also found to have higher prevalence rates for mental health 
problems. Out of the 12.3% of people diagnosed with a SUD, 40% also suffered from anxiety 
disorders and 29% suffered from any mood disorder. Although mood disorders were reported 
as the most disabling, SUDs was highlighted as one of the most concerns to safety, given that 
SUDs and comorbid mental and physical conditions are associated with increased rates of 
suicidal ideation, suicide planning, and suicide attempts (Oakley-Browne et al., 2006; Wells 
et al., 2006).  




The profile for specific substances, amphetamines and cannabis, in NZ has also been 
investigated as they are one of the most problematic substances (other than alcohol and 
tobacco) that New Zealanders struggle with. The Ministry of Health investigation into 
amphetamine use found that 0.2% of those aged between 16 and 64 years old reported using 
amphetamine monthly, finding no significant sex differences. This figure increased to 0.9% 
prevalence of amphetamine use over a 12-month period, equating to approximately 25 000 
New Zealanders reporting use of this drug (Ministry of Health, 2013). Māori were four times 
more likely to report using amphetamines, and the average age of use was 29 years old. 
However, underreporting was a key consideration in this investigation; therefore, a careful 
interpretation of results is needed. A similar investigation into cannabis use in NZ reported 
that cannabis is the most commonly used illicit substance with a 12-month prevalence of 11% 
of the population and a lifetime prevalence of 42%. Again, Māori males were more likely to 
report problems with cannabis (Ministry of Health, 2015). Taking all the information 
provided from nationwide studies of the impact of mental health and SUDs, the statistics 
provide an overview of the demographics of individuals struggling with these co-occurring 
problems and can be utilised as key considerations when developing a treatment programme 
that will be meaningful for an AOD population.  
In line with global findings, SUDs in NZ are considered a significant economic burden 
on society due to rising health care costs, lost outputs (unemployment and employment 
problems), justice sector demands (crime, prison, and other legal problems), and road crashes. 
The Ministry of Health and the Accident Compensation Corporation (ACC) found 
approximately $661 million costs for joint alcohol and drug use in NZ over a 12-month period 
(2005-2006). The report claimed that 50% of these costs could be avoided. One way costs of 
SUDs could be avoided was through the use of interventions that targeted supply and demand 
of the substances as well as interventions that aim to reduce harmful use of substances (Slack, 




Nana, Webster, Stokes, & Wu, 2009). In terms of specific costs to NZ, the Ministry of Health 
(2015) report specifically outlined how high rates of cannabis use impacted on learning and 
productivity. This impact resulted in reductions in educational achievements and employment 
opportunities, and an increase in the negative effects of use on mental health, prevalent legal 
problems involving the possession, use, cultivation, manufacture and supply of cannabis, and 
problems with driving under the influence (Ministry of Health, 2015). This issue further 
highlights the necessity of a therapeutic approach that is cost effective and time efficient and 
that can be applied to a variety of people struggling with a range of disorders.  
The New Zealand Drug Foundation (2018) reported that 44% of New Zealanders at 
some point in their life will use an illicit substance and 93% will try alcohol. Of those who 
use substances, only 45,000 people are estimated to seek help to address their substance use 
issues each year, which is thought to represent approximately a third of people who have a 
SUD. The Drug Foundation (2018) also provides updated estimates of specific substances 
such as cannabis and methamphetamine. Accordingly, Cannabis is considered the most 
common illicit substance used in NZ and causing the most harm to younger users. Over the 
last five years methamphetamine use has been stable, although specific communities may 
sustain more harm from methamphetamine use compared to other substances. Illicit substance 
use reportedly costs New Zealand approximately $1.8 billion per year, the majority of costs 
stemming from law enforcement. Recent marketing initiatives involve addressing alcohol and 
other drug use in NZ, with television and other media campaigns targeting alcohol free 
pregnancies, alcohol free teenagers, and promoting harm reduction strategies, with many 
resources incorporating Māori and Pacific Island needs. The focus continues to be on 
prevention and education, harm reduction, intervention, and community support, all with the 
intended purpose of decreasing the impact of SUDs on NZ as a whole (Health Promotion 
Agency, 2018). 




One last consideration in the profile of SUDs includes a specific type of barrier to 
accessing treatment services for people with SUDs. That is self-stigma, when a person feels 
marginalised and does not approach services for treatment. At a societal level, stigma 
perpetuates social alienation and can negatively impact a range of different areas in a person’s 
life such as decreased job opportunities, housing, and social relationships. At a treatment 
service level, stigma has a significant relationship with poor physical and mental health, 
increased risky behaviour, increased dropout rates in treatment setting (non-completers of 
treatment) and delayed recovery and poor reintegration (Luoma, Kohlenberg, Hayes, & 
Fletcher, 2012). Therefore, a treatment programme that is sensitive to this issue may produce 
higher therapy retention rates and promote a prompt recovery.  
It is clear from both global and local reports that the costs and prevalence of SUDs are 
relevant concerns for modern society. This suggests a strong rationale to further investigate 
potential treatments that may address the problem of SUDs locally and globally. An 
individual with a SUD often experiences mental health issues co-morbidly, which makes the 
treatment of these coexisting problems a complicated and complex challenge to those 
assigned to treat them. Not only does the individual suffer from the chronic enduring nature of 
these problems, but the families and communities surrounding the individual are also affected. 
These rippling effects further support the rationale for investigating and examining potential 
treatments for SUDs. A new therapy approach that has gained traction over the recent decades 
is Acceptance and Commitment Therapy (ACT). The evidence base for this therapy is 
growing and found to be effective for a wide range of problems including mental health issues 
and various other health conditions, as well as the self-stigma barrier commonly observed 
with SUDs. The following section will introduce ACT and briefly outline its theoretical 
foundations in Relational Frame Theory (RFT) as well as provide an overview of the current 
empirical stance of ACT.   




SECTION TWO: Acceptance and Commitment Therapy Origins 
This section provides an overview of the history of development of ACT and presents the 
evidence for ACT applied to various mental health and physical conditions. A comprehensive 
review of Contextual Behavioural Science (CBS) and Relational Frame Theory (RFT) are 
beyond the scope of this thesis; however, a brief overview of the philosophical and scientific 
approach is presented to help the reader to understand and acknowledge the theoretical 
underpinnings of ACT and how it came to be what it is today.  
Acceptance and Commitment Therapy Foundations  
The fundamental frameworks for both RFT and ACT are rooted in CBS and were first 
developed in the early 1980s by Steven Hayes and associates. CBS is a broad approach to 
research and practical development that is multi-dimensional (in that, it considers social, 
neurological, and behavioural factors) and multi-methodological (in that, several types of 
methods are implemented to analyse and understand human behaviour and human suffering in 
relation to language and cognition). It incorporates applied behaviour analysis, cognitive 
behaviour therapy, and evolutionary science to reach the underlying goal of predicting and 
influencing behaviour (Hayes, Strosahl, & Wilson, 1999; Hayes, Levin, Plumb-Vilardaga, 
Villatte, & Pistorello, 2013; Vilardaga, Hayes, & Schelin, 2007). The term functional 
contextualism, according to CBS, is the process of predicting and influencing behaviour that 
is based on interactions between psychological events and context (both historical, that 
focuses on past learning, and situational, that focuses on antecedents and consequence 
relationships and verbal rules) that gives that particular behaviour purpose. The functional 
aspect refers to what function the behaviour is serving in a particular context and how it 
works for the individual (Hayes, Luoma, Bond, Masuda, & Lillis, 2006). Functional 
contextualism and CBS are considered the philosophical science behind RFT and ACT, in 




which the focus is on a basic analysis of verbal behaviour and its impact on psychological 
wellbeing (Hayes, Strosahl, & Wilson, 2012).  
Relational Frame Theory. RFT is a psychological theory of language and cognition 
that builds upon behavioural theory by B.F. Skinner, in which he states that verbal behaviour 
is learnt through gradual shaping by successive approximation and through rule-governed 
behaviour as a mode of learning and relating (Skinner, 1957 as cited in Hayes et al., 1999). 
The first ACT training was presented in 1982 as a functional contextual treatment approach 
that detoured from traditional behavioural therapy and cognitive therapy (first wave and 
second wave therapies, respectively). Cognitive behavioural therapy (CBT) was seen as the 
original third wave therapy (Hayes, 2016). Nevertheless, research utilising ACT was not 
pursued until the early 2000s as the founders of ACT wanted to first establish a thorough 
understanding of the theoretical details (Hayes, Strosahl, & Wilson, 2011; Zettle, 2005; Zettle 
& Hayes, 1986). In this sense, ACT is considered part of the third wave therapy family 
(Hayes, Wilson, Gifford, Follette, & Strosahl, 1996; Hayes, 2016; Öst, 2008). Throughout the 
1990s, Hayes and associates continued to publish articles promoting the development and 
understanding of RFT and ACT, before delving into practical applications of the theory and 
therapy in order to provide a concrete backdrop to the scientific mechanisms first described in 
RFT and ACT (Biglan & Hayes, 1996; Hayes, Hayes, & Reese, 1988; Hayes & Wilson, 1993; 
Hayes et al., 1996).  
Hayes, Barnes-Holmes, and Roche (2001) stipulate that language is the key to 
understanding human behaviour, and that this is achieved through analysis of verbal 
behaviour and how verbal rules guide behaviour. There are three forms of rule-governed (also 
referred to as relational networks) behaviour called pliance, tracking, and augmenting that are 
based on verbal understanding. Pliance is a verbal rule learned from previous examples of 
socially mediated consequences between two or more people. For example, a person obeys 




the speed limits to avoid a speeding ticket. Tracking is the correspondence of natural 
consequences and the rule. Natural consequences can be described as the resulting 
consequence of behaviour in a particular situation. A simplified example of tracking would be 
following the verbal directions to get to the library where the rule and location of the library 
correspond. Lastly, augmenting is a term used to describe the changes to the function of a 
consequence that are contingent on following rules. Augmenting is used to establish the 
control of abstract, imagined, or never previously experienced consequences through 
reinforcers and punishers. There are two subtypes of augmentals, motivative augmentals and 
formative augmentals (Hayes et al., 2001; Hayes et al., 1999). Motivative augmentals are 
rules that can increase a person’s motivation to obtain the suggested consequence that has 
been produced by a verbal rule. For example, a person suggesting chocolate would be a nice 
treat today would increase the other person’s motivation to obtain the chocolate regardless of 
availability to the chocolate. Formative augmentals is a term referred to relational networks 
that use new events as having an important consequence (Hayes et al., 2001; Hayes et al., 
1999). An example of a formative augmental is if a person is told vouchers can be used at the 
supermarket, the vouchers now serve as a reinforcer. Therefore, the new event (receiving a 
voucher) now has an important consequence (can use at supermarket). These concepts explain 
how humans learn behaviour and the relationship language has with people’s behaviours. 
RFT  refers to people learning to respond relationally to various stimulus events (Hayes et al., 
2001). 
The theory of learned behaviour originally proposed by Skinner (Skinner, 1966 as 
cited in Hayes et al., 2001) described how behaviour is learned through the relational frames. 
There are three main properties of relating that include mutual entailment, combinatorial 
entailment, and transformation of stimulus functions. Mutual entailment refers to when 
individuals learn that A relates in a particular way to B in a particular context, which then 




additionally means some relation correspondingly exists between B and A in that same 
context. These relations (between A and B) show combinatorial entailment, meaning that if in 
a particular context A relates to B, and B relates to C, then some type of mutual relation 
between A and C in this particular context must exist. The relations between A, B, and C can 
transform the functions (transformation of stimulus functions) of another stimulus without 
additional learning if situated amongst related stimuli. As such, these derived stimulus 
relations are learned without explicit training and are brought under contextual control by the 
particular context in which they are experienced (Hayes et al., 2001; Barnes-Holmes, Barnes-
Holmes, & Cullinan, 2000; Hayes & Wilson, 1996). Once verbal relations are formed they 
cannot be eliminated from a person’s repertoire; you can add new information to them but 
these relations will not be completely removed (Hayes et al., 1999). From these relational 
networks, a verbal event can be said to have psychological functions because it participates in 
a relational frame. Human language is based on relational frames, particularly derived 
stimulus relations, in which the weakening of the literal underpinnings of verbal events 
requires a weakening of relational frames in specific contexts. For example, a person who is 
told they are not good enough would take the literal meaning of the language and relate it to 
their overall worth which would have a psychological function in this context. Therefore, the 
view that language is at the core of many psychological disorders gives rise to therapies that 
work on weakening these relational frames, and one such therapy that developed and aims to 
do this is ACT (Hayes et al., 2001; Hayes, 2016) 
Experiential Avoidance. It is from the perspective of how language and cognition 
influence human suffering that RFT can be understood in the context of psychopathology. A 
person unwilling to experience or accept their private events (that is, emotions, thoughts, 
memories, or bodily sensations) is said to engage in experiential avoidance. Experiential 
avoidance encompasses both emotional avoidance and cognitive avoidance and is a process in 




which an individual takes actions to avoid or alter the frequency of these unwanted 
experiences (Hayes et al., 1996). Suppression and situational escape or avoidance are 
considered the main forms of experiential avoidance (Hayes & Strosahl, 2004). These 
strategies to control or suppress and escape or avoid often lead to detrimental effects on an 
individual’s overall wellbeing (Hayes et al., 1999; Hayes et al., 2004). The concept of 
experiential avoidance is not exclusive to RFT or ACT and is an idea important to most 
modern behavioural therapies, for example, Dialectical Behavioural Therapy (DBT) (Linehan, 
1993; 1994, as cited in Hayes et al., 1999). Through the avoidance of these internal states 
there is short-term relief from discomfort and thus the avoidance behaviour is maintained 
through negative reinforcement, so the individual is likely to become trapped in a 
perpetuating cycle of avoidance that typically leads to poorer psychological wellbeing (Hayes 
et al., 1996).  
Control is the problem, not the solution. By attempting to suppress or control 
unwanted experiences a paradoxical effect occurs, in that, suppression often leads to an 
increase in experiencing whatever is attempting to be controlled (Cioffi & Holloway, 1993; 
Sharp, Wilson, & Schulenberg, 2004; Wegner, Schneider, Carter, & White, 1987, as cited in 
Hayes et al., 1999). Control and suppression techniques are frequently programmed into 
people, typically in the Westernised world, whereby people are told that they ought to be able 
to control any unwanted or uncomfortable private event. People can become stuck or rigid in 
their avoidance strategies and become fused with beliefs and evaluations of unwanted private 
experiences thus leading to an overall lower quality of life. This pattern is often observed in 
those who suffer from mental illness and considered by many as behaviours that are 
“unworkable” in the long term. This unworkable way of living is presented in the ACT 
literature as the FEAR acronym which stands for Fusion, Evaluation, Avoidance, and Reason 
giving (Hayes et al., 1999). Fusion is the process whereby a person becomes “fused” 




(excessively attached) to their content of unwanted private events. This process typically 
draws attention away from the present moment and is often experienced as thoughts or 
emotions from the past or about the future. Evaluation is the judgements and appraisals of 
self, others, and the world, whereby people view these evaluations as “good or bad”. 
Avoidance can be viewed as the same experiential avoidance as outlined previously. And 
lastly, reason giving is when a person attempts to justify or rationalise the continued use of an 
unworkable strategy and as a result, lessens their ability to address the consequences of said 
unworkable strategy in their immediate environment. This algorithm leads to further 
psychological rigidity and limited quality of life (Hayes & Wilson, 1994; Hayes et al., 1996; 
Hayes et al., 2004).  
Creative hopelessness is a concept that is used therapeutically when a person has the 
belief that there is a need to be in control of their emotions and other private events to have a 
good life. It is typically used when a person may be resisting or opposing the core concept of 
acceptance. This aspect of ACT centres on the idea of workability, which is whether the 
strategies a person is currently using is helping them build a good life in the long-term. In this 
context a sense of hopelessness is created in the person’s ability to control private events, 
which in theory and practice, angles the person towards the realisation that one cannot control 
internal unwanted experiences. If a person believes they can use control strategies then the 
ACT practitioner teaches the person that these strategies are only successful short-term and 
are often unworkable (Hayes et al., 2012; Hayes & Wilson, 1994; Ruiz, 2010). Essential 
questions asked to create this particular hopelessness includes “what have you tried?” and 
“how has that worked?” and “what has that cost you?” and “what is that life for you” and “are 
you open to trying something different?” Once a sense of creative hopelessness has been 
established then a new alternative way of relating to, rather than controlling, private events 
can be offered, which in this case, is the novel approach of ACT (Hayes & Strosahl, 2004).  




A Definition of Acceptance and Commitment Therapy  
Putting the previous concepts together (functional contextualism, RFT, cognitive fusion, and 
experiential avoidance) to offer an encompassing definition of the proposed therapy for the 
current research is a quote from Hayes and Strosahl (2004): 
“ACT is a functional contextual intervention approach based on Relational Frame 
Theory, which views human suffering as originating in psychological inflexibility fostered by 
cognitive fusion and experiential avoidance. In the context of a therapeutic relationship, ACT 
brings direct contingencies and indirect verbal processes to bear on the experiential 
establishment of greater psychological flexibility through acceptance, defusion, establishment 
of a transcendent sense of self, being present, values, and building expanding patterns of 
committed action linked to those values.” (p. 29) 
One of the goals of therapy is to rework the FEAR acronym (outlined above) towards 
the ACT acronym (which stands for Accept, Choose, and Take Action2). Accept is often seen 
as the functional and workable strategy that involves accepting those unwanted private events 
(thoughts, feelings/emotions, memories, and sensations) as well as external events and view 
them as being unable to be controlled and rather let them be as they are without judgement. 
Choose is when an individual chooses what is important to them by focusing on values that 
would give the person meaningful life direction. Lastly, Take Action is when a person 
commits to behaviours and actions that are in line with their identified values. If a person can 
harness these skills then they are seen to have psychological flexibility which, briefly put, 
means the ability to consciously live in the present moment while achieving valued life goals 
(Hayes et al., 2004). Hayes, Strosahl, and Wilson (2012) state that “the ultimate goal of ACT 
is to bring verbal cognitive processes under better contextual control and to have the client 
                                                          
2The use of the acronym ACT for Accept, Choose, Take Action is not exclusive to the authors and founders of 
Acceptance and Commitment Therapy as stated in Hayes, Strosahl, & Wilson (1999); however, they utilise this 
acronym to simply summarise the main goals of Acceptance and Commitment Therapy.  




spend more time in contact with the positive consequences of his or her actions immediately 
in the present as part of a valued life path” (p. 65).  
The core concepts accept, choose, take action can be presented as the six principles of 
ACT. They form the Hexaflex model of ACT, in which psychological flexibility is the intended 
outcome (see Figure 1. below). The six processes of ACT allow a person to develop skills in 
no specific order while promoting acceptance, commitment, and action towards personally 
valued goals. This model depicts how each principle interacts with each other but it does not 
include several other key philosophies of ACT such as, control as the problem and creative 
hopelessness. These concepts, as outlined above, are pivotal in developing the foundations that 
the six core processes are utilised and may be missed due to their exclusion in the model. A 
model typically serves to describe the underlying functions of the theory and therapy proposed 
therefore these aspects would be necessary to include to present an overall visual of the working 
pieces involved in ACT. ACT is also essentially boiled down to two concepts; acceptance and 
commitment which does not specifically acknowledge the other core processes of the therapy. 
Other aspects to consider are that the similar concepts of defusion and self as context may be 
difficult to differentiate. Practical implementation of the principles of ACT are typically 
achieved through the use of metaphors, paradoxes, stories, exercises, behavioural tasks, and 
experiential processes  (Hayes, Luoma, Bond, Masuda, & Lillis, 2006; Hayes et al., 2004). Each 
core principle represents opportunities for clinical intervention. Present moment awareness, 
acceptance, defusion, and self as context are all considered mindfulness and acceptance-based 
behaviours and strategies whereas values and commitment action skills are change behaviours 
(Ciarrochi, Robb, & Godsell, 2005; Hayes et al., 1999; Hayes et al., 2006; Hayes et al., 2004). 
Mindfulness-based techniques are a central part of third wave therapies. Bringing awareness 
and acceptance of thoughts, feelings, and sensations whether they are comfortable or not is an 
important part of ACT. This can be achieved through several techniques which include attention 




to breath (focusing and calming the mind), awareness of the present moment, and to not place 
















Figure 1. Hexaflex model promoting psychological flexibility via the six core processes of 
ACT (adapted from Harris, 2009 and Hayes et al., 2006). 
Psychological flexibility versus psychological rigidity. A fundamental assumption 
underlying ACT is that human suffering is normal rather than abnormal, as such people 
should not try to control their thoughts, feelings, sensations, memories, or other private events 
but rather notice, accept, and distance or unhook from these experiences while focusing on 
what is deeply important to them (values) and taking actions towards those values to make 
their life more meaningful and vital (Hayes et al., 2012). If a person can do this, it 
demonstrates an ability to be psychologically flexible. Psychological rigidity is when human 
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suffering is worsened by a person’s rigid ideas about themselves, lack of focus on what is 
important in their life, and their engagement in struggling to change their unwanted 
sensations, feelings, or thoughts that often produces greater levels of distress (Hayes et al., 
2012). This psychological rigidity stops a person from being able to adapt to different 
contexts, both internal (thoughts, feelings, sensations) and external (environment, situations). 
Hayes et al. (2012) stipulates that a person’s “verbal and cognitive processes tend to narrow 
human repertories in key areas through cognitive entanglement and experiential avoidance” 
(Hayes et al., 2012, p. 64). A key consideration for psychological flexibility is determining 
whether the verbal rules and cognitive processes are workable. Therefore, when people 
excessively fuse to unworkable verbal rules their behaviour and thoughts become narrowed. 
They lose contact with the direct consequences of their actions (that are guided by their rigid 
ideas of themselves and the use of their unworkable coping strategies) and cannot engage in 
alternative coping strategies when their existing strategies become unworkable. Through this, 
people lose touch with their personal values and instead they are controlled by external means 
such as social conformity or other people’s expectations, so a person may attempt to please or 
pacify them, or they engage in experiential avoidance to avoid unwanted psychological pain. 
Over time, if this behaviour continues, a person becomes stuck in major areas of life. One 
may begin to withdraw, isolate themselves from others, or engage in unhelpful behaviours 
such as drinking, using substances, cutting, or overeating. Overall, these strategies lead to a 
lifestyle of pain and suffering or living a life on autopilot. The main contributor to this human 
suffering is the fusion to verbal rules (i.e., what we tell ourselves and the language we use). 
The problem is thought itself and how overidentifying with such verbal and cognitive 
processes is supported and modelled by society as a way of regulating a person’s behaviour 
(Hayes et al., 2012; Hayes, 2016; Twohig, 2012).  




Present moment awareness versus past or future focus. A fundamental 
mindfulness behaviour promoted in ACT is present moment awareness. John Kabat Zinn 
defined mindfulness as the practice of “paying attention in a particular way, on purpose, in the 
present moment, non-judgementally” (Kabat Zinn, 2003, p. 145). By practicing this 
technique, a person can bring attention to the present moment without judgement or placing 
evaluations on what they are experiencing, internally or externally. This skill emphasises full 
participation in each moment; however, acknowledges that a wandering mind is a normal 
human process that is almost guaranteed to occur. As such, the present moment skill 
(mindfulness) is encouraged to be practiced daily, multiple times throughout the day to help 
people live in the here and now rather than focus on the past or the future. People who focus 
on the past are more likely to suffer from depression and those who focus on future orientated 
thoughts are more likely to experience anxiety, for example (Harris, 2006). The key concept 
of present moment awareness is to pull people back into what they are experiencing right 
now, just as it is. In ACT, this concept teaches people to recognise and experience their 
private events (i.e., emotions or sensations or thoughts, or urges to act) without trying to 
suppress. Mindfulness has been found to help people manage emotions and build the skill of 
acceptance towards themselves and others (Hayes et al., 1999; Hayes & Strosahl, 2004). 
Acceptance versus experiential avoidance. Acceptance or similarly willingness and 
openness is an abstract idea and a key ACT skill. The skill of acceptance orientates a person 
to make room and expand to accept their experiences as they are without struggling and 
engaging in behaviours and processes that make them worse (e.g., suppression or avoidance). 
This skill involves learning to accept unwanted experiences while making room for a flexible 
approach to behaviour and can lead to actions that are in line with a person’s values. When 
defining acceptance, it is important to beware of the myths that are associated with the word 
itself. Acceptance is often considered as a person “wanting” or “approving” or “allowing” 




their experiences. Or it can also be interpreted as resignation or “giving in” or “admitting 
defeat or failure”. Another important distinction is that acceptance does not mean tolerating 
unnecessary personal pain. Rather it means that a person has become able and willing to 
accept all unwanted psychological experiences that often produce feelings or sensations of 
discomfort. If a person is unable to foster the skill of acceptance the likelihood of engaging in 
avoidance behaviour of the discomfort produced by the unwanted private events is increased 
(Hayes et al., 1999; Hayes & Strosahl, 2004).     
Defusion versus fusion. Defusion is the process where people learn to change their 
relationship with unhelpful or unworkable thoughts that lead to the engagement in behaviour 
that is not in line with their valued goals. Essentially, it is a different way of relating to 
thoughts or private events to lessen the influence and impact they have on a person’s 
wellbeing. It teaches people to step back from entangling (or fusing) themselves in private 
events (thoughts, emotions, memories, sensations) that people can often fall into the trap of 
believing their thoughts are reality and truth in which they become “hooked”. This skill 
gradually influences the content and style of thinking as well, although, not through logical 
reprogramming but rather through exposure to new learning experiences being fostered by 
cognitive flexibility and openness. If a thought is workable and helpful in a person’s life, then 
fusion to this thought can guide their actions towards their valued life direction. However, 
when a thought is unworkable and unhelpful then learning to defuse is recommended. There 
are three different levels of defusion; 1) noticing is simply noticing what a person’s thoughts 
are telling him or her which creates distance from the thought, 2) naming is labelling the 
thoughts, and 3) neutralising involves several defusion techniques designed to support the 
process of disconnecting from thoughts and feelings (Harris, 2009). This helps people see 
them for what they are, that is, a stream of words, passing sensations, and not facts or threats 
about oneself (Harris, 2009). An example of noticing and naming defusion, “I am noticing the 




thought that I am not good enough” serves to place distance between the powerful sting of the 
thought “I am not good enough” by recognising that it is just a thought and a string of words 
that cannot hurt you. Whereas an example of a defusion technique designed to deliteralise 
language is Titchener’s repetition exercise. This is the repetition of the thought out loud 
quickly and as many times as it takes for the words to lose their meaning thereby creating a 
disconnection from the unnecessary human suffering language can have on a person. 
Practicing the skill of defusion provides distance, separation, space from thoughts as well as 
letting them come and go. When applying the acceptance skill in conjunction with present 
moment skill people can learn to notice their current experience and be mindful of how they 
are interpreting it and in turn how that interpretation is affecting them and then make room for 
their experience as it is. The idea in developing this skill is that the unhelpful and unworkable 
thoughts will typically reduce in their frequency as a person is not giving them as much 
weight or focusing on them or suppressing them, which as previously outlined leads to the 
paradoxical effect of an increase. However, if defusion is used as an avoidance strategy then 
the thoughts are not likely to decrease, and the person will still be stuck in the perpetual cycle 
of avoidance. True defusion happens when a person engages in the present moment and learns 
to hold thoughts lightly while committing to valued actions (Hayes et al., 1999; Hayes & 
Strosahl, 2004).  
Self as context versus self as concept. Self as context is another abstract idea that is 
often referred to as the “observer self” or “pure awareness” (Harris, 2009). It is helpful to 
compare the term “thinking self or conceptualised self”, which is defined by thoughts, beliefs, 
memories, judgements, or plans (private events) with the idea of self as context which is the 
observing self that is always noticing and aware of private events. In this way, self as context 
serves as a viewpoint from which thoughts and other private events can be observed without 
rigidly holding onto the roles and labels people give themselves and others. Self as context 




fosters a person’s ability to gain a different perspective and may provide reprieve from the 
unwanted content of their experiences. It is another way to build distance from unhelpful and 
unworkable private events and adds a deeper level of utility to the defusion skill, again whilst 
harnessing acceptance and present moment strategies as well (Hayes et al., 1999; Hayes & 
Strosahl, 2004).  
Values versus absent or confused values. Values are considered what an individual 
holds as deeply important. The values principle is a critical part of ACT whereby a person 
identifies and clarifies their personal values and what is important in their life. Values are 
positively reinforcing as they serve to guide a person’s actions and give meaningful direction 
to a person’s life. They are different from goals in that they cannot be achieved but rather 
provide a guiding force for a person’s life. Values provide meaning to potential experiences of 
pain associated with a person’s values in the service of living a life more meaningful and 
vital. By holding onto values, people can learn to accept and hold their discomfort lightly 
while engaging in important areas of their life. The worth of values is that they allow actions 
to be coordinated and directed over long term timeframes. Values are more abstract and 
global than concrete goals and thus provide a kind of glue that makes a set of goals more 
coherent. This means, values are relevant and less subject to satiation and change, which in 
turn produces a useful kind of persistence whereby there is an increase in sustainability of 
behaviour change when driven by values that the therapy sorts to identify and bring forth. The 
values work in ACT is a way of moving out of the narrowed life focus that avoidance can 
produce. When living in line with one’s values an inherent sense of purpose and vitality 
occurs that will make confronting unwanted experiences worthwhile (Hayes et al., 1999; 
Hayes & Strosahl, 2004).   




Committed action versus inactivity, avoidance, and/or impulsivity. Committed 
action is the second core category, focusing on change behaviours in ACT. Committed action 
is a skill that centres on the behavioural activation towards a person’s values while facing 
uncomfortable thoughts and feelings. Therefore, acceptance or willingness is a fundamental 
principle needed to carry out committed action, in that, people cannot commit to a behaviour 
when they are not completely willing. In the same vein, values are the cornerstone that give 
direction to people’s committed action and what that will look like through their behaviours. 
The ACT approach is successful when acceptance-based skills are applied to a value-driven 
life (Hayes et al., 1999; Hayes & Strosahl, 2004).  
Summary of Acceptance and Commitment Therapy processes. The underlying 
processes of ACT such as experiential avoidance, control as the problem, creative 
hopelessness, and psychological rigidity or flexibility can be applied to more than one 
condition, typically those that exhibit these common themes of human suffering. As such, the 
ACT skills serve to address multiple struggles and offer a new way of relating and being, 
aimed at reducing this human suffering and increasing the ability to live a vital and 
meaningful life. Therapies that have the ability to do this are considered transdiagnostic in 
nature. That is why ACT was chosen for the current study as emerging evidence continues to 
support the transdiagnostic qualities of ACT across a range of mental and physical health 
disorders.  
The Empirical Status of Acceptance and Commitment Therapy  
Since the inception of ACT, originally termed “comprehensive distancing” in the 1980s and 
the further theoretical development of ACT in the 1990s, empirical evidence supporting the 
use of the therapy began to rise in the early 2000s. This is clearly demonstrated when looking 
at the content of scientific research over the past few decades with a significant increase in 




studies conducted as depicted in Figure 2. A literature search of Web of Science, psychINFO, 
Google Scholar, and Scopus was completed using the term; “Acceptance and Commitment 
Therapy” with the limits of published journal articles.  
 
 
Figure 2. Number of published articles on Acceptance and Commitment Therapy 
since 1989.  
ACT has been applied across a broad range of physical and mental health problems 
including chronic pain, mood disorders, obesity, work stress, personality disorders, cancer, 
and diabetes. Several meta-analyses and systematic reviews highlight progress and efficacy of 
ACT. The APA Presidential Task Force on Evidence-Based Practice provided an indication of 
the strength of research supporting the use of ACT for particular health conditions and their 
2006 publication is included in the list of important findings of ACT applied to a range of (not 

































Table 3.  
Important Findings for Acceptance and Commitment Therapy Applied to Various Physical and Mental Health Conditions. 
Condition N Important findings 
Anxiety disorders  404  Potentially effective treatment for anxiety disorders including SAD, GAD, panic, and agoraphobia (Öst, 2014). Positive changes in 
experiential avoidance and cognitive fusion. Empirically supported by APA with modest research support.  
Depression  381  Possible efficacy of ACT for mood disorders were reported through improved self-confidence (Öst, 2014). Empirically supported 
by APA with modest research support.  
Chronic pain 144  Improved long-term functioning focusing on acceptance of pain and predicted pain severity (Öst, 2014). Most researched health 
condition and is empirically supported by APA with strong research support.  
Psychosis 47 Reduced rates of hallucinations and delusions suggest the possible efficacy of ACT for psychosis (Öst, 2014). Empirically 
supported by APA with modest research support.  
OCD 47  Positive changes in experiential avoidance and cognitive fusion (Öst, 2014). Empirically supported by APA with modest research 
support. 
Eating disorders 46 Considered a viable treatment showing decreases in eating pathology, lower rates of rehospitalisation at six-month follow-up 
(Juarascio et al., 2013). Positive changes in body image (less judgmental) shift in focus to values rather than body and eating 
(Fogelkvist, Parling, Kjellin, & Gustafsson, 2016). 
Cancer/Health incl. MS 46  Levels of distress and worries of relapse were reduced. Experimental phase (Öst, 2014).   
PTSD/Trauma 42 ACT more efficacious than waitlist and TAU with equal efficacy to CBT (Bean, Ong, Lee, & Twohig, 2017) significant 
improvements in trauma symptoms.   
Weight/Obesity 39  Several studies showed positive results for weight loss using ACT suggesting the therapy’s possible efficacy for this issue (Öst, 
2014).    
Trichotillomania and 
Excoriation  
20 Positive changes in experiential avoidance and cognitive fusion. Still in experimental phase (Öst, 2014).  
Personality disorders 19  Improved levels of functioning (BPD) however still in the experimental phase (Öst, 2014).  
Anger/Aggression 17  Significant reduction in trait anger and psychological rigidity and anger-related behaviours (Plambeck, 2016). Significant reduces 
physical and psychological aggression (Zarling, Lawrence, & Marchamn, 2015).  
Diabetes 18  Increased self-management behaviours (Ruiz, 2010). 
Stigma (excluding substances) 16 Reduction in body image dissatisfaction and weight self-stigma (Griffiths, Williamson, Zucchelli, Paraskeva, & Moss, 2018) 
reductions in stigma and improved outcomes compared to active controls (Krafft, Ferrell, Levin, & Twohig, 2017). 
Epilepsy 15  Experimental phase still (Öst, 2014) preliminary studies found improvements in depression, anxiety, quality of life, self-esteem, 
and work and social adjustment (Dewhurst, Novakova, & Reuber, 2015). 
Insomnia 12 Significant improvement in sleep related quality of life and subjective sleep quality (Hertenstein et al., 2014). Significant 
improvements in sleep interference and sleep efficiency and insomnia severity (Daly-Eichenhardt, Scott, Howard-Jones, Nicolaou, 
& McCracken, 2016) Further research needed.  




Brain injury 12 Feasible therapy in conjunction with other established therapies for brain injury (Whiting, Deane, Simpson, Ciarrochi, & Mcleod, 
2017) Further studies required.  
Tinnitus 6  Probably efficacious (Öst, 2014) 
Work stress  5  Another area that was reported to have possible efficacy however further studies are needed (Ruiz, 2010). 
Note: N = Number of articles published that mention the specific condition being examined with ACT. TAU = Treatment as Usual. MS = Multiple Sclerosis. This includes 
reviews, case studies, randomised control trials, and meta-analyses therefore reviews and meta-analyses for several conditions may come from the same article. Articles 
relating to the application of ACT to SUDs including research on stigma and shame related to SUDs are excluded from this table and will be discussed in detail in the 
following section.  




Research investigating the efficacy of the ACT approach is being conducted with 
increasing rigour, allowing for further support of ACT to emerge as a viable and empirically 
supported therapy for a range of problems. This is evident in the numerous reviews and meta 
analyses that have been completed in the past 15 years. In 2008, Öst published a systematic 
review and meta-analysis of third wave therapies involving 29 studies that were examined for 
efficacy. His findings showed no significant differences between ACT and DBT. Öst (2008) 
also reported that ACT showed no significant differences at post-treatment; however, ACT 
did show significantly positive differences at follow-up. In Öst’s article the methodological 
issues in ACT research are clearly outlined, and he provided a list of 15 recommendations for 
the future studies of ACT. For example, Öst suggested further research should focus on 
comparing ACT to other treatment conditions. The following year, Powers, Vӧrding, and 
Emmelkamp (2009) published a meta-analysis in which the authors appeared to heed Öst’s 
(2008) advice by comparing ACT and TAU/Control conditions using outcome measures 
across a range of problems. Their analyses found that ACT outperformed control conditions 
on both primary and secondary outcome measures and at both post treatment and follow-up 
phases (Powers et al., 2009). Ruiz (2010) further sought to examine the empirical evidence for 
ACT through a review which concluded that ACT is showing efficacy in a wide range of 
psychiatric problems including depression, anxiety, obsessive compulsive disorders (OCD), 
social anxiety disorder (SAD), generalised anxiety disorder (GAD), trichotillomania and 
excoriation, psychosis, and borderline personality disorder (BPD), all of which Ruiz (2010) 
states have a common underlying pattern of experiential avoidance.  
Using updated research on ACT since Öst’s (2008) review, Smout, Hayes, Atkins, 
Klausen, and Duguid (2012) conducted a review that specifically examined randomised 
controlled trials (RCTs) methodology. The authors stated that the ACT research over the 
previous four years had improved. The studies reviewed Smout et al.’s article support the 




efficacy of ACT in promoting improvements via primary outcome measures collected across 
a range of conditions. However, interpretations of primary outcome measures are confounded 
by factors such as concurrent therapies; the effects of these cannot be ruled out (Smout et al., 
2012). In the same year, Ruiz (2012) revisited the ACT literature in an attempt to address one 
of Öst’s (2008) core recommendations of comparing ACT to CBT. This review included 16 
studies of primary outcomes, in 11 of ACT was found to be superior to CBT. The effect sizes, 
in favour of ACT, were small to medium. A further investigation in the mediator and 
moderator effects was conducted by Ruiz (2012) with five additional studies. Ruiz (2012) 
concluded treatment format, type of problem, number of sessions, age, and gender had no 
significant mediating or moderating effects.  
An important consideration when comparing such third wave therapies like ACT and 
CBT is to acknowledge they are from the same therapeutic family but differ in their 
processes. A core difference between the processes of ACT and CBT is what each therapy 
targets as the cause of behaviour (Hayes, 2008). A CBT perspective involves teaching people 
to challenge their unhelpful thoughts and examine the evidence or truth of their thoughts and 
emotions and focuses on understanding how thoughts and emotions influence behaviour. 
Whereas an ACT perspective involves people learning to acknowledge their thoughts and 
emotions as they are, without judging them as good or bad, and are encouraged to reconsider 
what is getting in the way of living in line with their values. People using ACT are 
encouraged to commit to actions that are meaningful to their values regardless of the truth of 
their thoughts (Hayes, 2008).  
Woidneck, Pratt, Gundy, Nelson, and Twohig (2012) examined the cultural 
components and considerations of researchers conducting ACT outcome articles, noting the 
lack of studies clearly outlining demographic information of those involved. This article, 




makes clear the importance of collecting data that accurately describes those that participated 
in the research; this would serve to support the generalisability of ACT across cultures and 
countries (Woidneck et al., 2012). In 2014, Öst revisited and updated the evidence for ACT 
by examining 60 studies utilising ACT across a broad range of somatic and mental health 
conditions. Öst (2014) still concluded that ACT is not a well-established treatment, however, 
he recognised that six years (since his last review in 2008) of further research to support ACT 
may not be enough time to demonstrate its evidence base yet. Admittedly, he did state 
noticeable progress toward empirical support for ACT as summarised in Table 3 above. Öst 
(2014) provides minimal changes to his 15 recommendations for future ACT research. More 
recently, A-Tjak et al. (2015) conducted a rigorous investigation into the efficacy of ACT and 
provided a critique of the shortcomings of previous reviews and meta analyses methodology 
in reviewing ACT studies. The authors argued that many of the studies included were not 
conducted to a high methodological quality. Therefore, A-Tjak et al.’s (2015) sample only 
included 39 studies (RCTs) utilising ACT across a range of psychiatric and somatic disorders. 
Their findings supported the ability of ACT to outperform control, placebo, and TAU 
conditions at both post treatment and follow-up points. However, they reported that ACT was 
not seen as more effective than CBT. This may be due to their strict methodological inclusion 
criteria (for example, they included only seven articles out of the 16 studies included in Ruiz’s 
(2012) analysis). A-Tjak et al. (2015) article also provided further suggestions for future ACT 
research that includes; matching contact hours for TAU conditions, measuring therapist 
competency, monitoring effects of concurrent treatments, and utilising waitlist/placebo 
conditions to provide more substantial support for ACT.  
Applying the development and evidence of ACT to a range of mental and physical 
health conditions together, it can be said that ACT is a promising alternative therapeutic 
approach. This overview of the progression of research shows that ACT is following the same 




path as CBT towards becoming an empirically supported treatment for a variety of disorders. 
While many of the earlier ACT studies have methodological issues, often seen in case studies 
and less rigorous research designs, the trends observed in these are considered indicative of 
true effects that require further well powered and designed future studies that have been 
conducted with CBT. The transdiagnostic nature of ACT lends itself to further application to 
other disorders such as SUDs and has begun to be implemented in more recent research.   




SECTION THREE: Acceptance and Commitment Therapy and Addictions 
This section reviews the literature currently available for ACT and SUDs. This includes the 
theory of development and maintenance of SUDs from an ACT perspective as well as 
outlining the promising research and current empirical status of ACT applied to SUDs.  
An Acceptance and Commitment Therapy Formulation of Substance Use Disorders 
An important aspect to consider in the development and maintenance of SUDs is social 
learning theory developed by Rotter (1982) and modelling as described by Bandura and 
Walters (1963). It is through modelling and contact with the social environment that an 
individual learns to avoid or suppress aversive experience (internal and external). This in turn 
contributes to the development of psychopathology and the continued use of maladaptive 
coping strategies such as substance use (Gifford, 1994 as cited in Hayes et al., 1996). This 
social context is not exclusive to parent roles but also encapsulates the peer group. Andrews, 
Tildesley, Hops, and Li (2002) examined the influence of peers on substance use with 294 
young adults in which the role of peers in using substances was emphasised through 
normative use whilst increasing the chances of developing a SUD. Berkman, Glass, Brissette, 
and Seeman (2000, as cited in Sudhinaraset, Wigglesworth, and Takeuchi, 2016) also noted 
that health is influenced by social networks. This article specifically examined alcohol use 
and the role of the social environment (including home, work, and school) as well as the 
wider social context (society as a whole). Peer pressure in these contexts strongly influences a 
person’s substance use, in that those who associate with other substance using peers increase 
hazardous alcohol consumption (Studer et al., 2013; Patrick et al., 2013, as cited in 
Sudhinaraset et al., 2016).  
While social relationships play a role in the development and maintenance of SUDs 
through social learning theory, Rotter (1966) also suggests that a person’s locus of control is 




another important aspect to consider. People’s belief in their ability to control their lives is 
indicative of how they attempt to solve problems and plays a role in the maintenance of SUDs 
(Soravia, Schläfli, Stutz, Rӧsner, and Moggi, 2015). People’s belief that they have no control 
over their addictive behaviour serves to maintain the SUDs and what type of recovery they 
choose to engage in (Horvath & Yeterian, 2012). Internal locus of control (one’s belief in 
their own control over their life) is preferable to external locus of control (one’s belief that 
others or external influences control their life). An internal belief may give people power to 
direct their lives in the direction they want (Horvath & Yeterian, 2012; Rotter, 1966; Soravia 
et al., 2015). Nikmanesh, Baluchi, and Motlagh (2017) found that external locus of control 
(where people do not take responsibility for their own actions) mediates relapse risk in those 
who struggle with SUDs. In line with this finding, Soravia et al.’s (2015) study 
retrospectively analysed 509 patients’ general control beliefs related to their alcohol use and 
residential treatment. They found that those with low internal locus of control pre-treatment 
had higher risk of alcohol relapse during treatment. Therefore, consideration of a person’s 
sense of control is important within the context of developing a treatment approach for SUDs 
and coexisting problems. If a therapeutic approach can increase a person’s internal locus of 
control it can in turn increase positive outcomes in their recovery. This concept is important 
when considering the role of ACT applied to SUDs and recovery, in that committed action 
and values are core skills that serve to increase a person’s internal locus of control and guide a 
positive road to recovery (Bowen et al., 2006).  
Use of substances is often reported as a way of controlling, suppressing, or avoiding 
unwanted psychological experience (thoughts, emotions, memories, and aversive bodily 
sensations) and other private events such as expectancies and beliefs about the substances and 
cravings (Lee et al., 2015). For example, alcohol is often used as a coping mechanism to 
reduce a person’s experience of anxiety, or it can serve as a way of dulling unhelpful 




thoughts, or it can even be used to address feelings of boredom by increasing pleasure in the 
short term (Cooper et al., 1992 as cited in Hayes et al., 1996). Given that substance use alters 
a person’s experience of aversive private events, high comorbidity rates of SUDs are reported 
in several psychological and physical disorders (e.g., depression, anxiety, trauma, and chronic 
pain) (Hayes et al., 1996). In the instances where substance use does not begin as a strategy of 
experiential avoidance (e.g., those seeking recreational use) this is likely to develop in the 
later stages of use when there is typically a gradual evolution from positive reinforcement to 
negative reinforcement (see Figure 3). This negative reinforcement, often involving dysphoric 
or withdrawal side effects, serves to maintain the pattern of substance use whereby the 
unwanted private events can be suppressed, controlled, or avoided (Hayes et al., 1996; 
Marlatt, 1985). This strategy may work in the short-term and is often reported as a highly 
effective strategy to begin with, but it has a large cost, especially in the long-term.  
When people are struggling with a SUD they are typically not living in line with their 
values (Wilson & Byrd, 2004). A person’s world view often becomes narrowed, in that, his or 
her focus is limited to activities that involve using substances, associating with those who use 
substances, spending excessive amounts of time obtaining the substance, or recovering from 
the effects of the substance (these are some of the DSM-5 criteria for a SUD) (Hayes et al., 
1996; Hayes, Pistorello, & Levin, 2012; Wilson & Byrd, 2004; Wilson, Hayes, & Byrd, 
2000). Therefore, ACT and mindfulness-based strategies serve to decrease the impact of 
triggers, particularly internal (private events) by widening attention. They also promote 
motivational skills and values-based actions towards a life free from the long-term damaging 
effects of addiction. A life aligned with values puts the individual in contact with positive 
reinforcers which serve to increase the likelihood of long term recovery.   
















































Figure 3. Diagram depicting the temporal development of positive reinforcement to 
negative reinforcement often described in the addiction cycle (adapted from Koob, 2013; 



































Current Evidence for Acceptance and Commitment Therapy for Substance Use 
Disorders  
To date, several case studies, numerous RCTs, and now a handful of systematic reviews 
examining mindfulness-based interventions for SUDs have been published. More recently, a 
meta-analysis specifically investigating the effectiveness of ACT in treating SUDs was 
conducted by Lee et al. (2015). The following section dissects the studies, in which ACT has 
been applied to a range of different substances, including smoking, alcohol, methadone, and 
cannabis in different populations (viz., inpatient versus incarcerated settings from around the 
world).  
While it is important for case studies and pilot studies to be conducted in the early stages 
of the development of a new therapy, there are several limitations of such research. These 
studies all show the potential of ACT to treat SUDs; however, the major limitation of this study 
design is the generalisability of the results. Such study designs provide a necessary step towards 
the development of empirical evidence of ACT and all support the further investigation of ACT 
applied to SUDs.  RCTs are typically considered the gold standard for clinical trials to test if a 
treatment is effective (Hamer & Collinson, 2014). More and more RCTs for ACT applied to 
SUDs are being conducted and published with promising results dating back to the early 2000’s. 
Earlier exploratory case studies investigated nicotine, alcohol, methamphetamine, methadone, 
and polysubstance use, reporting results that support the application of ACT with SUDs.  
 Alcohol. A single case study utilising the values component of ACT was conducted 
with a man suffering from alcohol dependence (Heffner, Eifert, Parker, Hernandez, & Sperry, 
2003). The treatment included 21 sessions, whereby at the nine-month follow-up sobriety was 
achieved and maintained with only minor relapses reported. One RCT focused on treating 
people suffering from comorbid alcohol use and depressive disorders through individual 




sessions of either ACT or TAU (in the context of a 12-step programme). Their results showed 
that those in the ACT group were able to meet criteria for discharge from the inpatient unit 
quicker than the TAU group and reported a reduction in symptoms of depression and 
experiential avoidance (Petersen & Zettle, 2009). These results were reflected in a recent pilot 
study by Thekiso et al. (2015) where the effectiveness of ACT for comorbid alcohol and mood 
disorders was investigated. Participants were assigned to either ACT or TAU groups via a 
matched pilot design. The results also showed a reduction in mood symptoms and more days 
abstinent from alcohol use in the ACT group (Thekiso et al., 2015), thus providing support for 
effective treatment of comorbid problems alongside SUDs. These studies support the 
applicability of ACT to such common comorbid conditions.  
Bowen et al. (2006) investigated the effect of mindfulness meditation on alcohol related 
locus of control. While this study did not examine ACT specifically, ACT incorporates 
mindfulness-based skills and the authors found that such meditation behaviour increased 
participants’ internal locus of control post-treatment. This relationship was significant and 
demonstrated that drinking related locus of control reduced following mindfulness behaviours. 
These findings support the examination of locus of control via an ACT based intervention that 
may support the reduction in alcohol use. Vieten, Astin, Buscemi, and Galloway (2010) did not 
use ACT per se but investigated the role of acceptance and mindfulness techniques for alcohol 
dependence and found significant improvements across mood, stress, and overall wellbeing, 
and a trend in the data indicative of reductions in cravings post- treatment. Further support for 
ACT reducing alcohol use and cravings, stress, and changing participants locus of control and 
mood is provided in a dissertation by Crispin-Morrall (2013). The author examined an ACT-
based intervention within the NZ Army context investigating alcohol use and substance use 
with common coexisting problems: aggression, anxiety, stress, locus of control, and emotional 
management. This investigation compared 85 military personnel at pre and post assessment 




points. Findings supported the use of an ACT-based intervention for the range of common 
comorbid problems, showing significant reductions in alcohol use, verbal aggression, perceived 
stress, and anxiety as well as reducing perceptions of external locus of control. These 
preliminary results were later included in a larger, more recent study by Harvey, Henricksen, 
Bimler, and Dickson (2017), in which 275 military personnel were examined in a pre-post 
investigation with the ACT-based intervention for alcohol consumption, aggression, anxiety, 
stress, external locus of control and emotional management. The authors found that compared 
to the waitlist control group the ACT intervention showed greater reductions in alcohol use and 
coexisting problems including external locus of control, as well as improvements in mood 
management. These studies provide substantial evidence that ACT is a beneficial approach to 
use with those who struggle with alcohol use amongst other common comorbid problems.     
Nicotine and Smoking Cessation. So far, seven studies have been published and 
support the efficacy of ACT for smoking cessation. Gifford et al. (2004) conducted a RCT 
comparing ACT and pharmacological treatment for nicotine dependence. They found better 
results for the ACT group, with long-term smoking cessation being twice as likely compared to 
the medication group. A similar study investigating the effectiveness of combining medication 
with an ACT-based treatment showed similar results: the joint treatment was significantly better 
than the medication alone for smoking cessation (Gifford et al., 2011). These studies suggest 
ACT has long-term effectiveness in treating nicotine dependence through reported abstinence 
rates. 
Comparison studies between CBT and ACT applied to nicotine dependence has also 
been examined with findings further supporting the use of ACT for smoking cessation. The 
quasi-experimental design demonstrated the feasibility of ACT for effective treatment of this 
population, with a reportedly five times higher abstinence rate in relation to the CBT group 




(Hernández-López, Luciano, Bricker, Roales-Nieto, & Montesinos, 2009). Other strategies 
used to cope with the cravings associated with nicotine use are suppression of thoughts about 
smoking. One study examined the effects of acceptance-based and suppression-based strategies 
in a sample of adult smokers. Both coping strategies (acceptance and suppression) were 
compared to a control group that were given no instructions for dealing with quitting smoking. 
Interestingly, acceptance and suppression groups reported benefits for coping with the cravings 
and mood associated with smoking cessation compared to the control group (Litvin, Kovacs, 
Hayes, & Brandon, 2012). These studies suggest some forms of coping strategies are better than 
none and that ACT is equally as effective for treating nicotine dependence as CBT.  
The treatment of nicotine dependence with ACT continues to grow from telephone 
delivered ACT-based therapy (Bricker, Mann, Marek, Liu, & Peterson, 2010) to, more recently, 
a web-based ACT intervention for smoking cessation that was developed and tested in 2013. 
Researchers found that participants randomly assigned to this group spent significantly longer 
on the ACT website compared to those randomly assigned to the standard smoke-free website 
spent there. The pilot study design of this research showed promising results for ACT. Further 
follow-up was recommended to determine the long-term efficacy of ACT through an internet-
delivered intervention (Bricker, Wyszynski, Comstock, & Heffner, 2013). In the same year a 
further two studies investigating the application of ACT to smoking cessation were published. 
Brown et al. (2013) used an ACT-based treatment called Distress Tolerance (DT)3 compared to 
Standard Treatment (ST) for nicotine dependence. In a sample of adult smokers with a history 
of early relapse this study found the DT group to have larger reductions in smoking. Russell 
(2013) also reported higher rates of abstinence for adult smokers at a six-month follow-up 
compared to a cognitive behavioural skills training group. Bricker et al.’s (2013) 
                                                          
3 Distress Tolerance in this article is derived from concepts from two therapies; behavioural exposure therapy 
and ACT as described in the pilot study by Brown et al (2008) rather than distress tolerance from DBT.   




recommendation for further research was followed up in 2014, this time examining an ACT-
based treatment via a smartphone for smoking cessation. The results showed higher rates of use 
for the ACT application and higher rates of quitting smoking compared to the National Cancer 
Institute’s application for smoking cessation (Bricker et al., 2014). A second study using an 
updated version of the smartphone application was evaluated in 2017 that reported higher 
reductions in smoking compared to the original smartphone version’s study in 2014 (Bricker et 
al., 2017). Jones, Heffner, Mercer, Wyszynski, and Bricker (2015) used data collected from 
Bricker et al.’s 2013 study and examined the web-based ACT-based therapy for people who 
struggle with depression and smoking. The results showed that the ACT-based intervention 
reduced depressive symptoms and smoking urges, demonstrating how ACT can be used across 
disorders. While the above-mentioned studies show positive and promising results for ACT 
applied to nicotine dependence, they all stress the need for further studies with larger sample 
sizes and longer follow-up periods to ascertain the efficacy of ACT in the long-term treatment 
of smoking cessation. This literature also supports ACT as a transdiagnostic approach for an 
addictive behaviour and mental health problems such as mood disorders.  
Methadone. The applicability of ACT to the treatment of people on a methadone 
maintenance programme was examined through a RCT comparing ACT with a 12 step 
programme (Hayes, Wilson, Gifford, Bissett, Piasecki et al., 2004). Both groups (ACT and 12 
step programme) showed an additional positive effect compared to methadone maintenance 
alone. Although no significant differences were found between the additional treatments, the 
ACT group did report less substance use at the six-month follow-up ( Hayes, Wilson, Gifford, 
Bissett, Piasecki et al., 2004). Methadone detoxification and the effectiveness of ACT on this 
process was also investigated through an initial case study by Stotts, Masuda, and Wilson 
(2009), with initial findings reiterating the need for of larger ACT applied to methadone 
detoxification studies to support their findings. Therefore, in 2012 a RCT (Stotts et al., 2012) 




using ACT was compared to TAU (drug counselling) in a six-month methadone dose reduction 
programme. As in Hayes, Wilson, Gifford, Bissett, Piasecki et al.’s (2004) study above, similar 
results were found in the rates of successful detoxification of methadone at the end of the 
treatment compared to TAU (37% versus 19%, respectively) (Stotts et al., 2012). Both studies 
investigating ACT in the treatment of methadone-related substance use show promising results 
for ACT efficacy for this substance use group. Further support for ACT and methadone, in 
particular for cravings, was reported in a study by Saedy et al. in 2018. The authors reported 
ACT was successful in reducing methadone cravings and supported methadone dose-reduction 
which was in line with previous research.  
Methamphetamine. Smout et al. (2010) tested whether ACT would increase treatment 
attendance and reduce methamphetamine use compared to CBT. Both groups received either 
ACT or CBT for 60-minute weekly individual sessions over 12 weeks. Although results did not 
show significantly greater reductions in methamphetamine use or negative consequences of use 
for the ACT group compared to CBT, ACT was found to be on par with CBT. Treatment 
attendance also did not differ between groups and both reported a high attrition rate. The authors 
suggest further studies are needed to ascertain the potential ACT has as an alternative to CBT 
for this substance problem (Smout et al., 2010).  
Cannabis. A case study using ACT involved three adults who struggled with their 
cannabis use (Twohig, Shoenberger, & Hayes, 2007). Through a multiple baseline across 
participants design, this study reported that ACT aided the reduction of cannabis use for all 
three participants. One participant reported full abstinence from cannabis at the three-month 
follow-up and all three reported a reduction in symptoms of depression, anxiety, and withdrawal 
(Twohig et al., 2007). Again, highlighting the transdiagnostic nature of ACT.  




Polysubstance and general substance use diagnosis. The experience of shame and 
stigma related to substance use is an ongoing issue for people who suffer from alcohol and drug 
problems. A study that targeted the experience of shame in SUDs utilised ACT in the hopes of 
addressing difficult feelings associated with substance use compared to a TAU group via a 28-
day residential programme (Luoma et al., 2012). Results after treatment showed higher levels 
of attendance in an outpatient capacity for the ACT group and reduced substance use. Shame 
was reduced in both ACT and TAU groups, however, the initial post group reduction in 
substance use increased at follow-up. Although, the TAU group showed higher reports of 
substance use than the ACT group (Luoma et al., 2012). This study demonstrated the efficacy 
of ACT in reducing substance use as a secondary effect of the intended treatment for reducing 
shame associated with SUDs. Livingston, Milne, Fang, and Amari (2012) systematically 
reviewed the specific role of ACT in reducing stigma and shame for SUDs using over 13 
studies. The studies examined provided limited evidence that self-stigma related to SUDs can 
be reduced via group-based ACT treatment. The importance of such research into self-stigma 
and shame, specifically in the AOD population, is that the experience of shame can act as an 
intense internal trigger for continued substance use. Therefore, a therapy that serves to reduce 
the impact of internal experiences of shame and self-stigma is likely to decrease an individual’s 
drive to engage in substance use and experiences of other mental health problems commonly 
observed in the AOD population.  
ACT was also applied to treat SUDs in the context prison through a RCT design (Lanza 
& González Menéndez, 2013). This larger study provided a large female prisoner sample that 
several other articles examined different aspects of the overall data, such as the long-term 
outcome of ACT applied to drug problems in a female prison (González-Menéndez, Fernández, 
Rodríguez, & Villagrá, 2014) and ACT compared to CBT for the same sample (Lanza, García, 
Lamelas, & González-Menéndez, 2014). The authors from the RCTs suggested ACT has 




potential for an alternative treatment of SUDs. More specifically, results from González-
Menéndez et al. (2014) demonstrated the long-term effectiveness of CBT and ACT for this 
population through a reduction of substance use and associated mental health problems 
compared to a waitlist control group. Lanza et al. (2014) further examined the differences in 
long-term efficacy of ACT compared to CBT. This study found no significant differences 
between ACT and CBT at the 18-month follow-up. The authors still suggest that ACT is an 
adequate treatment option for this particular population (Lanza et al., 2014). Just last year, 
another pilot study was conducted assessing an ACT-based treatment for severe SUDs 
(Svanberg, Munck, & Levander, 2017). Eighteen participants who were institutionalised under 
the Care of Alcoholics and Drugabuser Act were administered measures of mental health, 
psychological flexibility, and executive dysfunction, pre and post intervention. Their results 
indicated no change in mental health measures post intervention; however, they noted trends of 
improved psychological flexibility and executive functioning including emotional control, 
tasking monitoring, and inhibition. No measures of substance use or cravings were conducted 
in this study. Like many of the ACT studies applied to SUDs this was a pilot study that had no 
comparison or matched control groups; therefore, the generalisability of this study was limited 
and underpowered. The authors, like many others, suggest larger, well powered studies are still 
needed to establish stronger evidence of ACT applied to SUDs.   
  




Table 4.  
Summary of Published Articles for Acceptance and Commitment Therapy for Substance Use Disorders.  
Substance  
Author(s)  
N Study type 
 
Intervention Outcomes/Important findings Limitations 
Smoking cessation 
(Nicotine) 
     
Gifford et al. (2004) 76 Randomise
d pilot 
study 
ACT versus NRT No difference post treatment. One year follow ACT had 
better long-term smoking outcomes due to improvements in 
acceptance related skills. 
Larger and more powerful 
replication study needed to support 
this study’s preliminary results 
Brown et al. (2008) 16  Pilot study  Exposure and ACT-
based distress 
tolerance  
Early lapse smokers were able to remain quit for longer 
than previously reported. Full relapse did not occur until 
later and participant continued to make efforts to quit. 






ACT versus CBT ACT treatment deemed feasible and equivalent to CBT 
treatment. Follow-up data showing superiority over CBT 
(30% ACT versus 13% CBT). Shows promising evidence 
for ACT.  
Replication in well powered, 
randomised, control trial needed 







Results showed positive direction and suggestive evidence 
for 12-month abstinence from smoking.  
Small sample size. Well powered 
study needed. 




Combined treatment significant better than bupropion 
alone. Data provides preliminary support for acceptance 
components which mediated the effects of combined 
treatment on smoking status. 
Intent to treat analysis. 
Generalisability restrictions due to 
strict inclusion criteria. 




Both coping strategies associated with benefits for cravings 
affect and this was maintained at three-day follow-up. 
Brief interventions. More research 
needed to differentiate acceptance 
benefits from suppression. 
Acceptance skill not taught properly. 
Motivational factors. Short follow-
up.  





Distress tolerance (DT) were 6.46 times more likely to be 
abstinent from smoking with medium to large effect sizes. 
DT reported larger decrease in experiential avoidance.  
Strict exclusion criteria of 
comorbidities. Small sample size. 
Total contact time greater for DT. 
DT combined with nicotine patch. 




Bricker et al. (2013)  222 
 




site (Smokefree.gov)  
Longer time spent on ACT website and were more satisfied 
with the site. Double the ACT participants had quit 
smoking at three-month follow-up. Acceptance of physical, 
cognitive, and emotional cues to smoke mediated results.  
Pilot – limited follow-up 
Bricker et al (2014) 196 RCT pilot ACT smartphone app 
version one 
(SmartQuit) versus 
US Clinical Practice 
guideline 
(QuitGuide) 
ACT app used more than other app. Overall quit rates 
higher for ACT app. Quitting rates associated with 
acceptance of cravings.  
Small sample size.  
Jones et al. (2015) 
Data used from 
Bricker et al. (2013) 
94 RCT ACT WebQuit.org 
versus 
Smokefree.gov 
Investigated smokers with depressive symptoms. 45 
participants completed three-month follow-up. Results 
showed preliminary evidence of lower depressive 
symptoms at follow-up and higher quit rates and acceptance 
of internal cues to smoke.  
Underpowered  
Bricker et al (2017) 99 Single-arm 
study  
ACT smartphone app 
version two 
Results showed high user receptivity, modest quit rates, 
high rates of smoking reduction. Higher user satisfaction, 
similar quite rates, and higher reductions in smoking than 
version one (Bricker et al., 2014) 
Small sample size. No comparisons 
made. Short follow-up period. Self-
report measures used as biochemical 
verification of abstinence is 
impractical and unnecessary.  
Methadone/Opioids      
Hayes et al. (2004) 138 Randomise
d pilot 
study 
MMT alone versus 
MMT with ACT 
versus MMT with 
ITSF 
ACT condition showed lower opioid and total drug use at 
follow-up with both objective and subjective measures. 
Both conditions were more effective than MM alone 
condition. No significant differences on secondary 
psychological and social measures.  
Intent-to-treat analysis  
Attrition rates – large dropouts in all 
conditions – ACT dropouts stabilised 
after two weeks of the programme.  




Client remained abstinence as measure by urine samples 
post treatment and a follow-up point. No significant 
changes in depression or experiential avoidance scores 
(BDI II and AAQ) 
Client was 57 years old so more 
likely to achieve abstinence from 
drug compared to younger age 
groups.  








No difference in opioid use during treatment. ACT group 
had higher rates of successful detox at post treatment. Fear 
of detoxification was also reduced in the ACT condition. 
Small sample size. Therapy training 
time was greater for the ACT 
condition potentially creating an 
allegiance bias.  












MMT and ACT 
versus control group 
only MMT 
Treatment group significantly decreased methadone dosage 
across assessment phases. Significant reduction in craving 
beliefs in treatment group.  
Strict exclusion criteria of no 
comorbid diagnoses and not under 
any other form of psychotherapy or 
using other substances. Methadone 
confounding factor on cravings. 
Small sample size. Longer follow-
up.   
Alcohol       
Heffner et al. (2003) 1 Case study Values component of 
ACT  
Alcohol dependence treated with ACT-based values work 
resulted in improved quality of life and near 100% sobriety 
at follow-up 
Case study limited generalisability of 
results.  





ACT versus. TAU 
within 12 step 
programme context 
Alcohol and depressive symptoms showed significant and 
equivalent reductions in depressive symptoms were 
observed for both ACT and TAU. ACT group met 
discharge criteria within shorter period with less time spent 
in therapy which supports ACT’s time efficient and cost-
effective qualities over TAU. 
Small sample size. No measure of 
alcohol use during and post 
treatment.  




ACT and TAU 
versus Control  
Alcohol use disorder and comorbid affective disorders 
results showed retention rates higher for ACT condition 
(100%) at follow-up. ACT had higher abstinence duration, 
significantly lower depressive symptoms and anxiety 
symptoms and significantly lower cravings and 
improvements sustained at follow-up. 
Small sample size limiting 
generalisability. Higher educational 
background and family history of 
psychiatric disorders in ACT group. 
Lack of parallel treatment for both 
groups. Use of historical control 
group. 







Showed greater reductions in alcohol consumption, 
aggression, anxiety, stress, and perceptions of others being 
responsible for their circumstances, improvement in 
emotion management compared to the waitlist.  
Small sample size, no active 
comparison group 
Cannabis       







ACT for marijuana 
dependence 
Abstinence from marijuana achieved at posttreatment 
confirmed by oral swabs. Three-month follow-up 
maintained abstinence for one participant with the other 
two reporting lower levels of use. Depression, anxiety, 
withdrawal symptoms, and experiential avoidance 
improved.  
Baseline length an ethical issue. 
Questionable quantity of use for self-
monitoring use. Mixed treatment 
goals i.e. abstinence versus 
moderation non-consistent 
assessment with AAQ.  Formal 
diagnosis not used.  
Methamphetamine       




Smout et al. (2010) 104 Preliminar
y RCT 
ACT versus CBT  No significant differences between treatment group 
attendance. Methamphetamine use, negative consequences, 
and dependence severity improvement in both groups. ACT 
seen as a viable alternative to CBT for methamphetamine 
use disorders.  
High attrition rates and missing data 
and underpowered.  
Stigma/Shame       
Luoma et al. (2008) 88 Pilot study ACT-based treatment 
for self-stigma for 
SUDs 
Medium to large effects across several variables at post 
treatments such as internalised stigma and shame 
decreased. Also found significant reductions in experiential 
avoidance and was highly correlated with internalised 
shame.  
Lack of control group – no mediation 
analysis. Self-report measures, lack 
of follow-up and concurrent 
nonspecific treatment.  
Luoma et al. (2012) 133 RCT ACT group-based 
intervention versus 
TAU targeting shame 
for SUDs 
ACT intervention showed smaller immediate gains in 
shame but larger reductions at four-month follow-up. Fewer 
days of substance use and higher treatment attendance at 
follow-up.  
Intent to treat analysis – missing data 
at follow-up. 
Difficult to characterise TAU 
Shame versus guilt debate  
Substance use 
disorders 
     
Batten & Hayes 
(2005) 
1 Case study ACT for comorbid 
substance abuse and 
PTSD 
By 12 months into therapy scores fell below the cut-offs for 
significant distress and these gains were maintained until 
the end of treatment. Began abstinence from substance at 
month 7 of therapy and maintained to completion of 
therapy.  
Limited generalisability. Abstinence 
due to pregnancy additional 










16 ACT sessions found 27.8% abstinence rates with 
accumulate effects at follow-up 43.8% abstinence rates 
(incubation effect). ACT also promoted improvement in 
comorbid psychopathology and anxiety sensitivity and 
increased psychological flexibility. ACT is an effect and 
appropriate treatment in prison context for SUDs. 
No guidelines for ceasing drug 
consumption were provided. Small 
sample size.  
González-Menéndez 
et al. (2014) 
 
37 RCT ACT versus CBT Long-term (18-month follow-up) outcomes of ACT was 
better than CBT in maintaining abstinence rates.  
Participants chronicity and 
polysubstance use, loss of 
participants due to transfers, small 
sample size, lack of therapist 
adherence measure.  
Lanza et al. (2014) 
(Full data set) 
50 RCT ACT versus CBT for 
incarcerated women 
with SUDs 
Posttreatment results favoured CBT over ACT for reducing 
anxiety sensitivity however at follow-up ACT was more 
effective at reducing substance use and improving mental 
health.  
Small sample size. Potential bias due 
to therapist not being blind.  









ACT versus other 
treatments 
Aggregate effect size analysis found significant small to 
medium effect size favouring ACT relative to active 
treatment comparisons. Other treatments included CBT, 
pharmacotherapy,12 step, TAU.  
Process of change means - determine 
how ACT improves substance 
abstinence not measured. Quality of 
life or psychosocial functioning not 
measured. Lack of cultural diversity 
limits generalisability. 
Underpowered studies. Some did not 
include post or follow-up 
assessment. Intent to treat outcomes 
conservative. Small sample size. 
Svanberg et al. 
(2017) 
18 Pilot study ACT intervention No change in mental health and a trend implying positive 
changes for psychological flexibility for 9/10 executive 
functions.  
Underpowered, small sample size. 
No follow-up data.  
Note: ACT = Acceptance and Commitment Therapy, CBT = Cognitive Behavioural Therapy, NRT = Nicotine Replacement Therapy, FAP = Functional Analytic 
 Psychotherapy, ITSF = Intensive 12 Step Facilitation, TAU = Treatment As Usual, DT = Distress Tolerance, ST = Standard Treatment, SUD = Substance Use 
 Disorder, RCT = Randomised Control Trial.




Reviews and meta-analyses of Acceptance and Commitment Therapy and 
Substance Use Disorders. Chiesa and Serretti (2014) specifically investigated mindfulness-
based interventions for SUDs via a systematic review which supported the use of third wave 
therapies such as ACT to treat SUDs. Several positive outcomes were associated with the 
implementation of mindfulness-based interventions such as reduced consumption of substances 
(including alcohol, tobacco, marijuana, opioids, amphetamine, and cocaine) as well as reduced 
cravings, and an overall improvement in mindfulness. They noted the implications of 
neuroimaging studies that find brain structure and activity changes with regular mindfulness 
practice. This in turn is associated with reduced mental ruminations, which may function as a 
way of reducing the rates of relapse via diminishing reactions to substance craving cues. 
However, as the other studies outlined, the authors stress the need for more rigorous and larger 
scale studies to support these findings. 
A recent initial meta-analysis examined the aggregated effect sizes of ACT compared 
to other treatments (including CBT, 12 step facilitation, pharmacotherapy, and TAU) using 
ten substance use outcome studies outlined above (Lee et al., 2015). Although the research in 
this area is preliminary, the authors observed potential trends in the data to guide future 
research. They concluded that ACT is a promising alternative for treatment of SUDs. More 
specifically, the authors found a significant small effect size (g = .29) for ACT compared to 
control conditions at post-treatment. Follow-up data from the ten studies examined showed 
that ACT had a small to medium effect size, supporting the long-term efficacy of ACT in 
continuing to promote positive change over time. Another noteworthy finding of this meta-
analysis was that the average attrition rate was lower for ACT compared to other 
psychotherapies from pre to post treatment (Lee et al., 2015). However, it is acknowledged 
that more studies are needed to make it an empirically supported treatment option, particularly 
studies that address the limitations in the previous research. Since then, ACT is still being 




investigated via systematic reviews and meta-analyses to provide further evidence of its 
potential benefits to SUDS. Barrett and Chang (2016) reviewed behavioural interventions, 
including ACT, for comorbid problems chronic pain, depression, and SUDs in the context of 
primary health care. The authors report that ACT, as well as other mindfulness therapies and 
interpersonal therapy, showed promising results with small to moderate effects observed; 
however, this was in comparison to TAU and not an active comparison group. The authors 
also examined for publication bias and found no systematic bias, supporting the integrity of 
the research published (Barrett & Chang, 2016).  
Summary of the evidence. The preliminary nature of the majority of studies on ACT 
and SUDs means further investigation into the efficacy of ACT is needed to confirm findings 
(Bricker et al., 2013; Brown et al., 2013; Gifford et al., 2004; Hayes et al., 2004; Hernández-
López et al., 2009; Russell, 2013; Smout et al., 2010). The main limitations discussed in the 
literature include small sample size, high attrition rates, therapist bias and training, short follow-
up periods, and TAU complexities acting as moderators (Bricker et al., 2013; Brown et al., 
2013; González-Menéndez et al., 2014; Hayes et al., 2004; Hernández-López et al., 2009; Lanza 
et al., 2014; Litvin et al., 2012; Petersen & Zettle, 2009; Russell, 2013; Smout et al., 2010; 
Stotts et al., 2012).  Some of the literature reported investigations of comorbid conditions such 
as alcohol and depression did not use any alcohol use outcome measure post-treatment 
(Petersen & Zettle, 2009) and further, some studies did not have a follow up assessment phase 
(Luoma et al., 2008; Svanberg et al., 2017). Of note, the reviews and meta analyses found no 
publication bias for ACT (Lee et al., 2015) and in general ACT was found to be just as effective 
as CBT for SUDs and superior to control groups such as waitlists, intent to treat and TAUs.  
  




SECTION FOUR: The Current Study Rationale and Objectives 
The present study is an attempt to design, develop, deliver, and evaluate the 
effectiveness of a pilot manual for ACT applied to SUDs in a group treatment programme in a 
community sample in NZ (Palmerston North). Group interventions for people with complex 
problems, including SUDs, have shown to be effective in time and cost. While group therapy 
has been reported as effective as individual therapy, group formats provide an opportunity for 
services to provide high intensity (several hours per week) treatment to several people at once 
(rather than one at a time) (Barrett & Chang, 2016; Corey, Corey, & Corey, 2013). Research 
supports the use of and demonstrates improved outcomes of group-based interventions 
compared to wait list controls or no treatment, specifically for ACT (Öst, 2008; 2014; Ruiz, 
2010; 2012). The specific benefits of delivering an ACT treatment programme through a group 
format include its interactive process through exercises, and group discussions. Support, 
validation, increased self-awareness, and better understanding through different perspectives 
can all be harnessed through the group format (Walser & Pistorello, 2004). Self-stigma may 
also be reduced through group interventions specifically for SUDs, as it allows those who 
similarly struggle to share and learn from each other (Livingston et al., 2012), which support 
the use of group formats with ACT.  
In the initial stages of the study design a randomised control trial was originally planned. 
However, discussions with the Palmerston North AOD service indicated that this was 
untenable. Given this was a real-world trial in a functioning AOD service, the notion of a RCT 
was considered disruptive to service delivery. Other issues with implementing a RCT was the 
amount of time and resources required to conduct such a study, as they typically involve highly 
selected participants with a single diagnosis that is not typical of the AOD Service clientele (it 
is a service that supports dual diagnosis). RCT’s are notoriously difficult to conduct in regular 




government funded services due to the funding priority towards the provision of services and 
not for the purposes of conducting empirically sound research; therefore the current study was 
conducted in what is best described as a real-world setting with realistic and achievable research 
designs in the community. There was also a barrier for collecting data for a TAU comparison 
group as this would require AOD staff or the lead researcher to administer the protocol of 
measures. Research requiring such a large number , approximately 120, of participants was 
unlikely, particularly given the number of participants and groups needed to be recruited, 
completed treatment, and assessed at follow-up within the two-year research project time frame.   
Other comparison groups were also considered to allow a mixed factorial design 
approach. Two comparison groups were approached, a Mindfulness-Based Relapse Prevention 
group also conducted by the AOD service, and a Cognitive Behavioural Therapy Group for 
Anxiety Disorders conducted by another DHB. The latter service ran two groups in 2016 and 
attempted to collect data using the protocol of measures for the current research. However, due 
to significant attrition rates and missing data for mid-group assessments, this comparison group 
could not be included in the current study. The Mindfulness-Based Relapse Prevention group 
was scheduled to start in 2016. However, the failure of this group to begin meant the ACT group 
programme for SUDs ran without any comparison groups. Therefore, the current study chose a 
repeated measures methodology as the preferable study design to assess the ACT group 
participants at pre, mid, post, and follow-up phases. Repeated measures design allows 
researchers to examine the effects for the same participants at different times, providing a 
snapshot of change, commonly at pre and post treatments. This research design also allows for 
greater statistical power relative to sample size which is essential in real-world research 
circumstances (Minke, 1997; Stevens, 2012). These reasons provided the rationale for 
conducting repeated measures for the ACT groups conducted in the current study.   




Evaluation of the group treatment programme and monitoring clients’ progress using 
repeated measures methodology (pre-treatment, mid-treatment, post-treatment, and follow-up) 
is considered appropriate in real-world settings and enables service provision to be evaluated 
while the service continue to operate as usual. The current study includes post and follow-up 
measures as recommended by several reviews and meta-analysis to increase methodological 
stringency (Lee et al., 2015; Ost 2008; 2014). This research also makes use of treatment 
fidelity checklists and follows a manual to account for treatment integrity. Specifically, the 
research had a two-pronged purpose to assess both the use of alcohol and other drugs, 
including substance cravings as well as use, and to assess coexisting problems via perceived 
stress, anxiety, locus of control, and mood management. An additional aspect investigated 
was mindfulness tendencies. These measures were included to help the author answer the 
following research questions: 
Research question one: Does an ACT-based group treatment programme reduce 
participants’ self-reported alcohol use and substance use and cravings at the end of the 
treatment (post-group) as well as the three-month follow-up? This reduction is expected 
to gradually occur over the course of the group programme, evidenced by reductions at mid-
group, post-group, and follow-up assessment points.  
Similar findings of such reductions have already been reported. Although preliminary 
the research outlined above demonstrates an ACT based treatment can reduce smoking, 
methadone, cannabis, and methamphetamine use. Alcohol has not been the focus of many 
studies utilising ACT. Nevertheless, it is still expected that there will be a decrease in use as a 
function of completing the current study’s group programme.  
Research question two: Does an ACT-based group treatment programme reduce 
common SUDs coexisting problems such as perceived stress, anxiety, and external locus 




of control and does an ACT-based group treatment programme enhance internal locus 
of control, resistance to peer pressure, and mood management? It is expected these 
changes will be gradually occurring over the course of the group, evidenced by changes 
observed at mid-group, post-group, and follow-up assessment points.  
Lee et al. (2015) recommended that secondary outcome measures targeting common 
coexisting problems like anxiety need to be assessed alongside SUDs. Therefore, the current 
study uses such measures to obtain outcomes on the level of perceived stress, anxiety, locus 
of control, resistance to peer influence, and mood management.  
Research question three: Given mindfulness is a core ACT strategy, would the 
self-reported use of mindfulness techniques be significantly related to improvements in 
coexisting difficulties and reductions in alcohol and other drug use and cravings? It is 
expected that participants will report an increase in mindfulness over the course of group 
(observed at mid-group, post-group, and follow-up assessment phases) and that significant 
relationships would be evident between mindfulness scores and all other dependent variables 
(alcohol use, substance use and cravings, perceived stress, anxiety, locus of control, resistance 
to peer pressure, and mood management).  
The current study’s contribution to the existing literature. As the literature 
demonstrates, previous studies have been tightly controlled, often excluding participants with 
multiple problems from testing the effectiveness of new therapies. The current study is an 
exception, navigating the complexities of outpatient group treatment to provide a more 
realistic understanding of ACT-based therapy. Applied within a DHB AOD Service in NZ, 
this study builds on previous AOD-based research in NZ that has applied ACT interventions 
to coexisting mental health problems (Crispin-Morrall, 2013; Harvey et al., 2017), adding 
both depth and breadth. This previous research has offered a reference point into ACT-based 




group therapy effectiveness, by examining military personnel over the course of a one-week 
ACT-based intervention. The current study takes a step further, assessing the effectiveness of 
a community-based group treatment over a 10-week period. An innovative approach to group 
treatment, the programme was conducted within a DHB service that sees frequent comorbid 
presentations of SUDs and mental health disorders. As such, this research also contributes to a 
growing evidence base for the use of ACT therapy for SUDs and associated issues. The 
uniquely real-world design of this study, over an extensive test period, thus adds new 
dimension to the current ACT research landscape. The findings will contribute significantly to 
understanding the feasibility of ACT group therapy approaches for both SUDs and comorbid 
mental health problems. 
 







The methods chapter describes how the research was implemented by outlining the 
pathway for the participants involved, the protocol of measures, and the treatment manual and 
materials, as well as describing the research procedures, ethical considerations, and the 
research design and data analysis. 
Participants 
Recruitment. The participant sample was drawn from the Alcohol and Other Drug 
(AOD) Service in Palmerston North, NZ, with recruitment occurring from May 2016 to 
August 2017. A service wide presentation of the proposed group treatment programme was 
conducted by the author and all AOD staff were provided information brochures to distribute 
to potential participants (see Appendix A). Information brochures were also provided in the 
AOD waiting room. Participants were referred by their AOD case managers to the group 
facilitators (the author and a Senior Clinical Psychologist from the Palmerston North AOD 
service) on a voluntary basis for an initial assessment and completion of pre-group 
questionnaires.  
Inclusion and exclusion criteria. Given that the research study was embedded within 
the AOD service, participants had met the referral requirements for the service, that is, they 
were struggling with significant substance use issues and related coexisting problems and/or 
were on the Opioid Substitution Programme (Methadone/Suboxone). Additional inclusion 
criteria for the group involved 1) being aged between 18 and 66 years old, 2) capacity to 
engage with the group (e.g., the participants can be sober and not under the influence of 




substances for the duration of the group session4, 3) be willing and motivated to attend the 
proposed group treatment programme including assessment points.  
The general exclusion criteria involved those who were 1) experiencing active and 
severe depression, significant suicidal ideation or behaviours, PTSD symptoms, and/or 
psychosis that were considered to have a possible derailing effect on the group, 2) active 
withdrawal from substances not supported by a withdrawal management plan, 3) personality 
disorders that could significantly interfere with group dynamics and processes, and 4) current 
legal charges preventing ability to complete the group treatment programme. Exclusion 
criteria were considered on a case by case basis given the nature of research conducted in a 
real-world setting. This flexible approach allowed participants to be included in the study on 
the provision that adequate support and management plans were in place for those with 
significant depressive, suicidal ideation, PTSD, psychosis, or personality disorders and legal 
problems and to reduce the likelihood of significant derailment of the group.  
Sample size and attrition rates across groups. Four group treatment programmes 
were conducted over the period of May 2016 to February 2018 (including follow-up). Across 
all four groups, an initial sample size of 39 participants, aged between 18-66 years old, 
completed the pre-group assessment. This number reduced at the mid-group assessment point 
to 26, with further reductions at post-group assessment (n=25) and follow-up (see Figure 4 
below), leaving a final sample size of 20. 
  
                                                          
4 This was based on the case managers and group facilitator’s clinical judgement in conversation with the 
participant.  







Figure 4. Study flow diagram and attrition rates. 
Completed mid-group assessment (n= 26) 
Group 1 (n=8) Group 2 (n= 7) Group 3 (n=6) Group 4 (n=5) 
Withdrew prior to 
start date due to 
another course 
(n=1) 
Withdrew at Session 
3 due to work 
commitments (n=1) 
Withdrew prior to 
start date (n=1) 
Withdrew prior to 
start date (n=2) 
Withdrew prior to 
Session 5 due to 
gaining work (n=1) 
 Withdrew due to 
work commitments 
(n=2) 
Withdrew at Session 
3 due to other 
commitments (n=1) 









Completed post-group assessment (n= 25) 
Group 1 (n=8) Group 2 (n= 6) Group 3 (n=6) Group 4 (n=5) 




Completed three-month follow-up-group assessment (n= 20) 
Group 1 (n=8) Group 2 (n= 4) Group 3 (n=4) Group 4 (n=4) 
 Unable to 
contact/DNA (n=2) 
Unable to contact 
(Disengaged from 
service) (n=2)  




Completed pre-group assessment (n= 39) 
Group 1 (n=10) Group 2 (n=8) Group 3 (n=11) Group 4 (n=10) 
 
Excluded (n=0) 




Participant demographics. All participants lived within the MidCentral District 
Health Board (DHB) area (situated in the middle of the lower North Island of NZ). The area 
encapsulates the wider Manawatu region including the central city Palmerston North and 
several surrounding small rural towns such as Otaki, Dannevirke, Feilding, and Foxton. Of 
the 20 participants who completed follow-up, ten were male and ten were female. Ages 
ranged between 21 and 66 years, with an average age of 44.7 years at pre-group assessment 
point. Most participants identified as NZ European (n = 15), with two identifying as Māori 
and two as NZ European and Māori, and one Australian. Participants varied in their level of 
severity of substance use problems as well as severity of their comorbidities. Participants also 
varied in their experience of residential treatment programmes and previous group work as 
well as involvement in individual therapy while attending the group treatment programme.  
Group facilitators. The assessors and group facilitators for all four groups were a 
Senior Clinical Psychologist with 22 years’ experience working with substance use and 
mental health problems and the researcher, a Doctorate of Clinical Psychology student at 
Massey University, with previous work experience in the AOD setting.   
Protocol of Measures 
The research protocol comprised eight brief psychometric measures, chosen to 
evaluate the group treatment programme efficacy in a range of areas including substance use 
and cravings, stress, anxiety, mood management, locus of control, peer pressure, and 
mindfulness behaviours (see Appendix B). This also included an initial semi-structured 
clinical interview (for assessment purposes) with the protocol of self-report measures used to 
assess therapeutic outcomes across pre, mid, post, and follow-up assessment points. The 
specific measures utilised were chosen based on the research hypotheses outlined on page 56 
and 57 of the thesis and were deemed suitable to provide relevant outcome data as they were 




already in use in a larger group-based programme utilising ACT for the NZ army via Massey 
University (designed by Dr Andy Towers) and utilised in previous research by Crispin-
Morrall, 2013 and Harvey et al., 2017. They were observed by this previous research to cover 
the range of issues that were expected to change when examining the effectiveness of such a 
transdiagnostic treatment approach. The measures were also recommended due to their 
availability and open access status. The addition of a mindfulness measure allowed for the 
examination of mindfulness tendencies in relation to changes in alcohol use, substance use 
and cravings, perceived stress, anxiety, locus of control, resistance to peer pressure, and mood 
management.  If participants had any difficulties in completing the protocol of measures the 
author provided the necessary assistance.  
Semi-structured clinical interviews. Semi structured clinical interviews with 
potential participants were conducted by the group facilitators. The author or the client’s case 
manager contacted potential participants via phone to schedule assessment sessions. The 
assessment interview included 1) current circumstances as well as a brief history of the 
participant’s substance use and coexisting problems 2) screening for risk issues 3) assessment 
for motivational levels based on clinical judgement 3) explanation of the study and group 
treatment programme 4) completion of consent forms and 5) completion of the pre-group 
measures.  
Self-Report Measures 
Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). The AUDIT-C, 
developed by the World Health Organisation, is a 3-item self-report measure that indicates the 
quantity and frequency of alcohol consumption on a typical day and highlights binge drinking 
patterns. Items are scored from 0 to 4, with the possible sum of scores ranging from 0 to 12. 
Scores above 3 are considered the standard cut-off that indicates hazardous drinking in the 




general adult population. The AUDIT-C has been widely used in primary health settings to 
screen for heavy drinking and indicates the severity of an individual’s alcohol use problem 
(Bush, Kivlahan, McDonell, Fihn, & Bradley, 1998; Bradley et al., 2007; Dawson, Grant, 
Stinson, & Zhou, 2005). The psychometric properties of the AUDIT-C are reliable with those 
of the full 10-item AUDIT which has shown moderate internal consistency with high 
correlations between scores on the AUDIT-C and AUDIT (Neumann et al., 2012). It has also 
been shown to be an effective screening tool across cultures (Frank et al., 2008). Within the 
NZ context, the AUDIT-C was found to be a promising standalone screening tool among 
university students for alcohol use problems (Blank, Connor, Gray, & Tustin, 2015). In 
accordance with previous research (Crispin-Morrall, 2013), Section B of the AUDIT-C was 
adapted to measure drinking behaviour changes in the past four weeks instead of the original 
timeframe of the past 12 months. 
World Health Organisation-Alcohol, Smoking, and Substance Involvement 
Screening Test Version 3.0 (WHO-ASSIST V3.0). The World Health Organisation also 
developed the WHO-ASSIST V3.0 (2016). This measure screens for a wide range of 
substance use and frequency of use, excluding alcohol, and elicits the frequency of cravings 
for substances. Responses are recorded on a 5-item Likert scale ranging from 1 Never to 5 
Daily or Almost daily. Humeniuk, Dennington, and Ali (2008) conducted validity testing in 
which concurrent and construct and discriminative validity were established. Further good 
test-retest reliability was achieved by McNeely et al. (2014). This measure was also validated 
within an Australian population as an effective way to screen for substance use problems 
(Newcombe, Humeniuk, & Ali, 2005). Again, in accordance with prior research (Crispin-
Morrall, 2013), phrasing for specific questions was adapted to facilitate sensitivity to changes 
in substance use and cravings in the last month to better encapsulate the potential changes 
made over the course of the group treatment programme and follow-up period.  




Perceived Stress Scale – 10 (PSS-10). The PSS-10 is a 10-item self-report measure 
that assesses the degree an individual perceives general life situations as stressful. Items are 
scored on a 5-point Likert scale ranging from 1 Never to 5 Very often. The total perceived 
stress score is calculated by the sum of items, with negatively worded items being reverse 
scored. Total scores between 0-13 indicate low stress, 14-26 suggest moderate stress, and 27-
40 indicate high perceived stress levels (Cohen, Kamarck, & Mermelstein, 1983, 1994). No 
adaptations were made to this measure. The PSS-10 is reported to have convergent validity 
between items, construct validity, and is considered a reliable and valid instrument for the 
assessment of perceived stress (Roberti, Harrington, & Storch, 2006). More recently, Taylor 
(2015) reported that inferences made from the PSS-10 are valid.  
Generalised Anxiety Disorder Screen (GAD-7). The GAD-7 is a 7-item self-report 
measure that assesses the severity of anxiety levels on a 3-point Likert scale ranging from 0 
(Not at all) to 3 (Nearly every day) with a total possible score ranging from 0-21 (Spitzer, 
Kroenke, Williams, & Lowe, 2006). Minimal anxiety is indicated by scores of 0 to 4, mild by 
scores of 5-9, moderate 10-14, severe 15-21. This measure was not modified for the study. 
Psychometric properties of the measure include good construct validity, internal consistency, 
convergent, and criterion-related validity (Lowe et al., 2008; Spitzer et al., 2006) 
Brief Locus of Control Scale (BLOCS). The BLOCS is the short-form version of 
Levenson’s 24-item Locus of Control Scale (LOCS) (as cited in Sapp & Harrod, 1993). It is 
composed of 9 items that measure the extent an individual agrees that they (internal), chance, 
and others have control over their lives. This is measured on a 5-point Likert scale ranging 
from 1 Strongly disagree to 5 Strongly agree. This measure was not modified during the 
study. Research for this specific measure is limited, with validity studies conducted in the 
1980’s by Lumpkin (1985; 1988) reporting the brief measure to be valid. Sapp and Harrod’s 




(1993) psychometric evaluation provided support for the BLOCS construct and predictive 
validity.  
Trait Meta-Mood Scale (TMMS). The TMMS is a 30-item self-report measure 
designed to measure an individual’s self-perceived emotion management. This measure also 
uses a 5-point Likert scale ranging from 1 Strongly disagree to 5 Strongly agree. Total 
emotion management scores are made up of the measure’s three subscales 1) attention, 2) 
clarity, and 3) repair, with selected items reverse scored appropriately (Palmer, Gignac, Bates, 
& Stough, 2003). Total scores between 30 and 89 indicate “needs to work on emotions”, 90 to 
149 indicates “has a handle on emotions, but could use more work”, with scores above 150 
indicating “excellent” emotion management skills. The attention subscale indicates an 
individual’s self-perceived ability to attend to their mood and emotional states, with scores 
between 13 and 38 suggesting “unaware of feelings, needs work”, 39 to 64 suggesting 
“growing awareness”, and scores above 64 suggesting “excellent” attention skills. The 
“clarity” subscale represents an individual’s self-perceived ability to clearly discriminate 
between mood and emotional states with scores between 11and 32 indicating “confused”, 33 
to 54 indicating a “growing clarity”, and scores above 55 indicating “excellent” clarity of 
moods and emotions. The “repair” subscale indicates the self-perceived ability to regulate 
mood and emotional states, with scores between 6 and 17 suggesting “needs to act”, 18 to 29 
suggesting “attempts to repair”, and scores above 30 suggesting “excellent” regulation 
management skills. No adaptations were made. Good convergent and discriminant validity 
were reported by Palmer et al. (2003), with adequate internal consistency also found by 
Palmer et al. (2003) as well as Salovey, Mayer, Goldman, Turvey, and Palfai (1995) and in a 
later study by Salovey, Stroud, Wollery, and Epel (2002).   
Resistance to Peer Influence Scale (RPI). The RPI is a 10-item scale that measures 
an individual’s self-perceived resistance to peer influence. A 4-point Likert scale uses a pair 




of descriptive statements within each item, and with each statement there are two response 
options, “really true for me” or “sort of true for me”. Participants choose one of the 
descriptive statements and then indicate one of the two associated response options. Specific 
items are reverse scored, and the total score is the sum of responses divided by the number of 
valid responses (a minimum of seven valid responses is recommended) (Steinberg & 
Monahan, 2007). The scale has good internal consistency as well as sufficient construct 
validity (Steinberg & Monahan, 2007; Sumter, Bokhorst, Steinberg, & Westernberg, 2009).  
Mindfulness, Attention, and Awareness Scale (MAAS). The MAAS is a 15-item self-
report measure that uses a 7-point Likert scale that assesses attention to, and awareness across 
cognitive, emotional, physical, and general aspects of everyday life, providing a sense of an 
individual’s mindful tendencies and practices (MacKillop & Anderson, 2007). There have 
been some challenges to the construct validity of the MAAS, which suggests an inability of 
response options to discriminate between trait levels (Van Dam, Earleywine, & Borders, 
2010). However, the authors state that the measure is one of the most popular self-report 
mindfulness measures and through MacKillop and Anderson’s (2007) studies the MAAS was 
found to be valid. A confirmatory factor analysis also supported the measure’s 
unidimensional factor structure (MacKillop & Anderson, 2007).  
Supplementary measures. Several supplementary measures were utilised to provide 
an opportunity for the participants to give feedback about the group therapy programme that 
was not restricted by pre-determined response formats. The responses to these questionnaires 
were not analysed using qualitative techniques (i.e. discourse analysis) but summarised 
according to key themes and reported verbatim in the thesis. These were used as an adjunct to 
numerical measures and to provide anecdotal information about the effectiveness of the 
treatment. Information obtained from these measures can also be used to guide the 




development of future treatment programmes for substance use problems and coexisting 
problems. 
Session rating scales (SRS). The SRS were administered at the end of every session 
to obtain additional information about the session’s level of helpfulness and enjoyability using 
closed and open-ended questions. Participants were asked to indicate how much they agreed 
with the statements “I ENJOYED this ACT session” and “This ACT session was HELPFUL” 
using a 4-point Likert scale ranging from 0 Strongly disagree to 4 Strongly agree. They were 
then asked to comment on aspects they deemed helpful, unhelpful, and if they had other 
suggestions or comments regarding the session (see Appendix C). The forms were collected 
by the group facilitators and were completed anonymously by the participants to reduce the 
likelihood of grateful testimonials.   
Group rating scales (GRS). The overall GRS were administered at the end of Session 
10 to obtain further feedback about the group programme (see Appendix D). Participants were 
asked another set of closed and open-ended questions using the same 4-point Likert scale 
outlined above for the SRS. Participants were asked how strongly they agreed or disagreed 
whether the group was: enjoyable, helpfulness, good style (i.e., weekly sessions/group 
discussions/exercises), facilitators fit (i.e., approachable, engaging, acknowledgeable), and 
relevant and helpful hand out material. Open-ended questions included how the overall group 
treatment programme was helpful, not helpful, and requested any other comments or 
suggestions about the programme.  
Follow-up feedback questionnaire. Further feedback to determine how well the group 
treatment programme benefited the participants was sought at the three-month follow-up 
interview by adapting Raeburn’s “PEOPLE” system (Raeburn, 1987). They rated 
improvements to their wellbeing, ability to carry out every day activities, ability to cope, 




satisfaction with life, and sense of happiness and wellbeing. These improvements were 
assessed using a 4-point Likert scale with 1 Excellent to 4 Poor. Further questions rated the 
satisfaction levels of the group facilitators’ responses to the participants’ as well as the 
facilitators’ level of competency and the participants overall contact with the group from 1 
Very satisfied to 4 Not satisfied. Additional questions rated on a scale ranging from 1 Yes – a 
lot to 4 No – worse now, sought to gather participants’ beliefs about the ACT group for SUDs 
helping them sit with unwanted psychological experiences, helped cope with problems related 
to addiction, improved their ability to live more in line with their values, and increased their 
commitment to carrying out value driven goals. Participants were also asked open-ended 
questions about the most helpful and least unhelpful aspects of the group, how they think the 
group could be improved and were able to make any comments (see Appendix E).   
Treatment fidelity checklists. Borrelli (2011) stressed the importance of attention to 
treatment fidelity and how the benefits of such outweigh the costs; he recommends 
audiotaping sessions for review. However, this was beyond the scope of the current study and 
the consent obtained from the participants did not cover audiotaping sessions. Several reviews 
on ACT have also recommended the use of treatment fidelity measures to enhance 
methodological rigor (Öst, 2008; 2014). Therefore, following each session, the group 
facilitators completed a treatment fidelity checklist to ensure the consistent integrity of the 
treatment programme delivered across groups (see Appendix F).  
Group Treatment Manuals and Materials 
The development of the manuals. Group facilitator manuals and group participant 
workbooks were developed by the author in consultation with feedback and suggestions from 
the supervision team and those involved in the project to ensure the face validity for the target 
population. This included service provider feedback from clinicians at the Palmerston North 




Alcohol and Other Drug Service and from the academic supervisors in the Psychology 
Department at both Massey University Palmerston North and Wellington campuses. Once the 
draft manuals were complete, further feedback and suggestions were made, including editing 
dialogue to make therapeutic exercises easier to understand.  
The initial literature review informed the development of the facilitators’ manual and 
participants’ workbook. Thus, research targeting ACT and SUDs were considered paramount, 
as well as research on group therapy. Accordingly, the manuals utilised practice guidelines 
within the ACT framework and were presented in a sequence designed to provide optimal 
impact for clients with SUDs (Hayes & Strosahl, 2004). The therapeutic elements used in the 
manuals originate from an ACT theoretical approach which is rooted in Relational Frame 
Theory (RFT) outlined in Chapter 2 of this thesis. Resources from the website Association for 
Contextual Behavioral Science (ACBS) were utilised to assist in construction of manuals. 
This included open access to all audio podcasts (ACT in Context: The Acceptance and 
Commitment Therapy Podcast) and published treatment protocols for ACT as well as other 
ACT-related resources. Other key resources for the activities and exercises in this manual 
were adapted from resources originally presented in DuFrene and Wilson’s (2012) book “The 
Wisdom to Know the Difference: An Acceptance and Commitment Therapy Workbook for 
Overcoming Substance Abuse”, Steven Hayes and Kirk Strosahl’s “A Practical Guide to 
Acceptance and Commitment Therapy” (2004), Russ Harris’s “ACT Made Simple” (2009), 
“Get Out of Your Mind and into Your Life” by Steven Hayes (2005),  “Acceptance and 
Commitment Therapy: The Process and Practice of Mindful Change”  by Hayes, Strosahl, and 
Wilson (2011), and the NZ Army Well-Being Course (Harvey & Dickson, 2010). 
The final selection of content also emerged from the diverse and complex needs of the 
client population in the AOD service in Palmerston North. Further, implicit development of 
the manuals included underlying principles of a primary focus on increasing mindful and 




value driven behaviour in the context of any SUD, as well as flexibility in the implementation 
of the therapeutic components throughout the programme guided by unique characteristics, 
circumstances, and needs of the particular group.  The treatment fidelity checklists were 
utilised to maintain the group treatment programme integrity. Therefore, the core content of 
the manual did not differ between groups; however, some modifications were made after 
receiving participants’ feedback and by reflecting on how well an idea or skill was explained. 
There was also a natural variation between groups due to participant-specific responses and 
understanding of the material presented. For example, if a participant(s) needed a concept 
further explained then more time and examples were given to achieve a comfortable level of 
understanding for the group. Additional material, such as a video, was used to augment 
themes presented in sessions.  
Manual session layout. The group was guided by a closed structured group model, 
with individual and group activities and exercises utilised in session (Bernard et al., 2008; 
Ziller, 1965). The duration of each session was up to three hours and followed the same 
general layout for each session, excluding session one. The first session was explanatory and 
included a short introductory statement giving an overview of ACT, group expectations, 
therapy agreement and commitment and programme material (see Appendix G for a generic 
copy of the group agreement). Group participants were also introduced to the concept of 
mindfulness and a practise exercise was administered in session one. Starting from session 
two the general structure followed a sequence of an opening mindfulness exercise, any 
apologies from participants who could not attend the session, a review of the feedback 
received from the previous session rating scale, a review of the previous session’s material 
and weekly challenges (homework practise), introduction to the key concept of the session, 
exercise(s) related to the key concept, a group discussion on the exercise, a relevant metaphor, 
quotes of the week, further group discussion of the key concept, an outline of the next weekly 




challenge, and closing with a short mindfulness exercise, followed by administration of the 
SRS. A refreshment break occurred at a convenient time between therapy components; after 
the break therapeutic activities would continue. Mid-group assessment occurred at session 
five and the post-group assessment occurred at session ten. Additional time was allocated for 
the participants to complete the self-report measures.  
 Pilot treatment manuals (facilitator manual and participant workbook). The 
facilitator manual describes the purpose and goals for each session, materials required, format 
and activities, and outlines weekly challenges (homework). The participants received a 
corresponding workbook on a weekly basis so as to not overwhelm them with the content of 
the group and to ensure participants did not complete the session exercises in advance without 
the guidance of the group facilitators. The group treatment programme comprised ten sessions 
as follows:  
Table 5.  
Session by Session Overview of Core Components in the Acceptance and Commitment 
Therapy-Based Group Treatment Programme.    
Session number and 
title  
Core components of each session 
Session one: 
Reasons for use 
• Introductions: Ice breaker exercise – Introduce the person next to you 
• Housekeeping: Confidentiality, toilets, duration of group 
• Group agreement and expectations: Orientation to how the group will be run and 
session structure 
• Introduction to ACT: Explanation and examples 
• Experiential exercises: Don’t think of a kiwi (adapted from white bear) and 
Chinese finger trap 
• Quotes of the week 
• Introduction to mindfulness and exercise: Take some breaths 
• Group discussion: Reasons for use (Good sides and bad sides) 
• Weekly challenges: Pros and cons matrix and mindfulness practise  
• Session rating scale (SRS) 
 
Session two: The 
habit – is it 
workable? 
• Opening mindfulness exercise: Mindfulness of sounds 
• Feedback from last session (SRS) 
• Recap previous session (take home messages) and review weekly challenges 
• Addiction evolution: Explanation, video “Nuggets”, positive versus negative 
reinforcement of addiction, lead group discussion 
• TED talk: A simple way to break a habit (Brewer, 2016) 




• The habit cycle and how to break the habit cycle: RAIN technique (Brewer, 2016), 
labelling emotions and their relationship with behaviour, lead group discussion 
• Metaphor: Person in the hole 
• Quotes of the week 
• Group discussion: Costs of using  
• Weekly challenges: Noticing urges/emotions (label emotions), continue pros and 
cons matrix, consider addiction goals, and continue mindfulness practise  
• Closing mindfulness exercise: Mindful eating (raisin) 




• Opening mindfulness exercise: Mindfulness of emotion in the body  
• Feedback from last session 
• Recap previous session: Take home messages 
• Review weekly challenges 
• Defining values: Values versus goals; values and pain 
• Quotes of the week 
• Exercise: Values card sort (Identify top ten values and pain associated with them) 
• Exercise: Values bullseye (group discussion and taking aim i.e. why at there and 
not here?) 
• Weekly challenges: 80th birthday party speech, values bullseye exercise and 
continue mindfulness practise  
• Closing mindfulness exercise: Waiting on yourself 
• Session rating scale 
Session four: 
Acceptance 
• Opening mindfulness exercise: Urge surfing 
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Introduce concept: Clean versus dirty discomfort (whiteboard exercise/group 
discussion) 
• Defining Acceptance: Metaphor (temper tantrum) and whiteboard exercise (myths 
of acceptance) 
• Quotes of the week 
• Urge surfing and RAIN technique 
• Metaphor: Joe the party crasher 
• Weekly challenges: Identify clean and dirty discomfort and continue mindfulness 
practise  
• Closing mindfulness exercise: Counting breaths 
• Session rating scale 
 
Session five: Present 
Moment 
• Opening mindfulness exercise: Body scan 
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Introduction to present moment  
• Exercise: Gaze exercise and group discussion (i.e. notice discomfort) 
• Quotes of the week 
• The thinking mind: Explanation, exercise (the Virtues of Saliva), and group 
discussion  
• Weekly challenges: Identify stories your mind tells you and continue mindfulness 
practise 
• Closing mindfulness exercise: Centring exercise 





• Opening mindfulness exercise: Leaves on a stream 
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Introduction to defusion: explanation and defusion techniques 
• Passengers on the bus: Metaphor, video, exercise, and group discussion 




• Quotes of the week: Rumi Poem (House Guest) 
• Weekly challenges: Identify value and passengers on your bus, practise defusion 
techniques and continue mindfulness practise  
• Closing mindfulness exercise: The mountain 
• Session rating scale 
 
Session seven: Self 
as context 
• Opening mindfulness exercise: The observing self  
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Exercises: Who are you? Labels and roles we give ourselves; polarization exercise: 
how our mind constantly evaluates; post it note exercise “addiction battle (straight 
versus addict mind)” and group discussion.  
• Video: Russ Harris self as context 
• Exercise: Time line and group discussion, relate to metaphors (the mountain, 
ocean, sky, movie theatre) 
• Defining self as context versus self-concept  
• Quotes of the week 
• Weekly challenges: Addict versus straight mind and the observer space and 
continue mindfulness practise  
• Closing mindfulness exercise: Where are your thoughts 




• Opening mindfulness exercise: Accepting, Choosing, Committing, Taking Action 
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Defining committed action: Explanation, video (Ten Metre Jump), and metaphor 
(swamp) 
• Quotes of the week  
• Exercise: My valued action plan and SMART guidelines 
• Exercise: Roadblocks: FEAR (not starting versus getting off track)  
• Metaphor: Gardening  
• Weekly challenges: FEAR that showed up when committing to a valued action and 
continue mindfulness practise  
• Closing mindfulness exercise: Self compassion 




• Opening mindfulness exercise: SOBER breathing space 
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Introduction to relapse prevention model: Euphoric memories, Seemingly 
irrelevant decisions, High risk situations, Problem of immediate gratification, 
Lapse, Rule violation effect, Relapse, and the Need to orient recovery around 
values 
• Exercise: What are your beartraps? (i.e. memories, decisions, high risk situations) 
• Applying ACT skills to relapse prevention 
• Quotes of the week  
• Weekly challenges: Revisit pros and cons and continue mindfulness practise  
• Closing mindfulness exercise: Forgiving ourselves 
• Session rating scale  
 




Session ten: Recap • Opening mindfulness exercise: The journey so far 
• Feedback from last session 
• Recap previous session: Take home messages and review weekly challenges 
• Recap all sessions: Group discussion and clarifying questions and understanding of 
the programme content 
• Quotes of the week 
• What now? Keep practising daily  
• All resources listed 
• Closing mindfulness exercise: Continue to be mindful, continue to be curious, 
cultivate self-compassion 
• Session rating scale and group rating scale 
• Post – group assessment phase: complete self-report measures 
• Certificate of participation and vouchers given 
 
Session one: Reasons for use. The aim of the first session was to orientate 
participants to the programme and foster motivation to continue attending further sessions. An 
important aspect of session one was to outline the group processes and expectations to 
provide a safe place where participants could experience an understanding of their struggles. 
Introductions of group members and facilitators began, the session with housekeeping 
information then outlined. Participants were both oriented to group expectations and asked to 
generate their own ground rules for the group. This included the issues of confidentiality, 
appropriate behaviour, how the group would be run, and commitment to the programme. 
Psychoeducation about the group therapy approach, ACT, was presented and supported by 
ACT-based metaphors such as “The Polygraph” and “The Emotional Avoidance Detour” 
followed by experiential exercises such as the Chinese Finger Traps and the “White Bear 
Exercise” that was adapted to a NZ example (Kiwi). These experiential exercises 
foreshadowed the idea that control is the problem and not the solution. Quotes of the week 
were introduced that were relevant to the session content. A brief introduction to mindfulness 
was presented and a mindfulness exercise was also executed before moving onto discussing 
the importance of between session therapy in the form of “weekly challenges” (homework). A 
key topic for group discussion was the positive and negative consequences of substance use. 
The purpose of this discussion was to help participants identify their reasons for using 




substance(s). Participants were asked, as their first weekly challenge, to think about what 
substance use gave them and what they were trying to avoid via substance use by completing 
a pros and cons matrix. This exercise was set as an introduction to completing therapeutic 
activities between sessions. Participants were also encouraged to complete mindfulness 
activities that included mindful colouring in, orientating them to guided mindfulness exercises 
online, and encouraging them to practise mindfulness informally (i.e., giving them brief 
instructions for mindfully doing everyday activities such as brushing their teeth).   
Session two: The habit – is it workable? Session two aimed to continue building 
motivation and rapport so participants were more likely to attend further sessions. The aim of 
“workability of use” was to build upon the idea that substance use, for most group 
participants, had become unworkable in their lives. Participants were shown a video depicting 
the process of addiction (Hykade, 2015) and were educated about the way that addiction tends 
to evolve in a person’s life, from positive reinforcement to negative reinforcement (informed 
by Miller and Carroll, 2006 and Koob, 2013). Another video highlighting how habits form 
supported a group discussion about addiction specific habit cycles (i.e., cue > behaviour > 
reward) (Judson, 2016). The idea of automatic pilot and the way a person has become 
programmed via repeated behaviours were also highlighted, alongside foreshadowing 
mindfulness as a helpful skill in addressing these problems. A brief overview about the 
function of emotions was also presented as emotions are considered one of the most powerful 
triggers and cues for a person’s habit cycle. Participants learnt to identify the underlying 
reasons for their substance use in relation to this cycle. The group was presented with Judson 
Brewer’s R.A.I.N. technique that aims to help break the habit cycle. This is a mindfulness-
based technique that can help manage cravings and urges to use substances that are triggered 
by various cues specific to the individual. R.A.I.N. is an acronym for Recognise, Accept, 
Investigate, and Note. Participants were asked to recognise when the cravings arise and to 




relax into the craving sensations (Judson, 2016). Next, they were instructed to accept the 
moment rather than attempting to ignore or distract from the cravings and were asked to 
investigate with curiosity what was happening in their bodies in the present moment when the 
craving sensation builds. Lastly, they were encouraged to note the sensations that were 
present in the moment without acting on them. This technique was coupled with the idea of 
urge surfing (Marlatt & Gordon, 1985; Marlatt & Donovan, 2005). Participants were educated 
about the cycle of urges in that they are time limited and will eventually reach a peak and then 
remit if the person remains committed to not using on that occasion. A key aspect of session 
two was to build a sense of creative hopelessness (Hayes & Strosahl, 2004) by discussing the 
various ways participants had attempted to address their substance use (i.e., what worked or 
did not work in the short-term and long-term?). The idea was to build upon the concept of 
control being the problem and not the solution. An adaptation of the “Man in the Hole” 
metaphor was presented and discussed for interpretation, highlighting the workability of 
substance use, and relevant quotes of the week were covered. This was followed by a group 
discussion outlining specific costs of substance use in major life areas, adapted from the book 
“The Wisdom to Know the Difference” (Dufrene & Wilson, 2012). This elaborated on session 
one’s group discussion about the reasons for use and increased participants’ awareness of the 
specific costs of their substance use in each area of their life. By uncovering the role 
substance use has played in participants’ lives it opens them to new ways to reduce the costs 
of their substance use on the aspects of their life they hold as deeply important (which also 
foreshadowed values as a core principle of ACT). The weekly challenges for this session 
included labelling emotions, applying the R.A.I.N. and urge surfing techniques to non-
threatening urges (i.e., to check their phones) and then to apply the same techniques to 
substance use cravings. Each participant was given a wallet sized R.A.I.N. technique cue card. 
The group was also asked to consider what their substance use change goals would be, 




whether it was full abstinence or reduced or controlled use. Participants were encouraged not 
to make “Dead Man’s Goals” which is the idea that it is often easier for people to say what 
they will stop doing, in the same way a dead man can stop doing a behaviour because he is 
dead. In other words, participants were asked to consider what goals and values they would be 
giving up (or changing) their substance use for. If they were aiming for controlled or reduced 
use, they were asked to consider what it would take to recognise that this goal was not 
workable.    
Session three: Values. This session was aimed at identifying and clarifying 
participants’ values, that is, what they found deeply important to them. At first, the difference 
between values and goals were outlined and supported by several examples. The experiential 
content in this session was based on a values card sort exercise that aimed to increase 
participants’ awareness of their own values. Hayes proposes that the flip side of values is 
pain. Once their values were identified, participants were asked to consider what pain they 
could experience if they followed their chosen values. This generated a discussion aimed at 
orienting them to “the dark side of values” or rather that a value driven life is not guaranteed 
to be a life without pain. Next, participants were asked how closely they think they were 
living in line with their clarified values at this stage of their life via a “Bullseye Exercise”. A 
group discussion centred on the realistic steps needed to move their lives closer in line with 
their values, which would serve to move the participants closer to the centre of the bullseye. 
The aim of the session was for participants to learn how to live with the pain in service of 
their values that may lead to a more meaningful and vital life, which Hayes et al. (2004) 
proposes is one of the main goals of ACT. Weekly challenges for this session were drawn 
from the ACT exercise “Tombstone” and adapted to “80th Birthday Party Speech”. This 
exercise serves the same purpose of the Tombstone exercise in that participants are asked to 
consider what they would want to hear friends and family say about their life and the type of 




person they were, thereby aiding clarification of values and identifying value driven 
behaviour.  
Session four: Acceptance. Session four presented the core ACT concept of 
acceptance, which can also be referred to as willingness or expansion. The aim of this session 
was to teach participants to accept their discomfort (uncomfortable thoughts, feelings, urges, 
images, memories, and sensations) by making room for them (expansion). A key aspect of 
this session was discussing what participants thought the definition of acceptance was and 
how the myths of acceptance can hinder true acceptance and willingness to their experience 
just as it is without judgement. The “Temper Tantrum” metaphor was used to support this 
concept. The idea of “Clean versus Dirty Discomfort” by Hayes (2005) was used to help 
participants recognise the added suffering that arises from the inability to accept pain that 
typically leads to experiential avoidance.  An adaptation of the ACT metaphor “Joe the bum” 
renamed “Joe the party crasher” was presented and discussed, highlighting the idea of 
acceptance and the unworkable strategies people have used to avoid discomfort. Urge surfing 
and the R.A.I.N. technique were revisited as an aid for the acceptance skill. Participants were 
asked to start small and build to acceptance of larger areas and issues in their lives.  The 
weekly challenge was to practise identifying clean and dirty discomfort and practise making 
room for discomfort.  
Session five: Present moment – be here now. This session focused on the core 
concept of present moment awareness, a mindfulness skill that promotes purposely paying 
attention to the present moment without judgement (Jon Kabat-Zinn). Research has shown 
that mindfulness can increase wellbeing by teaching people to live in the present moment 
rather than focusing on the past (ruminating) or being future orientated (worry and anxiety) 
(Witkiewitz & Marlatt, 2004). One way present awareness was taught was through the 
experiential exercise “The Gaze Exercise” in which participants were asked, in pairs, to stare 




into the eyes of the person opposite them. Following this, they were asked to label emotions 
and bodily sensations, promoting an increase in awareness of how discomfort presents itself 
for them. A short video by Matt Killingworth, “Want to be Happier, Stay in the Moment” was 
presented to highlight mindfulness-based research outcomes (Killingsworth, 2012). This was 
followed by a brief group discussion and relevant quotes of the week. Another important 
aspect of this session was to present the idea of “the thinking mind” as a way of describing 
how people’s mind wander, and how the mind tells stories of who they are and why. The 
experiential exercise “Virtues of Saliva” was used to support the idea of “the thinking mind” 
and to demonstrate how powerful the mere thought of something is, in that the thinking mind 
can elicit intense physical sensations and emotions. The weekly challenges for this session 
were to identify what specific stories participants’ “thinking mind” presented to them during 
the week; participants were asked to practise the acceptance by holding these stories lightly 
without judgement and refocus to the present moment.  
Session six: Defusion - watch your thinking. In this session the concept of defusion 
was outlined, a core skill of ACT that serves to separate and distance oneself from unhelpful 
thought processes. In this session, participants learnt different defusion techniques that aim to 
lessen the emotional impact of thoughts (e.g., treat thoughts as spam email, treat your mind as 
a separate person, and thank your mind). An experiential exercise that demonstrates this 
concept is the “Hands Over Your Face Exercise” that shows how defusion gives space from 
thoughts to allow participants to refocus on what is important to them and be in the present 
moment. Another experiential exercise involved participants holding a cactus with the idea of 
learning to hold the cactus lightly; they are to do the same with their thoughts. A key exercise 
of this session was the “Passengers on the Bus” metaphor, which was read aloud, then a short 
video depicting the metaphor was shown, before asking participants to act out the exercise. 
The exercise involved a participant volunteering to be the driver of the bus with the remaining 




participants and facilitators being the passengers (unhelpful thoughts, emotions, memories, 
sensations) on the bus. The quotes of week in this session were replaced with a poem, “Guest 
House”, by Rumi, that reinforced the idea of defusion as well as the acceptance skill from 
session four. Weekly challenges involved choosing one value participants would like to work 
towards and identifying passengers on their bus that show up when attempting to live in line 
with that value. Participants were encouraged to utilise defusion techniques when those 
“passengers showed up” and practise their acceptance and mindfulness skills, while 
committing to value driven behaviour.  
Session seven: Self as context – pure awareness. This session focused on the core 
concept of self as context. Participants were taught to focus and increase their awareness of 
their “observing self” by stepping back from their experiences and to simply notice 
themselves noticing. Key therapeutic components of this session involved defining the roles 
and labels we identify with (e.g., sister, son, friend, alcoholic, addict, psychologist, etc.). The 
purpose was to describe the difference between the conceptualised self (our self-concept born 
out of society’s roles and expectations, family’s expectations, our own expectations) and our 
contextualised self (the observing self, experiencing moment by moment, without judgement). 
An experiential exercise “Polarisation Exercise” was completed. which involved reading 
aloud statements that were likely to elicit negative or positive self-talk responses. This 
highlighted that the thinking mind is always judging and evaluating the conceptualised 
notions of the self. Another exercise involved participants writing down on post-it notes 
examples of what their “addict mind” and “clean mind” tell themselves in which the 
“Chessboard” metaphor was adapted to incorporate the idea of this “addiction battle”. 
Participants were asked to imagine themselves as the chessboard and learn to observe the 
battle playing out without getting caught up in it. A short video on self as context by Russ 
Harris was also shown to provide another explanation of this abstract concept in ACT. An 




experiential exercise called the “Time Line” provided an opportunity for participants to 
become in touch with their observing self by asking them to recall memories or experiences 
(specifically, mildly uncomfortable ones) from this morning, last week, and childhood. In this 
exercise they were also asked to view different perspectives from the different roles they 
identify with but to think about the part of them that is the same person who has experienced 
these different events and labels. Several metaphors were utilised to convey the concept of 
self as context including “The Mountain”, “The Ocean and the Sky”, and “The Movie 
Theatre”. The weekly challenge for this session was to be mindful of their own personal 
“addiction battle”, noting down what their “addict mind” and “straight mind” say; to practise 
getting in touch with their observer self and notice what happens to their thoughts, emotions, 
and sensations when they are in the observing space.   
Session eight: Committed action. The therapy content of session eight focused on 
practical goal setting for actions that could be taken by participants to live accordingly to their 
values. This involved introducing the concept of committed action and bringing together ACT 
skills covered in previous sessions. The “Swamp” metaphor was used to support the idea of 
committed action. A jumping demonstration was shown to the group in which one of the 
facilitators made a commitment to the behaviour of jumping, firstly, by jumping off a bit of 
paper then moving to jumping off a chair. This highlights the idea that it does not matter how 
big or small the behaviour is, it is the commitment to the action that matters. This was 
followed by a short video titled “Ten Metre Tower” where people were asked to jump off a 
high dive board (Danielson, & Van Aertryck, 2016). This video demonstrated the range of 
reactions from people, reinforced the idea of committed action and revisited the idea of 
willingness and acceptance of discomfort that may show up when committing to a value-
based behaviour. A key exercise was the “My Valued Action Plan”, in which participants 
were asked to revisit their top ten values from session three. Participants were then oriented to 




guidelines for goal setting using the acronym S.M.A.R.T.  (goals should be specific, 
measurable, achievable, realistic, and time limited). Another important aspect covered in this 
session was the acronym F.E.A.R. that stands for fusion with thoughts, evaluation of 
discomfort, avoidance of discomfort, and reason giving. This was used to outline the types of 
things that often prevent or derail people from following through with committed action to 
their values. Participants were given a wallet sized F.E.A.R. cue card as a reminder. The 
“Gardening” metaphor was presented and discussed to portray the idea of committed action. 
The weekly challenges for this session were to practise identifying their specific experiences 
of F.E.A.R associated with their valued action. They were also given extra worksheets for the 
“My Valued Action Plan” to complete S.M.A.R.T. goals for their other values (this was 
optional).       
Session nine: Relapse prevention. The therapeutic content of this session focused on 
Marlatt’s Relapse Prevention model. This session was not specifically ACT-based, but ACT 
skills were incorporated as strategies to prevent a lapse or relapse into the habit cycle of 
addiction. The session involved an explanation of the role euphoric memories play in the 
return to substance use. This explanation was demonstrated by revisiting the “Nuggets” video. 
The relapse prevention model was presented in diagram format and each aspect of the model 
was explained. Participants were asked to identify their own seemingly irrelevant choices and 
high-risk situations that lead to a lapse or relapse, with appropriate examples provided for 
each process. Core concepts such as the problem of instant gratification and the rule violation 
effect were also explained, and participants were encouraged to be aware of these thought 
process that make them particularly vulnerable to lapse or relapse. A thorough plan to cope 
with any triggers or high-risk situations was completed, informed by ACT skills presented in 
group, and the long and short-term problems and benefits were considered for their relapse 
plan (Marlatt & Donovan, 2005). This session’s weekly challenge for participants was to 




revisit their pros and cons matrix and elaborate on the benefits and costs for using substances 
versus stopping or reducing substance use. Extra copies of the pros and cons matrix were 
given for other behaviours participants may be considering changing.  
Session ten: Summing it up. The last session focused on reviewing all previous 
sessions to ensure participants understood the ideas presented, and offered a safe place to 
practise and gain a solid foundation to continue implementation of techniques learnt 
throughout the programme in everyday life. Participants were encouraged to ask any 
questions about the concepts and skills presented throughout the group. They were reminded 
of the importance of continuing to practise and use the skills learnt in the group into the 
future. They were encouraged to ask themselves: “How could your life be different if you just 
began growing, nurturing, cultivating the ACT principles in your life to make it more 
fulfilling and meaningful?” Lastly, participants were orientated to a list of resources including 
books, podcasts, websites, TED talks, and smartphone apps. Additional time was allocated to 
allow for completion of session rating scales, group rating scales, and the post-group self-
report measures.  
Procedures 
Recruitment, referral processes, and environmental setting. As outlined above, 
participants were recruited from the Palmerston North AOD Service with referrals accepted 
from AOD staff, typically case managers, but also nurses, psychologists, and psychiatrists. 
Email reminders to all AOD staff were conducted weekly during the recruitment period for all 
groups. Potential participants were deemed appropriate for the initial interview if they met the 
inclusion criteria. The author contacted each potential participant via telephone to schedule a 
face-to-face interview. This offered an opportunity to gauge motivation levels to attend a 
group and build rapport, as well as providing an opportunity for potential participants to ask 




any questions about the group and what the initial assessment entailed. Once an interview 
time was scheduled, an appointment letter was sent in the post. The minimum number of 
confirmed participants for each group was eight with a maximum of 12 participants possible. 
Therefore, each group did not begin until the minimum number of participants was obtained. 
The restriction on numbers of participants was implemented due to the size of the group room 
available as well as taking into consideration the ratio of facilitators to participants for 
effective group therapy to take place. The environmental setting for the group treatment 
programme was an off campus MidCentral DHB facility available to such group services. The 
room was available for the ACT group programme on a Wednesday morning from 9am-
12pm.   
Materials and assessment phases. At the initial face-to-face meeting, participants 
underwent a semi-structured clinical interview followed by an overview of the group 
treatment programme offered. Once participants agreed to partake in the study they were 
provided with an information sheet and a copy of the consent form (see Appendix H) and 
Russ Harris’s article providing an overview of the ACT therapy approach (Harris, 2006), and 
informed they would receive a voucher upon completion of session 10. They also completed 
the protocol of measures for the pre-group assessment, including an initial page for recording 
demographic information. The same protocol of measures was administered and collected 
immediately following the mid-group session (Session 5) and again immediately post-group 
session (Session 10). If participants were unable to attend any session that involved 
completing the measures they were followed up within the week and asked to complete them 
prior to the next session. At the end of Session 10 participants were gifted a $20 supermarket 
voucher for their attendance and completion of the self-report measures. They were also given 
a certificate of participation to acknowledge their attendance and engagement in the group. 
Vouchers were used as an incentive to increase the likelihood of programme completion. 




Several meta-analyses support the use of contingency management as an effective strategy for 
people who struggle with substance use problems to engage in treatment (Benishek et al., 
2014; Prendergast et al., 2006), and report incentives to be effective for both sexes in 
outpatient settings (Rash & Petry, 2015). Therefore, the use of vouchers was considered an 
important aspect of this research in attempting to reduce attrition rates.   
General materials included in each session were the facilitator manuals and participant 
workbooks, as well as pens, colouring pencils, whiteboard pens, A3 paper, Session Rating 
Scales, small adhesive note pads, USBs with relevant videos loaded, and refreshments such as 
tea, coffee, and biscuits. A materials checklist specific for each session was utilised to ensure 
all materials were provided during the group treatment programme. A cell phone, rented by 
Massey University, was used to contact participants via text message with a reminder of the 
start date of the group as well as weekly reminders of the group on a Tuesday afternoon. This 
was done to increase the likelihood of attendance rates. The cell phone was also available for 
participants to call if they had any questions or if they were running late or could not make it 
to the group. If participants missed a session and did not contact the facilitators in advance 
they were sent a text message stating that they were missed in group and the session material 
would be posted to them, as well as encouraging them to attend the next session. If 
participants missed subsequent sessions, they were telephoned to discuss any barriers that 
may be hindering their ability to attend the group. If a participant missed three sessions 
consecutively without establishing contact, then they were removed from the group. Every 
effort was made by the author to contact any participants who missed consecutive sessions 
and to inform them of this decision. If contact was made and the participant expressed their 
motivation and willingness to re-engage in the group, they could return under the condition 
they had read and completed the participant workbook that was sent in the post.  




Of note, the fourth ACT group treatment programme conducted from August 2017 to 
November 2017 had a break between Session two and three while the lead researcher and co-
facilitator had an exam. This means there was one week between resuming the programme. 
Therefore, the attrition rates and impact of the group may have been affected and needs to be 
mentioned. All other groups ran through the ten sessions uninterrupted.  
Follow-up measures were collected at three months post-group during face-to-face 
meetings with the author and co-facilitator held at the AOD service. Following the completion 
of the group treatment programme, participants were advised in the last session to expect a 
telephone call in the next three months from the author to organise a suitable face-to-face 
interview and that they would receive an incentive (a $20 supermarket voucher) gifted upon 
completion of the final set of self-report measures. Participants were contacted two weeks 
prior to their official three-month follow-up date. Once an interview time was scheduled, an 
appointment letter was sent in the post. However, time periods for follow-up differed across 
participants and were sometimes extended depending on the availability of the participant. 
Therefore, follow-up time ranged from three months to four months and one week, with a 
mean of three months and three weeks. Once participants completed the final protocol of 
measures they were gifted the voucher and given a summary of their individual scores from 
their pre, mid, and post self-report measures (see Appendix I for a generic copy of a feedback 
summary). They were also gifted a small keychain of a spade, representing the idea from 
“Person in the Hole” metaphor reminding them to “drop the spade, stop digging, stop 
struggling”. Participants were advised they would receive a summary of their complete results 
and, if indicated on the consent form, that they would receive the anonymised results from the 
study.  
Ethics statement and considerations. This research was conducted in accordance 
with the New Zealand Central Health and Disabilities Ethics Committee whereby full ethical 




approval was granted (15/CEN/134) (see Appendix J). A Memorandum of Understanding 
(MoU) between Massey University and the MidCentral District Health Board was also 
obtained prior to recruitment procedures being conducted (see Appendix K). Information 
sheets and informed consent forms were obtained from all participants and participants had 
the right to withdraw from the study at any point. The researcher expressed orally and in 
written form that participation in the research was voluntary and that participants had the right 
to decline to take part in the study at any time without treatment being withdrawn. Safety 
throughout the execution and compilation of the research project, including participant 
confidentiality and security of the data, was prioritised (i.e., participant identification codes 
were used to protect the anonymity and research material and data were stored in a locked 
filing cabinet). Participants were informed of the exceptions to confidentiality from the outset 
of the research (i.e., related to risk and safety) and were advised that full confidentiality in the 
group format could not be guaranteed but was strongly encouraged. If any risk of harm or 
safety issues arose the AOD service protocol was followed and participants were referred to 
the appropriate services. The research was considered low risk to the participants. The distress 
that could be induced by experiential activities and the discomfort of attending a group were 
considered the only potential harm. Participants’ distress was monitored throughout the 
group.  
Funding for the current research was obtained via the Massey University Post-
Graduate Research Fund. The vouchers provided in the study were funded by the supervision 
team’s research clusters. Dr Shane Harvey contributed on behalf of the cluster from the 
Community Health in Practicing Service (CHIPS) and Dr Simon Bennett contributed on 
behalf of the Te Kahui Rangahau Māori me Te Moana-nui-a-Kiwa ki te Hinengaro Tangata 
cluster. No conflicts of interest from funding sources were identified. The lead researcher and 
author of this thesis was also a co-facilitator of the group and collected the data, therefore the 




protocol of measures could not be scored blindly, and this may be considered a conflict of 
interest. However, the researcher and author as well as the co-facilitator conducted the study 
in accordance to the Code of Ethics for Psychologists Working in Aotearoa/New Zealand 
(2012). The integrity of research and ethical considerations are paramount, and the results 
presented in this thesis are genuine.  
Research Design  
Assessment and evaluation of the ACT-based group treatment programme was 
conducted to gain evidence for the efficacy of a transdiagnostic therapy applied to SUDs and 
coexisting problems. A repeated-measures design (within-subjects) was used via data 
collected at pre-treatment, mid-treatment, post-treatment, and three-month follow-up 
assessment phases. While a RCT or the use of comparison groups were desirable, it was 
beyond the scope of this research. Several attempts were made to collect data for a 
comparison group however this did not eventuate as outlined in the prologue. Given the 
current research was an exploration study, the data elicited from participants enrolled within 
the existing resources was used. This is principle described by Haynes (2012) as using “the 
patients I can get” (p. 139).  
Data Analysis 
 Quantitative data were analysed using the Statistical Package for the Social Sciences 
software (SPSS; version 20.0 for Windows, IBM Corp., Armonk, NY). Data were coded and 
entered into the SPSS database. Descriptive statistics for demographic variables of age, sex, 
ethnicity, levels of education, marital status, previous group experience, and if they were 
attending individual therapy throughout the group were also included. Preliminary analyses 
were completed and included checking the assumptions and internal consistency of the 
protocol of measures. Bivariate correlations were conducted as part of the preliminary 




analyses for the paired sample t-tests to evaluate any changes that occurred across all 
measures at the pre, mid, post, and follow-up treatment phases. Post treatment bivariate 
associations among dependent variables were analysed using Pearson product-moment 
correlation coefficient to evaluate any changes in relationships after the programme. Effect 
sizes were also reported to indicate the magnitude of change across the assessment phases.  
  





The research results chapter is presented in five sections. The first section presents the 
descriptive statistics across all participants. The second section provides the preliminary 
analyses of the data, in which specific measures were excluded due to poor internal 
consistency and the remaining measures were assessed for violations of normality. Following 
this, tests of statistical significance and magnitude of change are presented in line with the 
research hypotheses. It was hypothesised that participants would self-report improvements in 
mood management and mindfulness skills from the pre-group assessment phase when 
compared to mid and post-group scores. It was also expected that measures of alcohol use, 
substance use and cravings, stress, anxiety, and external locus of control would reduce from 
pre-group to mid and post-group assessment points. These changes were expected to be 
maintained or further strengthened at the three-month follow-up assessment phase. Bivariate 
correlations were also used to examine the following hypotheses: significant negative 
relationships between mindfulness levels are expected for substance use and cravings 
including the alcohol measures, as well as stress, anxiety, and the powerful others scale of 
external locus of control. A significant positive relationship between mindfulness tendencies 
and mood management was also predicted. Therefore, the results are summarised in a way 
that allows the predictions to be tested. The last section presents the feedback from 
supplementary measures obtained as additional anecdotal data, and this is examined to obtain 
the participants’ impression of the impact of the ACT-based group treatment programme.   
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 SECTION ONE: Descriptive Statistics 
No data were excluded from the analysis. The results for the pre-group assessment phase 
include data from all 39 participants, whereas 20 participants completed the follow-up group 
assessment phase, leaving this analysis to only include this cohort. The demographic 
characteristics across all assessment phases (pre, mid, post, and follow-up) are presented in 
Table 6. Of the 39 participants who completed the pre-group assessment phase, 18 were male 
(46.2%) and 21 were female (53.8%), with an average age of 39.80 years (SD = 12.08). Most 
of the pre-group assessment phase sample identified as NZ European (n = 31, 79%), single (n 
= 24, 62%), high school educated (n = 25, 64%), unemployed (n = 23, 60%), had participated 
in group work before (n = 24, 62%), and were receiving individual therapy or support (i.e. 
from a psychologist, clinical n = 8; intern n = 6, or an AOD counsellor or community mental 
health nurse n = 7) from AOD and other services (total n = 21, 54%). The range in concurrent 
therapies included individual ACT (n = 7), eye movement desensitisation and reprocessing 
(EMDR; n = 3), DBT (n = 1), CBT (n = 1), and AOD or ACC trauma or general counselling 
(n = 7). Some participants had more than one substance use problem and more than one 
coexisting mental health disorder. The severity of the substance use disorders and coexisting 
problems varied across participants. 
    At the follow-up assessment phase, the sample size reduced to 20 (49% reduction) resulting 
in an equal sex ratio (10:10). The sample’s demographic characteristics reduced 
proportionately across assessment phases except for age and the proportion of the sample on 
the Opioid Substitution Treatment (OST) programme. At follow-up the sample mean age was 
45 years (SD = 12.06 years). The pre-group sample included 12 participants (30% of the total 
pre-group sample size) on the OST programme, which decreased to five in the final sample 
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(58% reduction in the OST client population in the pre-group sample size). The majority were 
still NZE, single, high school educated, and unemployed.  
Table 6.  






















































































































































































                                                          
5 “In a relationship” encapsulates those that are in a non-cohabitating relationship as well as those who are in a 
defacto relationship or married. Single includes those who reported they were single, separated, divorced, or 
widowed.   








































































































Table 7 below presents all the dependent variable sample means, standard deviations, 
and standard errors of the means across all assessment phases. The standard deviations 
provide information about how much the participants differ from the mean value of each 
assessment point for each measure whereas the standard error of means measures the accuracy 
with which the sample represents a population.  
                                                          
6 This reflects the number of participants who endorsed using a substance in which the brackets represent those 
who identified the specific substance as their priority substance use problem. For example, 20 participants 
reported using alcohol with 17 reporting alcohol as their main substance use problem. No participant report 
tobacco as a substance use problem.   
7 Anxiety includes GAD, SAD, and other anxiety disorders. 
8 Mood includes depression and bipolar diagnoses. 
9 Medical conditions include chronic pain, multiple sclerosis, foot condition, and diverticulitis. 
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Table 7.  
Dependent Variable Sample Means, Standard Deviations, and Standard Errors of the Means Across all Assessment Phases. 
Dependent variable  Pre-group treatment 
n = 39 
Mid-group treatment 
n = 26  
Post-group treatment 
n = 25 
Follow-up-group treatment 
n = 20 
   SD  SEM   SD  SEM   SD  SEM   SD  SEM 
Audit-C 

















































































































































































































































































































































PSS-10 Total  21.90 6.70 1.07 20.35 6.40 1.25 18.17 6.11 1.25 20.05 8.50 1.90 
GAD-7 Total  10.84 5.63 0.90 10.27 4.83 0.95 7.92 4.38 0.88 8.75 6.40 1.43 


















































































MAAS Total 3.25 0.84 0.13 3.29 0.74 0.15 3.59 0.81 0.16 4.16 0.79 0.18 
Note:  = mean, SD = standard deviation, SEM = standard error of the mean, § = an abbreviation of ‘subscale’, AUDIT-C = Alcohol Use Disorder Identification Test – 
Consumption, ALC Section B = Alcohol Use Section B, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief Locus of Control 
Scale, Powerful Others§ = Powerful Others Subscale, TMMS = Trait Meta Mood Scale, Attention§ = Attention TMMS Subscale, Clarity§ = Clarity TMMS Subscale, Repair§ 
= Repair TMMS Subscale, MAAS = Mindfulness Attention Awareness Scale. Scores for cocaine, inhalants, hallucinogens, and “other” on the WHO-ASSIST V3.0 (World 
Health Organisation – Alcohol, Smoking, and Substance Involvement Screening Test Version 3.0) were excluded from the analysis due to minimal or no endorsement. 
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SECTION TWO: Preliminary Analyses 
Preliminary analyses involved checking the data and reverse scoring items to present the total 
scores across the measures, as well as rescaling certain measures to ensure accurate 
calculations of the totals (e.g., AUDIT-C scores were entered 1 to 5 and rescaled to 0 to 4). 
Cocaine, inhalants, hallucinogens, and “other” substances on the WHO-ASSIST V3.0 were 
excluded from the analysis due to minimal endorsement of use and cravings from participants 
across all groups at all assessment points. 
Internal consistency. Internal consistency is the degree to which items of a scale 
measure the same underlying construct. This is assessed by calculating the Cronbach’s alpha 
coefficient for each measure and subscale of the measures used in the current study. The 
protocol of measures was tested for internal consistency from participants’ responses across 
all assessment phases. The AUDIT-C (Alcohol use), Alcohol Use Section B (frequency and 
quantity of alcohol use in the past month), PSS-10 (Stress), GAD-7 (Anxiety), and MAAS 
(Mindfulness) measures were all found to have ‘good’ (α >0.8) to ‘excellent’ (α >0.9) internal 
consistency. Three subscales are used for the TMMS (Mood management) with the sum of 
scores across the subscales provides a total for this measure. While the total TMMS measure 
showed good internal consistency, the subscale attention at mid-group assessment point had 
‘poor’ internal consistency (α <0.7). However, for the final analyses, comparisons of scores 
collected at pre, post, and follow-up were considered most relevant and all were found to have 
‘fair’ (α >0.7) to good internal consistency. Clarity and Repair subscales across all assessment 
points fell within the good to excellent range. The BLOCS measure is also made up of three 
scales; internal, external chance, and external powerful others. The internal and external 
chance Cronbach’s alpha scores fell within the poor range across all assessment phases and 
therefore scores from these scales could not be included in the final analyses. However, the 
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BLOCS external subscale “Powerful Others” yielded fair to good internal consistency 
therefore this measure was included. Finally, the RPI measure returned a poor internal 
consistency score at both pre-group and mid-group assessment points therefore this measure 
is excluded due to no appropriate comparison point. 
Assumptions of normality. Initial observations of the data were completed by 
producing histograms for each measure across all assessment phases to obtain the pattern, 
frequency, and distribution of different scores. Histograms displayed whether the data were 
either negatively (data bunches to the left) or positively skewed (data bunches to the right) or 
if there was kurtosis present (scores are clustered in the middle or are flat). From these 
observations several trends were noted; for example, in the pre-group assessment phase for 
the AUDIT-C (Alcohol), scores showed a bimodal distribution (see Figure 5 below) in which 
there were two peaks in the data demonstrating two common types of responses by 
participants (either no alcohol use or significant alcohol use).   
Figure 5. Histogram demonstrating the bimodal pattern of responses that indicates a 
variation from normally distributed data for participants alcohol use via the AUDIT-C. 
  RESULTS 
99 
 
While the histograms provided a first-hand indication of the distribution, specific tests 
of normality were used to identify whether the data significantly varied from normality such 
as the Kolmogorov-Smirnov and Shapiro-Wilk tests. The key measure for these tests was the 
difference between scores from the assessment phases compared. To do this a new variable 
was computed by calculating the difference between the total means for the assessment points 
compared (i.e., pre-group versus post-group) across all measures (see Figure 6 below for an 
example).  
 
Figure 6. Histogram demonstrating kurtosis (peaked clustered scores in the middle) in the 
differences between pre-group scores and post-group scores on the AUDIT-C. 
A non-significant result from the tests of normality indicates that the assumption has 
not been violated and therefore parametric tests are suitable for analysis. For the current study 
a repeated measures design deems paired samples t-tests as appropriate to detect statistical 
significance between the same samples at two different time points. Significant scores 
indicate that a non-parametric test such as the Wilcoxon signed rank test should be used to 
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compare such data as an alternative to the repeated measures paired samples t-test. The 
AUDIT-C and Alcohol Use Section B scores as well as the WHO-ASSIST V3.0 (Substance 
use and cravings) violated the assumption of normality therefore non-parametric tests were 
utilised with these data. Ad-hoc data transformations were not conducted as a way of 
normalising the distribution of changes. Instead, the non-parametric approach addressed the 
issue of skewed responses on the substance specific measure, which as a population 
struggling with alcohol and other drugs problems was expected. The PSS-10, GAD-7, 
TMMS, and MAAS all produced non-significant results for tests of normality therefore paired 
samples t-tests were applied to these measures.  
Further graphic display of the data via scatterplots provided a visual aid for 
demonstrating the relationship between two variables as well as identifying outliers as part of 
the preliminary analyses for conducting correlation calculations. An upward trend indicates a 
positive relation where high scores on the X axis occur with high scores on the Y axis. A 
negative relation is where increasingly high scores on the X axis are associated with 
increasingly low scores on the Y axis. Through these preliminary analyses, several trends 
were observed in the data before conducting statistical significance testing and bivariate 
correlations. For example, Figure 7 below depicts the relationship between participants’ 
responses on the AUDIT-C at pre-group compared to post-group. This positive trend indicates 
that high and low drinkers remained high and low drinkers at post-group relative to other 
participants’ drinking patterns. However, the scatterplot also identifies those who increased 
their use. Those responses that fall below the reference line (a diagonal line on the scatterplot 
which demonstrates where pre-group scores are the same as post-group scores, in this case, if 
a participant reported no change in alcohol use between pre and post group assessments then 
that participant’s data point would fall directly on the reference line to indicate no change)  
indicate an overall reduction in alcohol use at post-group assessment phase. Markers are 
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colour coded to indicate the scores of in male and females. Overall, there were no statistically 
significant differences between male and females’ responses for all measures across all 
assessment points.  
Figure 7. Scatterplot demonstrating the relationship between participants’ responses at 
pre-group compared to post-group for the AUDIT-C. 
Completers and non-completers analysis. An additional analysis compared 
participants scores who completed the ACT group (n = 20) against those who did not (n = 19) 
obtained at the pre-group assessment phase. This analysis aimed to explore any meaningful 
differences between the participants who completed and those who did not. An independent 
samples t-test was conducted for PSS-10 (stress), GAD-7 (anxiety), TMMS (mood), and 
MAAS (mindfulness) and showed no statistically significant differences. A Mann-Whitney, 
non-parametric tests also found no statistically significant differences between completers and 
non-completers of the ACT group for alcohol and substance use and cravings. This indicates 
that the self-reported rates of substance use and coexisting problems, as well as mindfulness 
did not differ significantly between those who left the ACT group and does not indicate that 
those who left were significantly worse in their self-reported symptoms.
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SECTION THREE: Statistical Significance Testing and Magnitude of Change 
Parametric tests, paired samples t-tests, and non-parametric tests, Wilcoxon signed rank tests, 
were used to calculate the statistical significance of the differences between participants’ 
scores for six pairs of comparisons of assessment phases10 as per the research hypotheses (i.e. 
pre-group versus post-group, pre-group versus follow-up, post-group versus follow-up, pre-
group versus mid-group, mid-group versus post-group, and mid-group versus follow-up).  The 
differences in how these tests are calculated are below in Figures 8 and 9.  
 
 
Figure 8. Paired samples t-test formula.   
The paired samples t-test formula given above in Figure 8, where the difference 
between the means from the same sample of participants is calculated using two different 
assessment phase scores and the statistical significance of the difference between the means 
for the comparison being made is obtained. x1 and x2 are the mean scores from time one (e.g., 
pre-group) and time two (e.g., post-group). µ is the mean of the population of differences with 
n representing the number of paired samples. 
 
                                                          
10 Note: SPSS excludes cases that do not have data from each comparison point. This means that those who left 
the ACT group at the pre-assessment phase were not included in the comparisons for mid, post, and follow up 
comparisons. The number of cases being compared are presented in number of observations on Table 8 and 
the degrees of freedom on Table 9.  




Figure 9. The formula for Wilcoxon signed rank test.  
The Wilcoxon signed rank statistic is calculated by the using the median of two 
distributions when comparing assessment phases using a small sample and with data that are 
not normally distributed. 
While significance testing is important, the results do not convey the degree of change 
that has occurred between the two comparison points. Therefore, effect sizes were calculated 
to establish the magnitude of change for both parametric and non-parametric tests. Paired 
sample t-test effect sizes are presented using the effect size correlation r. Guidelines for 
interpreting effect sizes using Cohen’s (1988 as cited in Pallant, 2005) criteria are that 0.1 
represents a small effect, 0.3 medium, and 0.5 as large effect. This involves the square root of 
the portion of variance shared by the two variables using the degrees of freedom as depicted 
below in Figure 10. 
r = √(t2 / (t2 + df)) 
Figure 10. Effect size correlation r formula for parametric tests  
The Wilcoxon signed rank test effect sizes, as described by Pallant (2007), are 
calculated by dividing the Z value by the square root of N (for this purpose N is the number of 
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observations over the two time points instead of the number of cases). The same guidelines 
for Cohen’s criteria can be applied in which the r value is presented and scores of 0.1 
represent small, 0.3 medium, and 0.5 large effect. When using a Wilcoxon signed rank test to 
calculate the effect size the Z score is divided by the square root of number of observations in 
order to give the r value (see Figure 11.). 
 
Figure 11. Effect size estimator formula for non-parametric tests.  
Alcohol use and substance use and cravings results. Table 8 presents the Wilcoxon 
signed rank tests results and effect sizes for the alcohol and substance use measures across all 
pairs of comparisons as the data violated the assumptions required for parametric testing. It 
was hypothesised that reductions would be observed for alcohol and other drug use and 
cravings at mid-group and post-group when compared to participants scores at the pre-group 
assessment phase. Reductions in alcohol use and substance use and cravings were expected to 
be maintained or even further reduced at three-month follow-up. Wilcoxon signed rank tests 
are presented with Z values that reflect the difference between the two scores being measured 
accompanied with the p value that provides the significance level (two tailed) showing 
whether or not the two scores are statistically significant. Negative Z values represent a 
reduction in use and cravings whereas positive Z values indicate an increase in use and 
cravings with p values reported as reaching either 0.01 or 0.05 significance level or not being 
significant.  Effect size calculations for the Wilcoxon signed rank tests are presented as r 
values, keeping in mind the different formulas used to calculate these effect sizes as outlined 
above.    
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Table 8.  
Wilcoxon signed rank tests for Alcohol and Other Drug Measures Across all Comparison Points. 
Dependent variable 
(N of observations) sqrt(N) 
Pre versus Post 
(25) 5 
Pre versus Follow-up 
(20) 4.47 
Post versus Follow-up 
(20) 4.47 
Values  z p r z p R z p r 
AUDIT-C -1.05 0.29 0.21 -1.54 0.12 0.35 -1.42 0.16 0.32 










































































































































































































(N of observations) sqrt(N) 
Pre versus Mid 
(26) 5.10 
Mid versus Post 
(24) 4.90 
Mid versus Follow-up 
(20) 4.47 
Values 
z p r z p R z p r 
AUDIT-C -0.05 0.96 0.01 -1.61 0.11 0.33 -1.74 0.08 0.35 
ALC Section B -0.54 0.59 0.11 -0.06 0.96 0.01 -1.26 0.21 0.08 











































































































































































































Note: z value = z score statistic, p value = significance level, * = significant at the 0.05 level (2-tailed), ** = significance at the 0.01 level, r value = effect size, sqrt(N) = 
square root of the number of observations, AUDIT-C = Alcohol Use Disorder Identification Test – Consumption, ALC Section B = Alcohol Use Section B. Substance scores 
obtained from WHO-ASSIST V3.0 = World Health Organisation –Alcohol, Smoking, and Substance Involvement Screening Test Version 3.0 (excluding alcohol).  
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Alcohol use comparisons. Participants’ alcohol use was measured through the 
AUDIT-C as well as three additional questions (Alcohol Use Section B – ALC Section B) 
regarding frequency and quantity of use in the past month. The AUDIT-C results are scored 
on a scale of 0-12 in which higher scores indicate higher levels of hazardous alcohol 
consumption.  
Reductions in alcohol use can be seen in Figure 12, however, these changes did not 
reach statistical significance for any pair of comparisons. This indicates that participants’ 
alcohol use prior to the ACT-based group treatment programme was not significantly 
different at post-group (p = 0.29) with only a small to medium effect size (r = 0.21). The same 
trend was observed at the three-month follow-up assessment phase (p = 0.12) with a moderate 
effect size (r = 0.35).   
Figure 12. Line graph depicting AUDICT-C mean scores across all assessment 
phases. 
Alcohol Use Section B asks participants on how many days in the past month they 
consumed at least one drink, then at least four drinks, and lastly on how many days they 
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consumed more than eight drinks. The number of days out of the month endorsed for each 
question were summed to provide the total score for Alcohol Use Section B depicted as ALC 
Section B in Table 9. Higher scores indicate more frequent and higher quantity of recent 
alcohol use.  
Again, a general trend demonstrating reductions in alcohol use can be observed in 
Figure 1311 on the following page. Similar results for Alcohol Use Section B to the AUDIT-C 
results were found in that these changes did not reach statistical significance. Pre and post 
comparisons showed non-significant results (p = 0.34) with a small effect size (r = 0.19), with 
pre and follow-up comparisons also showing non-significant results (p = 0.10) with moderate 
effect size (r = 0.35). Although there was no statistical difference between pre-post-follow-up 
for alcohol use on both measures, there was a moderate effect size demonstrating a trend in 









                                                          
11 The error bars for Figure 13c and 13d extend into negative estimates as an artefact of the non-symmetrical 
distribution of the data. 
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Figure 13. Line graph depicting Alcohol Use Section B a) questions combined mean scores, 
b) question one (1 drink), c) question two (+4 drinks), d) question three (+8 
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Substance use and cravings comparisons. The WHO-ASSIST V3.0 was used to 
obtain participants’ self-reported level of substance use and cravings on a five-point Likert 
scale of ‘never’ to ‘daily or almost daily’. Specific substances were analysed separately for 
use and for cravings and then as combined totals (sum of use and cravings) across all pairs of 
comparisons. 
Tobacco use comparisons. Unexpected significant statistical increases in tobacco use 
were noted between pre-group and mid-group tobacco use scores (Z = - 3.72, p<0.01) with a 
large effect size (r = 0.73). Significant reductions were then observed between mid-group and 
post-group scores for tobacco use (Z = 4.03, p<0.01) with a large effect size detected (r = 
0.90). No further significant changes were found between post-group and follow-up scores (p 
= 0.63) with a small effect size (r = 0.11) indicating minor change. Figure 14a clearly 
demonstrates that tobacco use was still increased at post-group compared to pre-group 
tobacco use yet the difference in scores were non-significant (p = 0.19) and yielded a small 
effect size (r = 0.26). Pre-group and three-month follow-up scores were also non-significant 
(p = 0.12) with a moderate effect size (r = 0.35). However, this still showed an increase in 
tobacco use compared to pre-group which does not support the hypothesis that the ACT group 
would reduce tobacco use at post and follow-up assessment phases.  
Tobacco cravings comparisons. Across all assessment phases for tobacco cravings 
scores did not significantly differ (see Figure 14b) and their effect sizes were small (r <0.2) 
thereby not supporting the original hypothesis that reductions in self-reported cravings would 
be observed from pre to mid, mid to post, post to follow-up, as well as significant reductions 
observed when comparing pre-group scores to the post and follow-up scores.  




Figure 14. Line graph depicting mean scores across all assessment phases for a) tobacco use 
and b) tobacco cravings.   
Total tobacco comparisons. When combining scores for tobacco use and cravings, 
these totals produced statistically significant increases between pre-group and mid-group 
scores (Z = -3.36, p<0.01) with a large effect size (r = 0.65). Whereas total tobacco scores for 
mid-group and post-group showed statistically significant reductions (Z = -3.82, p<0.01) with 
another large effect size detected (r = 0.85). No significant change was noted between post-
group and follow-up scores (p = 0.54) with a small effect size (r = 0.14) indicating a minor 
increase in total tobacco scores. Total tobacco scores between pre and post-group were non-
significant (p = 0.34) and had a small effect size (r = 0.19). Pre-group and follow-up data 
were also not statistically significant (p = 0.13) but this comparison showed a moderate effect 
size (r = 0.34) which is indicative of a moderate level of change to participants’ overall 
tobacco scores for both use and cravings.  However, these changes were indicative of an 
increase in tobacco use and cravings rather than a decrease (see Figure 15).  
 
a) b) 
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Figure 15. Line graph depicting the total tobacco mean scores across all assessment 
phases. 
Cannabis use comparisons. No significant changes were found between any 
comparison pairs for cannabis use. Scores between mid-group and post-group showed no 
change whatsoever (p = 1.00, r = 0). A moderate effect size was detected between post-group 
and follow-up scores (r = 0.32) indicating moderate reductions in cannabis use, however 
differences were not significant (p = 0.13). Figure 16a demonstrates a reduction trend that 
supports the hypothesis that an ACT group can reduce participants’ self-reported cannabis 
use.  
Cannabis cravings comparisons. Again, no significant changes were found between 
any comparisons across assessment phases as shown in Figure 16b. Pre-group and post-group 
scores for cannabis cravings yielded non-significant results and minimal change (p = 0.90, r = 
0.02) with pre-group and follow-up scores also showing non-significant changes and minimal 
change (p = 0.13, r = 0.09).  




Figure 16. Line graphs depicting a) cannabis use mean scores and b) cannabis 
cravings mean scores across all assessment phases.  
Total cannabis comparisons. Cannabis use and cravings scores combined represent 
the total cannabis scores depicted in Figure 17. The results show that even when combining 
use and cravings scores for cannabis there is minimal change throughout the group, by the end 
of group, and at the three-month follow-up. Interestingly, total cannabis scores showed an 
unexpected increase from pre-group and mid-group (p = 0.13) with a moderate effect size 
detected (r = 0.30). Reductions were observed from mid-group to post-group and follow-up in 
line with predictions, however, these changes were not significant (p = 1.0). Pre and post 
comparisons were also not significant (p = 0.68) with small effect size detected (r = 0.08). 
Non-significant results were also found between pre and follow-up comparisons (p = 0.26) 
with small changes noted (r = 0.25). Due to the increase at mid-group scores the difference 
between scores at the three-month follow-up approached significance (p = 0.06) with a 
moderate to large effect size detected (r = 0.42) which is indicative of reductions in line with 
the research hypotheses.  
 
a) b) 
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Figure 17. Line graph depicting the total cannabis mean scores across all assessment 
phases. 
Amphetamine use comparisons. No statistically significant results were found for pre-
group and mid-group comparisons for amphetamine use (p = 0.71); however, as seen in 
Figure 18a, there is an increase, rather than decrease, in amphetamine use scores. From mid-
group, reductions were noted at post-group (p = 0.32) and follow-up (p = 0.26) assessment 
phases. Yet these changes were not statistically significant and yielded a small effect size for 
post-group scores (r = 0.22) and a moderate effect size for follow-up scores (r = 0.36). Pre-
group and post-group comparisons also showed reductions but were not significant results (p 
= 0.71). Further non-significant results for pre-group and follow-up comparisons (p = 0.32) 
were also found. However, effect sizes indicate that these reductions were small to moderate 
(r<0.29).  
Amphetamine cravings comparisons. Reductions in self-reported amphetamine 
cravings can be observed in Figure 18b; however, these reductions were not statistically 
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significant. Mid-group and post-group amphetamine cravings scores did not change at all (p = 
1.00) with the effect size showing no change as well (r = 0). Pre-group and post-group 
comparisons did not reach significance (p = 0.46) and had a small effect size (r = 0.15). Pre-
group and follow-up comparisons were also not significant (p = 0.12). Yet a moderate effect 
size (r = 0.35) indicates there was moderate reductions in participants’ reports of 
amphetamine cravings three months post-group.  
 
Figure 18. Line graph depicting a) amphetamine use mean scores and b) amphetamine 
cravings mean scores across all assessment phases.  
Total amphetamine comparisons. Amphetamine use and cravings scores combined 
represent the total amphetamine scores depicted in Figure 19. Pre-group and post-group 
analysis of amphetamine total means (p = 0.47) found no significant reduction accompanied 
by a small effect size (r = 0.15), suggesting minimal change. Total amphetamine scores 
between mid-group and follow-up comparison approached significance (Z = - 1.77, p = 0.08) 
with a moderate effect size indicating moderate reductions in amphetamine use and cravings 
combined (r = 0.40). A statistically significant reduction was detected between pre-group and 
follow-up comparisons for total amphetamine scores (Z = -2.20, p = 0.04) with a moderate 
effect size (r = 0.45) detected in line with the current study’s hypotheses.   
 
a) b) 




 Figure 19. Line graph depicting the total amphetamine mean scores across all 
assessment phases.  
Sedative use comparisons. Pre to mid-group comparisons for sedative use yielded non-
significant results (p = 0.76) and small effect size (r = 0.06). However mid to post 
comparisons for sedative use found statistically significant change (Z = -2.84, p = 0.01) with a 
large effect size detected (r = 0.63). Post-group and the three-month follow-up data found no 
significant results (p = 0.83) and a small effect size indicative of minimal change (r = 0.05). 
Significant change was detected for sedative use between pre and post-group comparisons (Z 
= -2.07, p = 0.04) with a moderate effect size (r = 0.41) as depicted in Figure 20a. Pre and 
follow-up sedative use comparison yielded a non-significant result (p = 0.24) with a small 
effect size (r = 0.26).  
Sedative cravings comparisons. An unexpected statistically significant increase for 
sedative cravings between pre-group and mid-group comparisons (Z = -2.09, p = 0.04) with a 
  RESULTS 
117 
 
moderate effect size was detected (r = 0.41). However, mid to post-group comparisons 
showed a non-significant decrease (p = 0.06) with another moderate effect size detected (r = 
0.42). Post-group and follow-up scores did not significantly differ (p = 0.73) and showed a 
small effect size (r = 0.08). Pre to post comparisons for cravings found no significant results 
(p = 0.13) however there was a moderate effect size detected (r = 0.30) indicating a moderate 
increase between participants cravings prior to group and the end of group (see Figure 20b). 
Comparisons for pre-group and follow-up scores (p = 0.47) as well as post-group and follow-
up (p = 0.73) yielded non-significant results and small effect sizes (r<0.16). 
 
Figure 20. Line graphs depicting a) sedative use mean scores and b) sedative cravings 
mean scores across all assessment phases. 
Total sedative comparisons. When combining scores for sedative use and cravings 
several comparisons yielded non-significant results including post to follow-up (p = 1.00), pre 
to post (p = 0.75), pre to follow-up (p = 0.83), with small effect sizes detected (r <0.06). As 
Figure 21 shows total scores between pre and mid-group increased, rather than decreased. 
However statistically significant reductions between mid-group and post-group scores (Z = -
3.11, p<0.01) with a large effect size (r = 0.70) were found. Mid-group and follow-up 
comparisons approached significance (p = 0.08) and found moderate effect sizes (r<0.40) 
indicating moderate reductions.  
a) b) 
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Figure 21. Line graph depicting the total sedative scores across all assessment phases. 
Opioid use comparisons. Pre to mid-group comparisons found no significant results 
for opioid use (p = 0.25) with small effect size (r = 0.23) indicating minimal increase as seen 
in Figure 22a. Mid to post-group comparisons also found no significant differences for opioid 
use (p = 0.36) with another small effect size detected (r = 0.21) but indicating small 
reductions rather than increases. Post to follow-up comparisons also found no significant 
change (p= 0.49) for opioid use with a small effect size (r = 0.15). No significant results were 
detected for comparisons between pre-group and post-group scores (p = 0.52) and between 
pre-group and follow-up scores (p= 0.73) with small effect sizes (r <0.15) indicating minimal 
changes.  
Opioid cravings comparisons. Figure 22b demonstrates the trend in participants self-
reported opioid cravings during group and at three months post intervention.  Again, 
unexpected increases were found between pre and mid-group scores (p = 0.16) as well as mid 
and post-group scores (p = 0.94) although these were not statistically significant and yielded 
small effect sizes (r<0.29). Whereas statistically significant reductions were observed 
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between post and follow-up cravings (Z = -2.04, p = 0.04) with large effect size detected (r = 
0.46) indicating large reductions for opioid cravings occurred three months post intervention. 
Pre and post-group comparisons showed non-significant results (p = 0.14) yet a moderate 
effect size was detected (r = 0.30) indicating moderate increases in cravings. Pre and follow-
up comparisons also found non-significant differences (p = 0.32) with a small effect size (r = 
0.22) indicating minimal reductions in participants’ opioid cravings prior to the group and 
three months following group.  
 
Figure 22. Line graphs depicting a) opioid use mean scores, b) opioid cravings mean 
scores across all assessment phases.  
Total opioid comparisons. Opioid use and cravings scores combined also showed 
increases rather than decreases across pre-mid-post comparisons as seen in Figure 23. 
Increases from pre to mid-group scores were not statistically significant (p = 0.09) with a 
moderate effect size detected (r = 0.33). Mid to post-group scores also increased however this 
was not statistically significant (p = 0.53) with a small effect size (r = 0.14) indicating this 
increase was minimal. However, post to follow-up comparisons yielded statistically 
significant reductions (Z = -2.06, p = 0.04) with a moderate to large effect size found (r = 
0.46). Pre and post-group comparisons were not statistically significant (p = 0.50) with a 
small effect size (r = 0.13) indicating reductions in scores at post-group were small. Non-
a) b) 
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significant reductions were also found between pre-group and follow-up scores (p = 0.73) 
with a small effect size (r = 0.08) indicating participants’ total self-reported opioid use and 
cravings were not significantly different to when they first started group.      
Figure 23. Line graph depicting the total opioid mean scores across all assessment 
phases.  
Exclusion of non-alcohol users and non-substance users’ analysis. Upon reviewing 
the data, a possible floor effect may have occurred due to including participants results who 
reported no alcohol or substance use across all assessment phases in the analysis. To account 
for any floor effect, each substance was analysed by excluding participants who reported no 
use or cravings for specific substances from each substance analysis. For example, 
participants who reported no amphetamine use or cravings across all assessment phases were 
excluded from the amphetamine analysis.  The results of this adjustment led to no change in 
outcomes and by implication, lowered the likelihood a floor effect occurred.    
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Coexisting problems results. Table 9 presents the paired sample t-tests results for the 
coexisting problems measured via the protocol of measures across all assessment phase 
comparisons. For the means, standard error of means, and standard deviation of these 
assessment phases see Appendix L. It was hypothesised that the transdiagnostic nature of 
ACT would result in significant reductions observed in participants’ self-reported measures of 
stress, anxiety, and external locus of control for powerful others throughout the group at pre-
mid-post comparisons. It was also hypothesised that significant improvements would be 
observed in mindfulness and mood management skills throughout group at pre-mid-post-
group comparisons. These changes were expected to be maintained or further improved at the 
three-month follow-up. T-test results are presented based on the t value which is the 
difference between the two means being compared and the degrees of freedom (df) 
representing the number of values in the final calculation that are free to vary. The p value 
represents the significance level (two tailed) that shows if the two scores are statistically 
significantly different. Positive values are expected to be found for the mood management 
measures (TMMS) and mindfulness measure (MAAS) and represent an improvement in 
skills. Negative values are expected for the stress, anxiety, and external locus of control 
measures and represent a reduction in stress, anxiety, and the belief that powerful others have 
control over participants’ lives. Effect sizes are represented using the effect size correlation r. 
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Table 9.  
Paired sample t-test for Coexisting Problems Measures and Mindfulness Measure Across all Comparison Points. 
Dependent variable 
(df) 
Pre versus Post 
(24) 
Pre versus Follow-up 
(19) 
Post versus Follow-up 
(19) 
Values t p r t p r t p r 
PSS-10 
 
3.69 0.00** 0.60 0.63 0.54 0.14 -2.17 0.04* 0.45 
GAD-7 2.60 0.02* 0.47 0.88 0.39 0.20 -0.66 0.50 0.16 
BLOCS§ 2.85 0.01** 0.50 0.35 0.73 0.08 -1.31 0.21 0.29 
TMMS -4.07 0.00** 0.64 -1.88 0.08 0.40 0.67 0.51 0.15 
ATTN§ 0.00 1 0 0.77 0.45 0.17 0.60 0.55 0.14 
CLAR§ -6.34 0.00** 0.69 -3.59 0.00** 0.64 1.30 0.21 0.64 
REP§ -2.71 0.03* 0.44 -1.91 0.07 0.40 -0.84 0.41 0.19 
MAAS -1.74 0.01 0.44 -2.87 0.01** 0.40 -2.82 0.01** 0.55 
Dependent variable 
(df) 
Pre versus Mid 
(25) 
Mid versus Post 
(23) 
Mid versus Follow-up 
(19)  
Values t p r t p r t p r 
PSS-10 2.00 0.06 0.37 2.43 0.02* 0.45 -0.46 0.65 0.10 
GAD-7 1.44 0.16 0.28 1.97 0.06 0.38 0.09 0.93 0.02 
BLOCS§ 0.77 0.45 0.15 0.75 0.46 0.15 -1.24 0.23 0.27 
TMMS -1.93 0.07 0.36 -2.53 0.02* 0.47 0.67 0.51 0.15 
ATTN§ 1.59 0.13 0.30 -1.41 0.17 0.28 0.60 0.55 0.14 
CLAR§ -3.97 0.00** 0.62 -2.47 0.02* 0.46 -0.96 0.35 0.22 
REP§ -1.02 0.32 0.20 -1.65 0.08 0.32 -1.60 0.13 0.34 
MAAS -0.02 0.99 0.00 -1.86 0.08 0.36 -3.37 0.00** 0.61 
Note: t value = T-test statistic, p value = significance level, * = significant at the 0.05 level (2-tailed), ** = significance at the 0.01 level, r value = effect size, df = degrees of 
freedom, § = an abbreviation of ‘subscale’, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief Locus of Control Scale, Powerful 
Others§ = Powerful Others Subscale, TMMS = Trait Meta Mood Scale, Attention§ = Attention TMMS Subscale, Clarity§ = Clarity TMMS Subscale, Repair§ = Repair 
TMMS Subscale, MAAS = Mindfulness Attention Awareness Scale. BLOCS scales for internal locus of control and external chance locus of control were also excluded. 
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Perceived stress comparisons. The PSS-10 collected data on participants self-reported 
levels of perceived stress in the last month. Scores were calculated on a four-point Likert 
scale with higher scores indicating higher levels of perceived stress.  
 
Figure 24. Line graph depicting perceived stress (PSS-10) mean scores across all 
assessment phases.   
Pre-mid-group comparisons: As shown in Figure 24 reductions in stress scores 
between pre-group and mid-group were observed; however, the differences in scores only 
approached statistical significance (p = 0.06) yet the effect size effect size (r = 0.37) indicated 
moderate reductions. 
Mid-post-group comparisons: Statistically significant reductions were achieved 
between mid-group and post-group scores as predicted (t (23) = 2.43, p= 0.02) with a 
moderate to large effect size (r = 0.45) detected. 
Post-follow-up-group comparisons: Although statistically significant change occurred 
between post-group and follow-up scores, this change indicated an increase in stress levels 
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rather than a decrease (t (19) = - 2.17, p = 0.04) with a moderate to large effect size detected 
(r = 0.45).  
Pre-post-group comparisons: As hypothesised there was a statistically significant 
reduction in perceived stress scores between pre and post-group scores (t (24) = 3.69, p<0.01) 
with a large effect size detected (r = 0.60), indicating participants self-reported levels of 
perceived stress were significantly reduced by the end of the ACT group.  
Pre-follow-up comparisons: Although the increase in follow-up scores were not as 
high as pre-group scores, this reduction in perceived stress was not statistically significant (p 
= 0.54) with a small effect size detected (r = 0.14). These results indicate that although the 
ACT group appears to reduce stress levels post-group, these changes are not maintained at the 
three-month follow-up and a rebound effect has occurred.  
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Anxiety comparisons. Scores obtained from the GAD-7 indicate participants levels of 
anxiety in the past two weeks on a four-point Likert scale. Higher scores suggest higher levels 
of anxiety. Figure 25 below presents the trend in anxiety scores across all assessment phases.  
Figure 25. Line graph depicting anxiety (GAD-7) mean scores across all assessment 
phases.   
Pre-mid-group comparisons: Anxiety scores between pre-group and mid-group 
approached statistical significance (p = 0.16) with a small to moderate effect size found (r = 
0.28), indicating that moderate reductions in anxiety levels were observed mid-group.  
Mid-post-group comparisons: This trend continued between the mid-group and post-
group scores in which results approached statistical significance (p = 0.06) with another 
moderate effect size detected (r = 0.38). These results indicate that although there were steady 
reductions in anxiety levels throughout group, these changes did not reach statistical 
significance.  
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Post-follow-up-group comparisons: However, a non-significant increase in self-
reported anxiety symptoms at the three-month follow-up assessment phase compared to post-
group was found (p = 0.50) with a small effect size (r = 0.16). This pattern of scores was also 
observed for the stress measures between post-group and follow-up, that is, self-reported 
symptoms increased rather than decreased for both stress and anxiety which again suggests a 
rebound effect has occurred.  
Pre-post-group comparisons: As hypothesised a paired sample t-test revealed a 
statistically significant decrease in self-reported symptoms of anxiety from pre-group to post-
group (t (24) = 2.60, p = 0.02) with a moderate to large effect size detected (r = 0.47). 
Pre-follow-up-group comparisons: Although there was a reduction in scores between 
pre-group and follow-up, a paired sample t-test yielded non-significant results (p = 0.39) with 
only a small effect size detected (r = 0.20). Again, these results show that there were 
reductions in anxiety symptoms throughout group, these reductions were not maintained at 
the three-month follow-up with a rebound effect observed again. 
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External locus of control – ‘powerful others’ comparisons. As the other subscales of 
the BLOCS measure were not included in the data analysis due to poor internal consistency, 
the powerful others subscale is the only BLOCS measure included as it had fair to good 
Cronbach’s alpha scores. This measure rates the perceived locus of control on a five-point 
Likert scale. Those who score highly on this subscale perceive powerful others to have more 
control over their life compared to their own internal locus of control.  
Figure 26. Line graph depicting locus of control (BLOCS§) external subscale 
‘powerful others’ mean scores across all assessment phases.  
Pre-mid-group comparisons: Reductions between pre and mid-group scores were 
observed (see Figure 26) yet these differences did not reach statistical significance (p = 0.45) 
with a small effect size detected (r = 0.15).  
Mid-post-group comparisons: Similar results were observed for this comparison in 
that reductions were non-significant (p = 0.46) with the same small effect size detected (r = 
0.15).  
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Post-follow-up-group comparisons: Scores for this comparison show an increase 
rather than a decrease (p = 0.21) with a small to moderate effect size detected (r = 0.29) 
which was unexpected yet similar to the stress and anxiety results showing a rebound effect.  
Pre-post-group comparisons: As hypothesised, a statistically significant decrease in 
participants scores was found between pre and post-group assessment phases (t (24) = 2.85, p 
= 0.01) with a moderate to large effect size detected (r = 0.50). 
Pre-follow-up-group comparisons: Reductions in external locus of control for 
powerful others was not maintained at the three-month follow-up in which non-significant 
results were found (p = 0.73) with a small effect size (r = 0.08) indicating minimal change 
between pre-group and follow-up scores, thus not supporting the research hypothesis.  
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Mood management comparisons. Self-reported mood management skills were 
examined via the TMMS which comprises of three subscales; attention, clarity, and repair. 
These are measured on a five-point Likert scale with the sum of all three subscales indicating 
a person’s total mood management ability.  
Attention subscale results. The attention subscale comprises of 13 items that indicate a 
person’s awareness of moods and emotions. Figure 27 on the following page demonstrates 
the changes in attention scores across all assessment phases. Although no statistically 
significant results were found for this subscale when comparing pre-group and mid-group 
scores (p = 0.13), there was an improvement in participants’ scores with a moderate effect 
size detected (r = 0.30). However, mid to post-group comparisons found scores decreased 
rather than increased but not to a statistically significant level (p = 0.17) and with a small 
effect size (r = 0.28) which is not in line with the research hypothesis. Post to follow-up 
comparison showed an improvement in attention to mood scores; however, these results were 
not statistically significant (p = 0.55) and showed a small effect size (r = 0.14).  
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Figure 27. Line graph depicting mood management (TMMS§) subscale ‘Attention’ 
mean scores across all assessment phases. 
Pre and post-group comparisons showed no difference at all between scores for the 
attention subscale (p = 1.00) indicating no change in scores evidenced by an effect size of 0. 
Pre-group and follow-up comparisons showed a decrease rather than increase in attention to 
mood scores. However, this change did not reach statistically significant levels (p = 0.45) and 
had a small effect size (r = 0.17). These results do not support the research hypothesis for this 
measure and indicate that participants ability to increase awareness of emotions and mood 
states was not improved following the ACT-based treatment group programme.  
Clarity subscale results. The clarity subscale comprises of 11 items that indicate a 
person’s ability to clearly discriminate between moods. Figure 28 on the following page 
demonstrates the changes in clarity scores across all assessment phases. As predicted pre-
group and mid-group comparisons found statistically significant improvements in clarity of 
moods (t (24) = - 3.97, p<0.01) with a large effect size (r = 0.62). Further significant 
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improvements were found between mid-group and post-group scores (t (23) = - 2.47, p = 
0.02) with a moderate effect size detected (r = 0.46) which thus far supports the research 
hypothesis. However, post-group and follow-up comparisons found clarity scores decreased 
rather than increased which does not support the original hypothesis. This change did not 
reach statistical significance (p = 0.21) yet a large effect size was detected (r = 0.64).  
Figure 28. Line graph depicting mood management (TMMS§) subscale ‘Clarity’ 
mean scores across all assessment phases. 
Pre and post-group comparison found a statistically significant increase in clarity 
scores (t (24) = - 6.34, p<0.01) with a large effect size detected (r = 0.69) as predicted. These 
results were further maintained between pre-group and follow-up scores reaching statistical 
significance (t (19) = -3.58, p< 0.01) with a large effect size (r = 0.64) which also supports 
the proposed hypothesis. 
Repair subscale results. The repair subscale comprises of six items that indicate a 
person’s ability to regulate their moods and emotions. Figure 29 below demonstrates the 
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changes in repair scores across all assessment phases. Pre-group and mid-group scores show 
an improvement however they did not reach statistical significance (p = 0.32) with a small 
effect size detected (r = 0.20). Mid-group versus post-group scores also showed an 
improvement that approached statistical significances (p = 0.08) and found a moderate effect 
size (r = 0.32). Similar trends were also found between post-group and follow-up data (p = 
0.41) with a small effect size (r = 0.19) indicating small improvements in participants’ self-
reported ability to regulate moods. While these results are in line with the research hypothesis 
they did not reach statistical significance. 
Figure 29. Line graph depicting mood management (TMMS§) subscale ‘Repair’ mean 
scores across all assessment phases. 
Pre and post-group comparisons found statistically significant improvement in mood 
repair skills (t (24) = - 2.71, p = 0.03) with a moderate effect size found (r = 0.44). Pre-group 
versus follow-up scores also showed improvements in ability to regulate moods with the 
results only approaching statistical significance (p = 0.07) yet a moderate effect size was 
found (r = 0.40). These results indicate that although participants were able to improve their 
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ability to regulate their moods following an ACT-based group treatment programme these 
improvements did not reach a statistically significant level.  
Total mood management. When participants score on the above subscales were 
summed (all 30 items) their results provided an indication of their total mood management 
score. Figure 30 on the following page demonstrates the changes in total mood management 
scores across all assessment phases. Comparisons between pre-group and mid-group scores 
showed no statistically significant change (p = 0.99) with an effect size of 0 indicating that no 
change occurred. However, mid-group and post-group comparisons scores approached 
statistical significance (p = 0.08) with a moderate effect size detected. Post-group and follow-
up scores showed a statistically significant improvement (t (19) = - 2.82, p = 0.01) with a 
large effect size detected (r = 0.55) which supports the research hypothesis. 
  




Figure 30. Line graph depicting the total mood management (TMMS) mean scores 
across all assessment phases. 
Pre-group and post-group comparisons also showed that participants’ total mood 
management scores improved following the ACT-based group treatment programme.  
However, the difference did not reach statistical significance (p = 0.10) but a moderate effect 
size was detected (r = 0.44). When comparing pre-group scores to follow-up scores the 
results indicated improvements that approached statistical significance (p = 0.07) with 
another moderate effect size detected (r = 0.40). While these results partially support the 
research hypothesis they did not reach statistical significance needed to confirm that an ACT-
based group treatment programme significantly improves participants’ overall mood 
management skills.  
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Mindfulness comparisons. The MAAS was used to measure participants’ everyday 
mindfulness tendencies on a six-point Likert scale. Higher scores indicate more frequent 
mindfulness in everyday activities. Figure 31 below demonstrates the changes in mindfulness 
tendencies across all assessment phases. Pre-group versus mid-group comparisons found that 
mindfulness tendencies did not significantly change (p = 1.00) with an effect size of 0 
indicating no change occurring between the two time points. However, mid to post-group 
comparisons showed an increase in mindfulness scores that approached statistical significance 
(p = 0.08) and showed a moderate effect size (r = 0.36). Further comparisons between post 
and follow-up data found statistically significant increase in mindfulness scores (t (19) = -
2.82, p = 0.01) with a large effect size detected (r = 0.55). 
Figure 31. Line graph depicting the mindfulness (MAAS) mean scores across all 
assessment phases. 
Pre-group versus post-group comparisons found no statistically significant increase in 
scores (p = 0.10) but did detect a moderate effect size (r = 0.44) indicating moderate change 
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occurred in participants’ mindfulness tendencies following immediate completion of the 
ACT-based group treatment programme. These positive changes were observed to a 
statistically significant level between pre-group and follow-up data (t (19) = -2.87, p = 0.01) 
with a moderate effect size detected (r = 0.40) thus supporting the hypothesis that positive 
changes in participants’ mindfulness tendencies would be improved at the three-month 
follow-up assessment phase. 
The results for coexisting problems assessed throughout the ACT-based group 
treatment programme showed a mixture of significant changes that, in part, supported the 
research hypotheses proposed. Specifically, although there were reductions observed between 
pre to mid and mid to post for PSS-10 (stress), GAD-7 (anxiety), and BLOCS powerful others 
subscale (external locus of control) they did not reach statistical significance due to the small 
sample size and attrition rates further reducing the sample size. However, post to follow-up 
scores indicated these measures increased thus not supporting the hypothesis that reductions 
would be maintained or further observed from post to follow-up. Improvements in total mood 
management (TMMS) and TMMS subscales Clarity and Repair were observed as predicted. 
However, the attention subscale did not differ significantly throughout the group. Pre and post 
comparisons found significant changes in line with the hypotheses for all measures except 
MAAS (mindfulness) and the TMMS attention subscale. These results showed that PSS-10, 
GAD-7, and BLOCS powerful others subscale all showed significant reductions by post-
group as predicted. However, MAAS score did not significantly increase as predicted, 
although at follow-up MAAS scores showed statistically significant improvement which 
supports the hypothesis that mindfulness would demonstrate an accumulative effect at follow-
up.    
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SECTION FOUR: Bivariate Correlations 
Bivariate correlations were conducted using the bivariate Pearson product-moment correlation 
coefficient (r)12 (see Figure 32) to demonstrate the strength and direction of the relationship 
between two variables. A positive correlation indicates that there is a direct relationship, 
meaning as one variable increases so does the other variable. Whereas a negative correlation 
indicates an indirect relationship, that is, when one variables increases while the other 
decreases. It is important to note that these relationships do not imply causality. Cohen’s 
(1988, as cited in Pallant, 2007) criteria for evaluating the strength of the associations are that 
an r value of 0.1 is small, 0.3 is moderate, and 0.5 is considered a strong relationship. 
Calculating the coefficient requires the number of pairs of scores, the sum of the products of 
paired scores, sum of x scores, sum of y scores, and the sum of squared x scores and y scores 
as depicted below in Figure 32. 
 
Figure 32. Formula for bivariate Pearson product-moment correlation coefficient, r.  
Each dependent variable that had reliable internal consistency (α >0.70) was examined 
across all assessment phases. Correlation tables are used to show the relationships with each 
other from the same assessment phase and can be found in the appendices (see Appendix M). 
Most measures were highly correlated with one another, which is in line with research that 
shows the high rate of coexisting problems with AOD populations. However, the purpose of 
the current research was to assess the relationships specifically between mindfulness 
                                                          
12 This is not the same r value used for effect size calculations in the previous statistical significance testing 
section. This is an important distinction for the bivariate correlations section. 
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tendencies and participants’ alcohol and other drug use and cravings as well as coexisting 
problems. Therefore, it was hypothesised that significant negative correlations would be 
detected between mindfulness and alcohol use as well as substance use and cravings. That is, 
it was expected that when mindfulness scores increase, alcohol and other drug use and 
cravings scores would decrease. Further significant negative correlations were also predicted 
for participants’ self-reported scores for perceived stress, anxiety, and external locus of 
control for powerful others. A significant positive correlation was expected between 
mindfulness scores and mood management scores, meaning that both scores are predicted to 
show an increase. Mindfulness scores were also expected to be highly correlated with each 
other when comparing the change over time, that is, it was expected that participants who 
scored highly on the mindfulness measures at the pre-group assessment phase were more 
likely to score highly on the mid-group, post-group, and three-month follow-up assessment 
phase.  
Table 10 presents the Pearson product-moment correlation coefficients showing the 
strength and direction of associations between measures across all assessment phases for 
alcohol use, substance use and cravings, stress, anxiety, external locus of control subscale 
powerful others, and mood management, compared to mindfulness measures for all 
assessment points. Scatterplots are presented to aid visual interpretation for some of the 
significant relationships found between variables measures with data points colour coded to 
represent male and female scores.13 
                                                          
13 Differences between male and female scores are provided to provide a detailed visual pattern of the data; 
however, of note there were no statistically significant differences between male and female participants in 
their self-reported substance use or coexisting problems or mindfulness.  
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Table 10.  
Bivariate Correlations Between Mindfulness and all Other Dependent Variables Across all Assessment Phases. 
Note. AUDIT- C = Alcohol Use Disorder Identification Test-Consumption, ACL Section B =Alcohol Use Section B, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General 
Anxiety Disorder – 7, BLOCS = Brief Locus of Control Scale, Powerful Others§ = Powerful Others Subscale, TMMS = Trait Meta Mood Scale, Attention§ = Attention 
TMMS Subscale, Clarity§ = Clarity TMMS Subscale, Repair§ = Repair TMMS Subscale, MAAS = Mindfulness Attention Awareness Scale. BLOCS scales for internal 
subscale locus of control and external chance subscale locus of control were also excluded. § = an abbreviation of ‘subscale’. **Correlation is significant at the 0.01 level (2-
tailed) *Correlation is significant at the 0.05 level (2-tailed).    
MAAS AUDIT-C ALC Section B Totals TOB Totals CAN Totals 
 Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U 
Pre 0.13 0.12 0.17 0.09 0.19 0.31 -0.10 -0.05 -0.07 -0.00 -0.02 0.02 -0.03 0.02 0.08 0.13 
Mid 0.03 -0.04 -0.06 -0.07 0.10 0.21 -0.13 -0.12 -0.23 -0.15 -0.12 -0.22 -0.38 -0.37 -0.08 -0.22 
Post 0.03 -0.13 -0.04 -0.12 0.03 0.23 -0.14 -0.21 -0.16 -0.08 -0.04 -0.39 -0.14 -0.10 0.09 -0.08 
F/U 0.26 -0.92 -0.13 -0.30 0.37 0.26 -0.26 -0.33 -0.25 -0.40 -0.42 -0.42 -0.07 -0.09 -0.35 -0.23 
     
 AMPH Totals SED Totals OPI Totals  
 Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U 
Pre -0.31 -0.26 -0.29 -0.12 -0.29 -0.49* -0.33 -0.21 -0.12 -0.22 -0.22 0.13 
Mid -0.17 -0.23 -0.15 -0.02 -0.35 -0.21 -0.15 -0.11 -0.00 0.03 -0.04 0.25     
Post -0.35 -0.42* -0.34 -0.40 -0.32 -0.32 -0.35 -0.43 -0.08 -0.09 -0.13 -0.04     
F/U -0.16 -0.25 -0.34 -0.47* -0.06 -0.23 -0.32 -0.39 -0.05 -0.01 -0.15 -0.10     
  
 PSS-10 GAD-7 BLOCS§ TMMS Totals 
 Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U 
Pre -0.55** -0.59** -0.26 -0.10 -0.53** -0.51** -0.25 0.20 -0.21 -0.32 -0.29 -0.35 0.53** 0.46* 0.28 0.23 
Mid -0.47* -0.70** -0.51* -0.16 -0.15 -0.25 -0.40 -0.23 -0.48* -0.40* -0.55** -0.15 0.65** 0.60** 0.44* 0.44 
Post -0.32 -0.60** -0.39 -0.42 -0.34 -0.51* -0.36 -0.01 -0.57** -0.33 -0.65** -0.47- 0.35 0.27 0.54** 0.52* 
F/U -0.14 -0.51* -0.53* -0.56* -0.02 0.31 -0.31 -0.43 -0.59** -0.66** -0.64** -0.60** 0.03 0.04 0.42 0.50* 
  
 TMMS Attention§ TMMS Clarity§ TMMS Repair§ MAAS 
 Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U Pre Mid Post F/U 
Pre 0.31 0.17 -0.04 0.26 0.39* 0.54** 0.44* 0.19 0.47** 0.44* 0.16 0.05 1    
Mid -0.54** -0.45* 0.19 0.36 0.38 0.61** 0.57** 0.32 0.42* 0.38 0.12 0.34 0.65** 1   
Post 0.36 0.20 0.29 0.43 0.20 0.37 0.60** 0.50* 0.09 0.09 0.19 0.24 0.54** 0.58** 1  
F/U -0.09 -0.06 0.26 0.25 0.22 0.09 0.42 0.49* -0.06 0.08 0.29 0.42 0.17 0.21 0.52* 1 




Alcohol correlations. Alcohol use, as measured by the AUDIT-C and by Section B of 
alcohol use in the protocol of measures, was examined for associations with mindfulness 
tendencies via the mindfulness, attention, awareness scale (MAAS). AUDIT-C results across 
assessment phases all showed small strengths of associations (r <0.30) with mindfulness, 
except for the relationship detected between follow-up phases that showed a moderate 
negative association between scores (r = - 0.30), which suggests that as mindfulness 
increased, alcohol use as measured by the AUDIT-C decreased. The remaining associations 
for mid-group and post-group and follow-up were negative correlations, indicating as 
mindfulness scores increased alcohol scores decreased, which is in line with the hypothesis, 
yet the strength was small.  
Alcohol Use Section B total and mindfulness correlations showed positive relationship 
for both pre-group and mid-group scores across all assessment phases with the strength of the 
associations ranging from small to moderate (r = 0.10 - 0.30). Whereas associations for post-
group and follow-up data showed a negative relationship. The correlation between follow-up 
assessment points showed a negative relationship with moderate strength (r = - 0.33, see 
Figure 34), which indicates that mindfulness scores increased and alcohol use in the past 
month decreased, which is also in line with the hypothesis proposed. 
 Substance use and cravings total correlations. Substance use and cravings 
scores from the WHO-ASSIST V3.0 were summed to provide totals and the relationship 
between mindfulness scores were examined.  
 Tobacco correlations. All associations between tobacco use and cravings scores 
combined (tobacco totals), and mindfulness scores showed a negative relationship, apart from 
the relationship between tobacco scores at follow-up assessment phase and pre-group 
mindfulness scores. This exception, however, only showed a small positive association, that 
suggests that higher mindfulness scores at pre-group were positively correlated with tobacco 




use and cravings totals at follow-up. Negative correlations observed between mid, post, and 
follow-up total tobacco scores with follow-up scores on the MAAS showed a moderate 
strength in relationship (r = 0.40 – 0.42). This indicates that those who had higher scores on 
the MAAS at follow-up had lower scores at mid, post, and follow-up for tobacco use and 
cravings combined.   
Cannabis correlations. The majority of correlations between mindfulness and 
cannabis use and cravings scores were negative non-significant but with weak to moderate 
strength. Four correlations were positive, in that higher scores on cannabis use and cravings 
were associated with higher scores on the mindfulness measure; however, these were not 
significant and weak (r <0.13). The strongest relationship was found between post-group 
cannabis total scores and follow-up mindfulness scores with a negative correlation (r = - 
0.35) indicating that as mindfulness scores increased, cannabis scores decreased. Participants 
who scored highly on mindfulness tendencies at follow-up were likely to have scored lower 
on cannabis measures of use and cravings combined (total) at post-group assessment phase. 
This trend was also noted at both cannabis and mindfulness follow-up scores; however, the 








 Amphetamine correlations. All associations between amphetamine scores and 
mindfulness scores across all assessment phases showed a negative relationship with weak or 
moderate strength, indicating as mindfulness scores increased, amphetamine scores decreased. 
Correlations between mid-group amphetamine scores and post-group mindfulness scores (see 
Figure 33 below) as well as follow-up mindfulness and follow-up amphetamine scores (see 
Figure 34 on the following page) showed significant associations with moderate strength (r = 
-0.47). These results suggest that higher scores of mindfulness were associated with lower 
scores of amphetamine use and cravings, especially for those that showed a significant 
negative relationship with a moderate strength.  
Figure 33. Scatterplot demonstrating the moderate negative correlation between mid-group 











Figure 34. Scatterplot demonstrating the moderate negative correlation between follow-up 
total amphetamine scores and follow-up MAAS scores that reached significance.  
 
Sedative correlations. All relationships between mindfulness scores and sedative 
scores were negative and ranged between small and moderate strength. A significant moderate 
negative correlation was found between mid-group sedative total scores and pre-group 
mindfulness scores (r = -0.49, see Figure 35 below), indicating that those who scored higher 
for mindfulness tendencies at the pre-group assessment phase had lower scores for sedative 
use and cravings at mid-group assessment phase. This is in line with the hypothesis that those 
who are more mindfulness have lower rates of sedative use.  




Figure 35. Scatterplot demonstrating the significant moderate negative relationship between 
total sedative scores at mid-group assessment phase and MAAS pre-group scores. 
Opioid correlations. The majority of associations between mindfulness and opioid 
scores showed a weak negative relationship (r< -0.30) that indicates higher mindfulness 
scores are related with lower opioid use and cravings scores. Weak positive correlations were 
found between mid-group scores of mindfulness and total opioid scores (r = 0.03), as well as 
opioid scores at follow-up and mindfulness scores at pre-group (r = 0.13) and mid-group (r = 
0.25) which suggests higher scores on both measures at these points. These relationships are 
not indicative of the predicted theory or previous research outlined in the literature review that 
has shown higher mindfulness rates are related to lower opioid use and cravings (Hayes, 
Wilson, Gifford, Bissett, et al., 2004; Stotts et al., 2012). 




Perceived stress correlations. Nine out of 16 correlations between stress levels as 
measured by PSS-10 and mindfulness scores were significantly negative as hypothesised, 
with strengths in associations ranging from weak to strong.  All mid-group stress scores 
showed strong negative associations with mindfulness scores across all assessment points. 
This indicates that as stress levels increased, mindfulness levels decreased. A significant 
strong and negative correlation between follow-up scores on stress and mindfulness levels 
indicates as mindfulness levels increased, stress levels decreased (see Figure 36 below). 
Figure 36. Scatterplot demonstrating the significant strong and negative relationship between 
PSS-10 scores and MAAS scores at the three-month follow-up assessment phase.  




Anxiety correlations. Several strong negative relationships between anxiety levels and 
mindfulness scores were found. Specifically, pre-group mindfulness scores and pre-group 
anxiety scores were significant and indicate that those who scored high on the mindfulness 
measure were likely to have lower scores on the anxiety measure (r = -0.53). Significant 
relationships were also found between mid-group anxiety scores and pre-group mindfulness 
scores (r = - 0.51) and mid-group anxiety scores and post-group mindfulness scores (r = -
0.51, see Figure 37). A moderate strength was detected for a negative relationship between 
anxiety and mindfulness scores at follow-up which could suggest people who are more 
mindful experience less anxiety.   
Figure 37. Scatterplot demonstrating the negative and significant relationship between GAD-
7 scores at mid-group and MAAS scores at post-group.  





 External locus of control – “powerful others” subscale. Most of the 
relationships between mindfulness and the subscale of powerful others as measured by the 
BLOCS across all assessment phases were negative, with moderate to strong strength. Three 
of the associations were considered weak, however, several relationships reached statistical 
significance. For example, those who scored high on the mindfulness measure post-group 
were likely to show lower scores on the external locus of control subscale at follow-up (r = 
0.64, see Figure 38 below). Overall these results indicate that higher mindfulness tendencies 
are strongly associated with lower external locus of control beliefs for powerful others. This 
supports the hypothesis that being awareness of the present moment may increase a person’s 
sense of control of their actions and thereby reduce perceived control by others on their lives.  
Figure 38. Scatterplot demonstrating the strong negative and significant relationship between 
BLOCS subscale ‘powerful others’ scores at follow-up and MAAS scores at post-group. 
 
   




 Mood management correlations. All associations between total mood 
management scores and mindfulness scores across all assessment phases were positive, 
indicating that increases in mindfulness tendencies are correlated with increases in mood 
management skills. Several relationships were significant with a strong association found (r 
>0.50). The strongest relationship was found between pre-group total mood scores and mid-
group mindfulness scores (see Figure 39 below). This means that participants who had higher 
mood management scores at pre-group assessment phase were found to have higher 
mindfulness tendencies at the mid-group assessment point. The same trend is noted at follow-
up phases for total mood management and mindfulness scores.  
Figure 39. Scatterplot demonstrating the strong positive and significant relationship between 
total TMMS pre-group scores and MAAS mid-group scores.  
  
  




 Attention subscale. A mixture of positive and negative relationships were 
detected between the attention subscale scores and mindfulness scores across assessment 
phases. Positive relationships were expected to be found and for most of the correlations this 
proved to be true, however, there were five associations that were negative. Of the negative 
associations, two met significant levels with moderate to strong strength in relationships, 
indicating that as mindfulness scores increased attention scores decreased, which does not 
support the theory that increasing mindfulness would also increase attention to mood. The 
remaining positive associations ranged between weak to moderate strength.  
Clarity subscale. As with the total mood management correlations, the clarity subscale 
relationships with mindfulness were all positive as predicted, with nearly half demonstrating a 
strong positive correlation meeting significant levels (e.g., see Figure 40 below). These 
results indicate that as mindfulness tendencies increase participants ability to clearly 
discriminate between moods improves.   
Figure 40. Scatterplots demonstrating the strong positive and significant relationship between 
MAAS follow-up scores and TMMS ‘Clarity’ subscale follow-up scores. 




Repair subscale. Apart from one negative correlation found between pre-group repair 
scores and follow-up mindfulness scores, the rest showed positive associations that varied in 
strength (small to moderate). Significantly positive relationships with moderate strength were 
found between pre-group scores of repair and pre-group (r = 0.47) and mid-group (r = 0.42) 
mindfulness scores (see Figure 41 below). A significant and positive relationship between 
mid-group repair scores and pre-group mindfulness scores was also detected. These results 
indicate that as mindfulness scores increase participants ability to regulate moods increases 




Figure 41. Scatterplots demonstrating the significantly moderate positive relationships 










 Mindfulness correlations. As expected, the majority of associations between 
mindfulness scores with each other across assessment points were positively and significantly 
correlated with strong associations detected (r >0.50). This means that participants who 
scored highly on the mindfulness measure at pre-group were likely to score higher at mid-
group and post-group.  However, the relationship between pre-group and follow-up 
mindfulness scores although positive was not significant and weak (r = 0.17). A significant 
and positive relationship was detected between post-group and follow-up scores (see Figure 
42 on the following page). These results are in line with the prediction that those who those 
who had more mindfulness tendencies were likely to retain high scores of mindfulness at the 
three-month follow-up.  
Figure 42. Scatterplot demonstrating the significant and positive relationship between MAAS 
scores at post-group and follow-up assessment phases.  
 
  




Executive Summary  
The overall results from the analysis are summarised as follows:  
• Significance testing highlighted few statistically significant differences between 
substance use throughout the ACT group treatment programme assessment phases. 
Consistent patterns were noted whereby all substance use analysed (with the exception 
of alcohol use), showed increases from pre-group to mid-group, followed by 
reductions in use and cravings at post-group and follow-up assessment points. Alcohol 
use reduced across all assessment phases.  
• Comparisons between pre-group, post-group, and follow-up showed reduced 
substance use and cravings with moderate to strong effect sizes reported. The lack of 
statistically significant differences between comparisons may be due to the small 
sample size. 
• Stress, anxiety, and mood management outcomes were all statistically significant 
between pre-group and post-group. No significant change over time was found for 
mindfulness scores. Statistically significant changes were no longer evident at follow-
up for the majority of measures, suggesting a degree of regression following the 
completion of the ACT group. The exception to this trend related to the mood 
management clarity subscale and the mindfulness scores, which remained statistically 
significant at follow-up.  
• Overall the bivariate correlation analyses showed no significant relationships between 
mindfulness and alcohol, tobacco, cannabis, and opioids. Some evidence pointed to a 
significant relationship between mindfulness and both amphetamine and sedative 
scores. This pattern must be interpreted with caution as significant findings may be 
due to chance given the number of tests that showed no significant relationships. 




Nevertheless, the general trends suggested that the majority of these were negative 
relationships, indicating that as mindfulness increases, substance use decreases.  
• Bivariate correlations between mindfulness and coexisting problems revealed many 
significant relationships. These findings support the hypotheses that increased rates of 
mindfulness decreased self-reported stress, anxiety, and external locus of control as 
well as increased mood management. The cluster of significant relationships identified 
suggests these results are unlikely to be due to chance.  
• The significant correlations of different variables against mindfulness supported the 
prediction that those who score higher on mindfulness are likely to retain high scores 
throughout the assessment phases.  
 
  




SECTION FIVE: Supplementary Measures 
Responses from the various feedback questionnaires were used to provide anecdotal 
information about the effectiveness of the group treatment programme. Of note, this 
qualitative data was not analysed using standard thematic analysis due to the qualitative 
information being obtained from participants’ hand-written feedback from session rating 
scales, group rating scales, and via the follow-up questionnaire that was administered 
following a semi structured interview three-month post-group. Therefore, the themes of such 
were not able to be significantly analysed but offer the participants of the group a voice and 
gives context to the groups that were conducted in the current study.  
Session rating scales results  
Session rating scales were utilised at the end of every session. Participants rated the sessions 
overall enjoyability and helpfulness on a four-point Likert scale of 0, strongly disagree, to 4, 
strongly agree. Table 11 presents the means across all sessions for each group. Group one had 
an average rating of 3.32 and 3.37 for enjoyability and helpfulness of the sessions, 
respectively. Group two averaged 3.55 for enjoy-ability and 3.64 for helpfulness, with group 
three showing similar results (3.50 and 3.56, respectively). Group four demonstrated the 
highest rating 3.60 enjoy-ability and 3.65 helpfulness on average across all sessions. These 
results indicate that, on average, participants agreed or strongly agreed that the sessions were 
enjoyable and helpful. Three open-ended questions sought to identify specific aspects of the 
session that were either helpful or unhelpful. Most of the feedback for the unhelpful aspects of 
sessions from participants across all four groups were “nothing” in answer to this question or 
left it blank when completing the questionnaire. Most helpful aspects included feeling not 
alone in their struggle with alcohol or substance use in the group format and listed the skill for 
the specific session as helpful. The third open ended question sought to elicit any other 
comments from the participants to which most participants responding with thank you.   





Session Rating Scale Means, Standard Errors of the Means, and Standard Deviations for 
Each Group.   
Overall SRS Enjoyed Helpful 
 Mean SEM SD Mean SEM SD  
Group 1 3.34  0.95 0.76 3.37  0.90 0.72 
Group 2 3.55  0.07 0.56 3.64  0.73 0.55 
Group 3 3.50 0.09 0.67 3.56 0.08 0.60 
Group 4 3.60 0.08 0.54 3.65 0.08 0.52 
 
Group rating scales results  
Combining the group rating scale results for all four groups, participants scored enjoy-ability, 
helpfulness, structure, facilitators, and resources of the group on a four-point Likert scale 
ranging from 0 strongly agree to 4 strongly disagree (see Table 12). Results indicated that the 
23 participants who completed the group rating scales strongly agreed that the overall ACT-
based group treatment programme was enjoyable, helpful, well structured, had appropriate 
and competent facilitators, and provided appropriate and helpful resources. 
Table 12.   
Overall Group Rating Scale Means, Standard Errors of the Means and Standard Deviations 
for all Groups. 
(All groups) Mean  SEM SD 
Enjoyability 3.86 0.07 0.34 
Helpfulness 3.91 0.06 0.28 
Structure 3.65 0.10 0.48 
Facilitators fit 3.91 0.06 0.28 
Resources provided 3.86 0.09 0.46 
 
  




Table 13 presents the common themes obtained from the three open-ended questions 
sought to identify specific aspects of the whole group that were helpful and unhelpful.  
Table 13. 
Common Themes from the Open-ended Questions in the Group Rating Scales. 
Helpful themes Percentage  
Change of thought process/different perspective  30.4% 
Help with urges to drink/thinking before drinking/help with addiction issues/commitment to 
sobriety 
21.7% 
Strategies/practical skills to help with issues/coping strategies 21.7% 
Acceptance  13.0% 
Mindfulness  13.0% 
Living aligned with my values/gave direction 13.0% 
Confronting demons/challenging/avoidance/talking about my issues 13.0% 
Positivity and non-judgemental forum 8.7% 
Quotes, stories, and Ted talks 4.3% 
Relapse prevention 4.3% 
Everything was helpful 4.3% 
Unhelpful themes Percentage 
Nothing or left blank or cannot think of anything 65.2% 
Getting off topic 8.7% 
Complex ideas, a lot of material and information to take in 4.3% 
Longer sessions 4.3% 
Having it in working hours  4.3% 
 
  




Follow-up feedback questionnaire results  
The final sample of 20 participants were administered additional questionnaires that included 
specific questions about the impact of the ACT-based group treatment programme. Questions 
and responses on a four-point Likert Scale are outlined in Table 14 on the following page. 
Responses were reversed scored with higher scores out of four representing positive responses 
whereas lower scores such as one or two indicated neutral or undesirable responses. Various 
response statements applied to specific questions, for example most response statements 
ranged from ‘yes – a lot’, ‘yes – a bit’, ‘no change’, and ‘no – worse now’ (applied to 
questions 2, 3, 5, 6, 7, 8, 9, 13, 14, 15, 16). Whereas questions 1 and 4 response statements 
ranged from ‘excellent’, ‘good’, ‘fair’, and ‘poor’. Other response options for questions 10 
and 12 were ‘very satisfied’, ‘somewhat satisfied’, ‘somewhat dissatisfied’, and ‘very 
dissatisfied’. Lastly, question 11 ranged from ‘very competent’, ‘moderately competent’, 
‘somewhat competent’, and ‘not at all competent’.  
  





Follow-up Feedback Questionnaire Means, Standard Errors of Means, and Standard 
Deviations. 
Question (0-4 Likert Scale) Mean 
 
SEM SD 
1. State of wellbeing at time of contact? 3.15 0.13 0.59 
2. Since then has your state improved? 3.25 0.20 0.91 
3. If wellbeing has change is it due to contact with ACT group? 3.40 0.15 0.68 
4. Ability to carry out everyday activities at first contact with ACT 
group? 
2.95 0.18 0.83 
5. Since then has ability of everyday activities improved? 3.25 0.19 0.85 
6. If ability changed is it due to contact with ACT group? 3.20 0.16 0.70 
7. ACT group helped cope/manage life better?  3.50 0.11 0.51 
8. ACT group improved sense of happiness and wellbeing? 3.40 0.11 0.50 
9. ACT group contributed to satisfaction with life?  3.35 0.15 0.67 
10. Overall satisfaction with facilitators responses?  3.65 0.11 0.49 
11. How competent were the facilitators?  3.95 0.05 0.22 
12. Overall satisfaction with the ACT group? 3.75 0.10 0.44 
13. Since the ACT group has it helped you sit with unwanted 
psychological experiences?  
3.35 0.13 0.59 
14. Since the ACT group has it helped you cope with addiction related 
problems? 
3.40 0.11 0.50 
15. Since the ACT group are you living in line with your values? 3.30 0.13 0.57 
16. Since the ACT group has your committed action to value driven goals 
improved?  
3.35 0.15 0.67 
 
Overall, most participants responses corresponded with ‘yes – a lot’ or ‘yes -a bit’ 
(scores 3 and 4) indicating that the ACT group had improved participants’ psychological 
wellbeing, everyday abilities, ability cope/manage in life, sense of happiness and wellbeing, 
satisfaction with life, ability to sit with unwanted psychological experiences, ability to cope 
with addiction problems, ability to live in line with their values, and ability to commit to 
value-based goals. The majority of the final group responded with ‘good’ for state of 




wellbeing at first contact and ability to carry out everyday activities at first contact.  Most 
participants indicated satisfaction with facilitators’ responses and overall satisfaction with the 
ACT group was ‘very satisfied’ as represented by means of 3.65 and 3.75, respectively. A 
mean of 3.95 for question 11 indicates participants felt the facilitators were ‘very competent’.  
Four open-ended questions were included to elicit further feedback for the most 
helpful and least helpful aspects of the group as well as how they think the group could be 
improved with the last question eliciting any further comments or suggestions. Table 15 
provides a summary of the common themes from participants’ responses for the most helpful 
and least helpful aspects and improvement suggestions of the ACT-based group treatment 
programme. The other comments question consisted of expressions of gratitude to the 
facilitators and the programme. Most common answers are presented first. 
Table 15. 
Common Themes with Supporting Verbatim Quotes from Open-ended Questions in the 
Follow-up Feedback Questionnaire. 
Most helpful themes and supporting verbatim quotes Percentage 
Development and practise of the mindfulness skill, learning to be in the present moment 
“Realising how little attention I was paying to what I was doing, and to things going on 
around me…practicing mindfulness and sitting and feeling emotions”  
50% 
Contact with others, support and interaction within the group format 
“I never felt alone, I felt very supported. They listened” 
30% 
Acceptance skills 
“Learning that acceptance is a developed skill and working on that”  
20% 
Learning to cope with emotions/feelings/addiction differently 
“Being able to cope with previous addiction patterns and be able to cope and deal with 
them easier” 
20% 
Different perspective on problems and life 20% 




“Different way of handling problems and different ways of thinking about problems” 
Increased self-awareness and awareness of the costs of addiction 
“learning to be more self-aware…. awareness of how addiction has ruined my life” 
20% 
Values, making choices and living in line with values 
“I like the values – helps to describe/quantify what a “good life” may look like” 
15%   
The facilitators 
“The people running it have helped me a lot to open up…their friendliness has touched 
my life” 
10% 
Responding not reacting 
“Learning to think more before acting” 
5% 
Websites and resources directed outside of group 
“Having the facilitators guide me to websites and resources outside the course material” 
5% 
Least helpful themes Percentage 
Nothing or left blank 50% 
Poor attendance record for some sessions 10% 
Lack of continued programme 5% 
Not enough time for group discussions 5% 
Not long enough programme 5% 
Need to redo the programme to reinforce ideas/skills 5% 
First few weeks were hard and felt worse 5% 
Unhelpful contact from a group member 5% 
Group members going off topic or talking over others 5% 
Improvements Percentage  
Nothing or left blank 40% 
Longer group programme 15% 
Establishing of group meetings (AA format) and/or follow-up classes 10% 
Longer group discussions 10% 
More in-depth information specific for each person 5% 
Easier questions and homework 5% 
 




Treatment fidelity results 
Across all groups treatment fidelity did not fall below 80%. Sessions four, five, seven, and 
nine across all groups had 100% treatment fidelity rates (see Table 16). This means that 
integrity of the treatment programme designed remained intact, promoting minimal variation 
between the groups delivered, and ensured participants received the same ACT-based group 
treatment.  
Table 16.  
Treatment Fidelity Means, Standard Errors of the Means, and Standard Deviations for Each 
Session Across all Groups. 
Session number (All groups) Mean  SEM SD 
Session 1 9.25  0.32 0.65 
Session 2  9.00  0.20 0.41 
Session 3 9.75 0.25 0.50 
Session 4 10 0.00 0.00 
Session 5 10 0.00 0.00 
Session 6 9.75 0.25 0.50 
Session 7 10 0.00 0.00 
Session 8 9.37 0.38 0.75 
Session 9 10.00 0.00 0.00 
Session 10  8.75 0.25 0.50 
 
  




Overall summary of feedback 
Therapy feedback indicated that all participants rated treatment components as helpful, but 
through selecting common themes, mindfulness was considered the most helpful. No major 
modifications were suggested other than an increase in the number of sessions and the length 
of the group programme. A number of participants suggested monthly group meetings that 
would function similar to Alcoholics Anonymous (AA) with respect to checking in with other 
participants and discussing the benefits of implementing the ACT skills learnt in group. A 
participant letter in Appendix O of this thesis highlights the meaningful contribution of the 
ACT group programme that outlines the idea of a monthly ACT maintenance group. There are 
a number of implications from the current research results and a number of confounding 
factors and limitations that will be discussed further in the following chapter.  
  








Group facilitator: “What has been the most helpful aspect of the ACT group?” 
Group participants: “These sessions have been so valuable to me. I have changed for the 
better. I see life with more meaning and purpose. I have now got a great sense of direction as 
to which road I hope to stay on now” … “It has helped me to refocus my efforts at staying 
clean, and also provided me with a bit more direction and motivation around getting my life 
back on track. It has been good to get out and feel less isolated” … “I learned skills for 
dealing with anxiety, emotions, thoughts etc in life that will help me remain drug free. Gained 
confidence in my ability to be able to live drug free and improve quality of life” 
- Anonymised quotes, ACT Group 
These quotes illustrate some of the positive, life changing outcomes observed from the current 
study’s ACT-based group treatment programme. Several participants reported improvements 
in managing substance related problems but also reported improvement in quality of life. 
Anecdotal results such as the quotes above will be presented alongside the overall findings of 
the current research with references to the hypotheses delineated in the literature review in 
section one of this discussion chapter. Hypotheses will be presented alongside interpretation 
of the research results in the context of the existing literature before discussing the 
implications of the key findings. Remaining sections of the discussion chapter present the 
strengths and limitations of current research, recommendations for future research, and a final 
conclusion.  




SECTION ONE: Summary of the findings and hypotheses 
The overarching aim of this study was to develop a manual for an ACT-based group treatment 
programme for SUDs and deliver and evaluate said programme in a real-world setting with 
people who struggle significantly with alcohol and other drug problems. A repeated-measures 
design was used to assess the effectiveness of the manualised group treatment programme 
with adults aged between 29 and 66 years old who were clients from the Palmerston North 
Alcohol and Other Drug Service. The current research sought to examine three specific 
research questions:  
Research question one: Does an ACT-based group treatment programme reduce 
participants’ self-reported alcohol use and substance use and cravings at the end of the 
treatment (post-group) as well as at the three-month follow-up? This reduction is 
expected to gradually occur over the course of the group programme, evidenced by reductions 
at mid-group, post-group, and follow-up assessment points.  
Alcohol use findings and interpretation. The AUDIT-C is a valid and reliable tool for 
measuring hazardous drinking patterns (Bradley et al., 2007; Bush et al., 1998; DeBenedetti et 
al., 2007; Dawson et al., 2005). Therefore, the current study’s AUDIT-C results can be 
considered valid and reliable. Cautious interpretation of the Alcohol Use Section B results is 
required as it is not a psychometrically supported tool for measuring alcohol use. However, 
the results of the Alcohol Use Section B allow a more recent indication of frequency and 
quantity of alcohol consumption in the past month (Cripsin-Morrall, 2013) and is considered 
an appropriate and effective way to measure changes for a ten-week group programme. The 
current study showed that there was minimal change in alcohol use between pre and mid-
group assessment points; however, there were reductions in alcohol use post-group and at 
three-month follow-up for both alcohol measures used. Although these reductions did not 




reach statistical significance, moderate effect sizes provided corroborative evidence for 
reductions in alcohol use between pre-group and follow-up as measured by the AUDIT-C. 
However only a small effect size was detected with the Alcohol Use Section B measure.  
While previous studies have demonstrated the applicability of ACT to alcohol use 
disorders, such as Heffner’s et al.’s 2003 study and Thekiso et al.’s 2015 study; the current 
study did not yield statistically significant changes in participants’ alcohol use. Heffner et al.’s 
(2003) findings showed successful abstinence from alcohol following implementation of the 
values component of ACT to support this change. Thekiso et al. (2015) found significantly 
higher rates of days abstinent from alcohol and significantly lower rates of alcohol cravings. 
These examples provided the basis for the research hypothesis and while the initial trends in 
the current data set suggest participants reduced their alcohol use, the small sample size meant 
the study only had the power to detect statistical significance with moderate to large changes.  
Changes in the alcohol measures across the assessment phases as measured by effect 
sizes were small, however a moderate effect size was found between pre and follow-up 
scores. This suggests there was a moderate change in participants’ alcohol use at follow-up 
which may support the “incubation” effect as reported in smoking cessation studies (Gifford 
et al., 2004; Gifford et al., 2011). Svanberg et al. (2017) also mentioned this phenomenon, 
that significant changes in substance use have been commonly seen at the follow-up for ACT 
groups compared to other treatment groups such as CBT, TAU, and waitlist controls. 
However, without a treatment comparison group in the current study it is unknown whether 
these results are specifically due to the ACT-group treatment programme. Although a CBT 
comparison group was initially sought, the attrition rate and incomplete data from those 
groups meant that these comparisons could not be made.   




Additional information received as part of the interview process at the follow-up phase 
showed that several participants had stopped drinking alcohol completely and attributed this 
change to the ACT group. The following two quotes highlight the positive impact that the 
ACT group had on participants’ alcohol use.  
“Was very reinforcing in regard to my commitment to sobriety. Found it gave me extra tools 
to help with coping strategies when things became difficult.” 
“This programme helped me so much to believe in myself. Excellent strategies to help with my 
anxiety and also how to help with my thinking before I want to drink.” 
– Anonymised quotes, ACT Group 
Substance use and cravings findings and interpretations. The outcomes for 
substance use and cravings were also mixed. Overall, substance use, cravings, and their 
combined totals demonstrated reductions for amphetamine, sedatives, and opioids from pre-
group to post-group and follow-up. Of these substance changes, many showed moderate 
reductions with only a few showing statistically significant results. Tobacco and cannabis, 
however, had small reductions and non-significant differences between post-group and 
follow-up scores, yet showed increases at mid-group assessment phase. Although the majority 
of statistical significance tests showed non-significant results, there was a significant 
reduction observed for sedative use at post-group with a moderate change detected. There was 
also a significant reduction in total amphetamine scores at follow-up with another moderate 
change detected.   
Numerous studies, as outlined in the literature review of this thesis, have demonstrated 
that the use of ACT was influential in smoking cessation, through web-based, telephone-
based, or smart phone apps (Bricker et al., Bricker et al., 2010; Bricker et al., 2013; Bricker et 




al., 2014; Bricker et al., 2017, Brown et al., 2008; 2013; Gifford et al., 2004; 2011; 
Hernández-López et al., 2009; Litvin et al., 2012). However, the current study’s results for 
tobacco use and cravings increased rather than decreased at several points. A noteworthy 
explanation for this trend is that the intention of those screened to participate in the ACT 
group was not to address their smoking behaviour but rather other substances like alcohol and 
other drugs that they themselves identified as significantly interfering with their lives. 
Therefore, given smoking cessation was not a primary goal for this sample, their motivation 
to change smoking behaviour was understandably low. Other explanations for the increase in 
smoking may include the influence of group members who were smokers on those who had 
previously quit and took up smoking during the breaks with the other group members. 
Substance substitution could be an additional factor leading to the increase in smoking. 
Reduction in the use of their target substance meant they substituted their use with an 
alternative, seemingly less problematic substance. An alternative to this theme is that some 
may have changed their form of smoking. For instance, some participants stated they had 
changed to vaporisers throughout the course of the treatment. Finally, routinely sitting with 
uncomfortable thoughts and feelings in the group may lead some to seek temporary reprieve 
from unpleasant internal events through smoking. 
There is limited literature on cannabis and ACT specifically, however, Twohig et al.’s 
(2007) study found ACT was effective in reducing, and in some cases, seeing clients 
abstaining from cannabis use. Although no significant changes in cannabis use or cravings 
were found in the current study, post-group data indicated small effect sizes, and these 
increased to moderate at follow-up, suggesting an incremental reduction over time. One 
participant at follow-up even revealed she had been abstinent from cannabis since the group 
and attributed this change to the ACT intervention. She also reported that the values and 
committed action work contributed to her gaining confidence to successfully apply for jobs.  




Changes in opioid use and cravings showed very small effect sizes and most analyses 
did not show significant change. A moderate effect size change was found for opioid cravings 
post-group, with no significant changes observed at follow-up when compared to pre-group 
data. However, there are two important considerations for the lack of effect in these findings, 
1) most opioid users were on the OST programme therefore dose reduction or changes to their 
prescribed dose are typically conducted over long periods of time and at a very slow rate, and 
2) more than half of the participants who used opioids dropped out by the follow-up phase. 
Again, two participants reported at follow-up that they were able to reduce their dose 
throughout the programme; one even reported becoming completely abstinent from 
methadone and had since gone off the OST programme and obtained employment. These 
stories seem more in step with the existing dose reduction literature on ACT and methadone. 
Saedy et al. (2018) for instance, found the ACT group had lower methadone doses post-
treatment compared to controls and there were significant reductions in cravings at post-
treatment and at three-month follow-up. The current study’s results support Saedy et al.’s 
(2018) findings somewhat, in that significant reductions in opioid cravings between post-
group and the three-month follow-up occurred. No significant changes were found at post-
group, suggesting a delayed effect occurred in change post-intervention. There were no 
significant differences in the length of treatment offered or the number of participants in the 
group of Saedy et al.’s study and the current study. 
Other studies examining ACT and methadone support the use of ACT in conjunction 
with an established dose reduction programmes like methadone maintenance (referred to as 
the OST programme in NZ). Hayes et al. (2004) found the use of ACT was related to lower 
rates of methadone and total drug use at follow-up, providing further support for effective 
longevity and accumulative effects of ACT. Stott et al.’s study (2012) provides further 
support for the additive benefits of ACT when combined with methadone dose reduction 




programmes. Not only were there higher rates of complete detoxification at end of treatment, 
but there was also a reduction in the fear of detoxification. Fear of detoxification was reported 
as one of the main reasons people struggle with becoming abstinent from methadone (i.e., 
coming off the OST programme). This includes the fear of the well-known significant 
aversive withdrawal symptoms (e.g., sweats, nausea, pain). Several participants in the ACT 
group reported their hesitation to become fully abstinent from methadone for these reasons. 
ACT provided skills that aided people through this process by focusing on what was deeply 
important to them while utilising acceptance of their experiences in the present moment (e.g., 
making room for withdrawal symptoms and urge surfing).  
Although there has been only one study conducted for methamphetamine treatment 
using ACT, the outcomes showed reduction in methamphetamine use (both objective and 
subjective reports), negative consequences, and dependence severity (Smout et al., 2010). The 
authors endorse ACT as a viable alternative to CBT for stimulant use disorders. The current 
study found that the use of the stimulant, amphetamine, did not significantly change at post-
group and there were only small effect sizes for both use and cravings. However, at the three-
month follow-up, similar results to that found by Smout et al. (2010) occurred, in that 
amphetamine use and craving scores combined showed statistically significant reductions 
with moderate effect sizes. Amphetamine use and cravings alone at the follow-up showed 
moderate effect sizes, suggesting ACT moderately impacts amphetamine use and cravings 
and that the non-significant findings may be due to the study being underpowered. Due to the 
real world setting of this study, it was not surprising that issues with detecting statistically 
significant change were observed. However, the effect sizes found for amphetamine use and 
cravings demonstrate there was a moderate reduction following the ACT group, which 
supports the promising evidence for ACT applied to these SUDs.  




No specific studies examining sedative or benzodiazepine use and cravings were 
identified. The current study found a significant reduction in sedative use at the post-group 
assessment point, with a moderate effect size detected. However, this change deteriorated at 
the three-month follow-up, with no significant changes detected. This pattern differs from the 
amphetamine and opioid reduction trends. One explanation for this difference may be that 
many participants reported they were prescribed sedatives and therefore did not consider they 
craved sedatives as such but rather took them when needed or as prescribed, generally for 
pain or sleep. This may also indicate that people are more likely to follow rule-governed 
behaviour, in that they are following the rules of someone else, typically, someone of 
respectable status (e.g. a psychiatrist or doctor) and may be less likely to abuse the substance 
or be more likely to be resistant to change. Another consideration, similar to that discussed 
when reporting the tobacco findings, was that the sedative use and cravings were not reported 
as the substance target for change for most participants; therefore, significant reductions for 
sedatives was unlikely. Again, qualitative information obtained from the three-month follow-
up interviews found that a few participants were able to wean off or reduce their sedative use 
by the end of treatment which accounts for the statistically significant reductions reported in 
the thesis.   
Other studies such as those conducted by Lanza and Gonzalez-Menendez (2013), 
Gonzalez-Menendez et al. (2014), and Lanza et al. (2014) investigated the utility of ACT for 
SUDs for incarcerated women. These articles were produced from the same large RCT 
sample but examined different aspects of the data set. Overall, their results supported ACT as 
a viable alternative to CBT for SUDs and as an effective treatment for SUDs and co-occurring 
mental health disorders, as well as demonstrating the well-known incubation effect for 
improved outcomes at long-term follow-up points of ACT. Overall, the current study was able 
to show some reductions in substance use and cravings, however, due to the study being 




underpowered, many of these reductions did not reach statistical significance. Unexpected 
increases in tobacco were also observed, and explanations for such unexpected findings have 
been attempted. The main reason may be that the gradual reductions expected over the course 
of group may have been under the wrong premises and rather it could have been expected that 
increases in substance use or other problems would be seen in the early stages of the therapy 
which is more in line with the literature on exposure. The secondary aim of this research, like 
that of many of the other studies mentioned, was to investigate co-occurring mental health 
problems commonly seen in the AOD population. These were assessed through perceived 
stress, anxiety, external locus of control, and mood management skills.    
Research question two: Does an ACT-based group treatment programme reduce 
common problems coexisting with SUDs such as perceived stress, anxiety, and external 
locus of control, and does an ACT-based group treatment programme enhance internal 
locus of control, resistance to peer pressure, and mood management? It was expected 
these changes would be gradually occurring over the course of the group, evidenced by 
changes observed at mid-group, post-group, and follow-up assessment points. These changes 
were expected due to the transdiagnostic qualities ACT encapsulates whereby common 
underlying mechanisms for a range of psychopathology can be targeted simultaneously.  
The results for coexisting problems assessed throughout the ACT-based group 
treatment programme showed a mixture of significant changes that, in part, supported the 
research hypotheses proposed for coexisting problems. Pre to mid, and mid to post 
comparisons for stress, anxiety, and external locus of control for ‘powerful others’ subscales 
between were not significant; however, the general trend did demonstrate reductions. These 
reductions are partially in line with the hypothesis that these changes would gradually occur 
over the course of the group. By post-group assessment phase significant and large reductions 




in stress, anxiety, and external locus of control for powerful others were detected as predicted. 
These reductions however did not appear to be sustained at the three-month follow-up. 
Significant improvements for overall mood management skills and mindfulness tendencies 
were detected at post-group. However, for total mood management scores, these changes were 
not maintained at the follow-up, whereas mindfulness scores showed an accumulative positive 
effect suggesting further improvement over time.  
Anxiety and stress findings and interpretations. The current study’s anxiety and 
stress outcomes showed mostly significant reductions from pre to post-group, which is in line 
with existing research that supports the utility of ACT in addressing these common problems 
typically observed alongside SUDs. However, Svanberg et al. (2017) found no change in 
mental health with the context of severe SUDs post ACT intervention as measured by the 
DASS-21. They argued that change with severe SUDs takes time, with longer recovery for 
those struggling with anxiety alone typical of this population. Therefore, reductions in these 
symptoms may take longer to occur with people who are changing their problematic 
substance use than those who do not have a comorbid SUD diagnosis. Severe withdrawal 
symptoms from alcohol in some serious cases may include post-acute-withdrawal syndrome. 
This involves a prolonged delay in improvements in anxiety and mood withdrawal symptoms. 
An individual may experience such withdrawal symptoms for one or two years post 
abstinence. The current study’s follow-up results for anxiety showed no significant decrease 
compared to pre-group scores. In fact, there was an increase in anxiety and stress levels at 
follow-up, suggesting a rebound effect. A key factor that may explain the trend in the current 
study’s results is the idea that ACT promotes exposure-like processes (i.e. from an ACT 
perspective people should face their unwanted experiences rather than avoid them) therefore 
unpleasant emotions are likely to initially increase; whereas over time these aversive 
experiences are likely to decrease with continued exposure. These findings suggest that 




further gradual reductions in anxiety and stress may be more likely to be observed over an 
extended period of time with continued abstinence. However, the overall trend for the current 
anxiety results clearly demonstrates and reiterates existing literature that deems ACT as an 
empirically supported treatment for anxiety. Additionally, these findings provide evidence to 
suggest that ACT can also effectively treat anxiety within the context of a comorbid SUD.   
Mood management findings and interpretations. The findings for mood 
management are in line with the existing literature that supports an integrative approach that 
ACT has demonstrated for treating coexisting mood disorders and SUDs. That is, significant 
improvements in total mood management skills were detected throughout the group, thus 
supporting Vieten et al.’s (2010) findings in which positive affect increased while negative 
affect decreased when using mindfulness-based skills. Similar results from Heffner et al 
(2003), Petersen & Zettle (2009), and Thekiso et al (2015) can be applied to the current 
findings as well, in that they all reported significant reductions in depressive symptoms post-
treatment and at the follow-up assessment phases. This study measured mood management 
where improvements in mood management skills can be considered to relate to lower levels 
of depressive symptoms. Again, the current study adds support for the use of ACT with mood 
disorders as well as providing evidence that ACT is also effective for coexisting SUDs and 
mood disorders.  
Locus of control findings and interpretations. The subscale ‘powerful others’ on the 
BLOCS rated participants’ perceptions of others being responsible for their circumstances 
(i.e., external control). Results showed a large effect size for post-group data that reached 
statistical significance, suggesting reductions in participants’ powerful others’ locus of control 
compared to pre-group. These findings are line with Harvey et al.’s (2017) results utilising the 
same measure whereby significant reductions were found post-intervention for a military 




group-based programme targeting anger and alcohol. However, the current study found that 
by the three-month follow-up, the effect size reduced to small and no statistical significance 
was found in the changes between pre and follow-up scores on this measure. An explanation 
for these rebound effects may be that several participants reported in their three-month 
follow-up interviews that significant stressful life events had occurred, with most feeling out 
of control. This sense of lack of control is likely to diminish this change and also 
correspondingly increase stress and anxiety scores.  
Further explanations for rises in anxiety, stress, and external locus of control and 
reductions in mood management at the mid-group assessment point may be influenced by one 
of the underlying philosophies in ACT, that is, the aim is “to not feel better but to get better at 
feeling” (Eifert & Forsyth, 2005, p. 158). Instead of wanting participants to suppress or avoid 
their unwanted experiences a core goal of ACT is to increase people’s ability to reduce the 
impact of unhelpful thought processes and unworkable behaviours on their lives. Focusing on 
taking action towards value-driven behaviours and being in the present moment without 
judgement allows an individual to become psychologically flexible (Hayes & Strosahl, 2004; 
Hayes, 2016). In this psychological flexible state, a person is better at feeling rather than 
feeling better. This fundamental idea also lends itself to the underlying processes of exposure. 
As already briefly outlined, when exposing people to unwanted psychological experiences it 
is normal that there are increases in aversive experiences in the initial stages of the exposure 
work, whereas decreases in aversive experiences are normally observed after some time.  
Another explanation for the increase rather than a reduction that was predicted is that 
participants who were reducing their alcohol and or other drug use were not using their well-
learned coping strategy (that is, substance use) to suppress or self-medicate their unwanted 
psychological experience. Therefore, increases in anxiety and stress and external locus of 
control are a normal part of the process as well.  




The incubation effect of ACT was not evident in the current study for measures of 
stress, anxiety, external locus of control, and mood management skills. It seemed that 
significant positive change peaked by post-group assessment phase followed by reductions of 
this positive change at the follow-up phase. Although these reductions at follow-up did not 
support previous literature on the incubation effect, the follow-up scores for most measures 
(excluding mindfulness) were still indicative of positive changes compared to their pre-group 
scores. However, the difference between pre and follow-up scores was not as significant as 
the differences between pre and post comparison scores. It may be that a three-month follow-
up was too short, in that, a longer follow-up period may have produced results similar to 
previous studies that demonstrated the incubation effect commonly observed post ACT 
interventions. The existing literature for this phenomenon includes follow-up timeframes 
ranging from six months (Lanza et al., 2014), 12 months (Batten & Hayes, 2005; Bricker et 
al., 2010; Gifford et al., 2004; Gifford et al., 2011; Stotts et al., 2009) and 18-month follow-up 
points (González-Menéndez et al., 2014); all studies exhibiting continued improvements in 
outcomes following ACT treatment, even when compared to CBT. Furthermore, following 
the ACT group, it may be natural for participants to struggle on their own, attempting to 
implement the skills learnt as they are no longer accountable to the group members or 
facilitators. This may explain the reduction in scores observed in the current study’s follow-up 
data.  
Research question three: Given mindfulness is a core ACT strategy, would the 
self-reported use of mindfulness techniques be significantly related to improvements in 
coexisting difficulties and reductions in alcohol and other drug use and cravings? It was 
expected that participants would report an increase in mindfulness tendencies over the course 
of group (observed at mid-group, post-group, and follow-up assessment phases) and that 
significant relationships would be evident between mindfulness scores and all other dependent 




variables (alcohol use, substance use and cravings, perceived stress, anxiety, locus of control, 
resistance to peer pressure, and mood management). Specific predictions were that 
participants who scored higher on the mindfulness measure would have lower scores on 
substance use and cravings, perceived stress, anxiety, and external locus of control. Higher 
mindfulness scores would be highly correlated with higher mood management scores and 
those who reported higher mindfulness tendencies at pre-group were predicted to have strong 
positive relationship with higher scores on the mindfulness measure at mid, post, and follow -
up assessment points.  
Mindfulness findings and interpretations. Mindfulness scores, as measured by the 
Mindfulness Attention Awareness Scale (MAAS) did not gradually increase throughout the 
group process thus not supporting the original hypothesis. By the post-group assessment 
point, self-reported mindfulness tendencies had increased; however, this change was not 
statistically significant and was small. Yet at the three-month follow-up mindfulness scores 
showed statistically significant improvement which supports the hypothesis that mindfulness 
would demonstrate an accumulative effect over time. 
Significant relationships, that is correlations that reached statistical significance, 
between mindfulness scores and amphetamine totals (use and cravings), sedative totals, stress, 
anxiety, external locus of control for powerful others, and total mood management as well as 
mood management subscales were found. Non-significant relationships were found between 
mindfulness scores and alcohol scores, tobacco scores, cannabis scores, and opioid scores. 
While there was a mix of significant and non-significant results as well as positive and 
negative relationships between variables, the overall picture given by bivariate correlations 
findings for the current study was that higher scores for mindfulness appear to be related to 
lower scores for alcohol use, substance use and cravings, perceived stress, anxiety, external 




locus of control as well as higher scores of mindfulness relating to higher scores of mood 
management skills. All of these results are in line with the existing literature on mindfulness-
based behaviours observed in those who have lower rates of substance use and mental health 
problems (Bowen et al., 2006; Brewer, 2016; Chiesa & Serretti, 2014).  
Qualitative information collected at the follow-up interviews and via the 
supplementary feedback measures showed that participants rated the mindfulness components 
of the group the most helpful. Many participants had continued to practise daily mindfulness 
since the group and attributed their overall wellbeing to this practice. One unexpected finding 
was the relationship between mindfulness scores and the attention subscale on the Trait Meta 
Mood Scale (TMMS). The attention subscale indicates participants’ awareness of moods. The 
assumption is that mindfulness tendencies (i.e., attention to the present moment) 
correspondingly increase with awareness of mood states. However, the attention subscale data 
were at odds with this assumption in that relationships between mindfulness and attention 
were non-significant with small effects. This may be due to no change in attention subscale 
scores between pre-post scores which may have been due to participants not understanding or 
interpreting the measure correctly.   




SECTION TWO: Strengths and limitations 
The current study implemented several design features to address issues previously outlined 
as recommendations for future research by the existing literature. This includes the use of post 
treatment data and three-month follow-up data, as well as the use of treatment fidelity 
checklists to ensure treatment integrity, and session rating scales to obtain feedback directly 
from participants. This study was conducted in a real-world setting and demonstrates the 
feasibility and positive results of an ACT-based group treatment programme tailored towards 
SUDs. Also noteworthy is that the ACT group appears to have the same effectiveness for both 
males and females, demonstrated by the non-significant differences in self-reported scores 
across all assessment phases for all measures. However, there are several limitations that 
warrant further discussion.  Methodological constrains include the research design, aspects of 
the procedures, and lengthy assessment measures. Other general issues involve confounding 
factors such as contamination of treatment conditions by concurrent therapies, impact of co-
facilitators’ experience as well as dual roles of the co-facilitators, and group attrition rates.    
Research design and small sample size  
A randomised control trial was beyond the scope of the current study. Additionally, 
comparison groups were attempted for recruitment but did not eventuate due to attrition rates 
amongst other issues. This meant a repeated measures design was preferable. This design 
allows an assessment of effect over time and excludes effects of individual differences as they 
assess the same person across time. This design is also cost effective, time efficient, and 
amendable in real-world contexts. However, this design method also carries a number of 
limitations. Order effects are a consideration; participants may have become fatigued with the 
assessment measure throughout the group. Hence participants’ scores may have decreased or 
alternatively participants may have learned what each measure was trying to capture. This 




means their scores may have increased as a result of demographic characteristics rather than a 
direct change from the group treatment implemented.  
Perhaps the most important limitation was the small sample size. This had the effect of 
reducing the power of the study to detect change. The combination of small sample size, with 
multiple comparisons conducted across all assessment phases means there is the possibility of 
type one error. This means that the significant results in the current study may be due to 
chance and need to be interpreted with caution. The small sample size also limits the 
generalisability of the results. The ethnic profile of the sample for the current study was 
consistent with that of the general population of NZ, in that the majority identified as NZ 
European with Māori as the second largest identified ethnicity. However, a key finding from 
the NZ mental health survey was that young Māori males were more at risk of struggling with 
SUDs (Oakley-Browne et al., 2006) which indicates that the current sample was not 
representative of NZ’s AOD population. Therefore, future studies that sought to include 
culturally diverse participants would be beneficial to increase the generalisability. Lee et al.’s 
(2015) meta-analysis stated the need for more cultural diversity within ACT studies.  
Protocol of measures  
While efforts were made to keep the protocol of measures brief and measure several aspects 
of interest, shorter measures that encapsulate depression, anxiety, and stress such as the 
DASS-21 may have provided similar information in a succinct fashion compared to the three 
measures used in the current study to obtain information about mood, stress, and anxiety 
(TMMS includes 30items, PSS-10 includes ten items, and GAD-7 includes seven items). It is 
also important to acknowledge that the choice of psychometrics can influence what 
participants believe about the purpose of the group. For example, an item embedded in the 
GAD-7 asks respondents to state how often they had difficulty controlling their worry. The 
implicit message given is that anxiety can be controlled, a message antithetical to the 




philosophy embedded within ACT theory and applied within the group treatment programme. 
Therefore, careful consideration of outcomes measures is vital to ensure synergy between 
what is being measured and what the participants are being asked to do.  
Another consideration might be that different techniques would have been effective 
for different purposes and that this was not captured by the outcome measures. For example, 
the follow-up feedback questionnaire sought to investigate if participants practised and 
recognised improvements in ACT-based skills as a result of the group. However, these 
questions were not part of the protocol of measures and were not asked throughout the group. 
Therefore, development of ACT-skills and the impact of such were not able to be explored.  
Further, the mindfulness measure (MAAS) was implemented to investigate whether 
mindfulness tendencies increased because of the ACT-based group intervention. The MAAS 
was used to assess not only participants’ mindfulness tendencies but also relationships 
between being mindful and participants’ experiences of substance use and cravings as well as 
perceived stress levels, anxiety, external locus of control for powerful others and mood 
management. Although this measure was useful to understand the degree of these 
relationships, the Acceptance and Action Questionnaire (AAQ) is a viable alternative 
designed to evaluate psychological flexibility. Psychological flexibility is considered the 
underlying process of ACT in which the goal of treatment is to increase an individual’s ability 
to be flexible when managing their psychological experiences, both positive and negative or 
wanted and unwanted. However, AAQ was not included given that the other measures already 
made the assessment protocol lengthy and an addition of another measure had not been 
approved by the HDEC committee. Other process measures were not used, and this limitation 
is outlined in the findings from Lee et al.’s (2015) meta-analysis in which the authors 
highlight the need specifically for AOD studies using ACT to gather information on the 




process of change in order to help further understand the mechanisms of ACT applied to 
SUDs.  
Self-report measures. A number of issues exist with self-report measures utilised 
with the AOD population. Other, more stringent measures for collecting accurate data for 
substance use were not used in the current study due to a potential deterrent effect for 
participants and may have conveyed distrust by the service and group facilitators. For 
example, participants were not asked to provided urine samples to indicate what, if any, levels 
of substances were in their system at any point during the group programme or thereafter. 
Participants did not provide hair samples or oral swabs, or any physical substance use 
measures. These measures were used by Villagra-Lanza and Gonzalex-Menendez (2013) for 
smoking, Smout et al. (2010) for methamphetamine, Stotts et al. (2013) for methadone, and 
Twohig et al. (2007) for cannabis, to support self-reported measures of substance use during 
their study. 
Other considerations for the use of the self-report measures are personality 
characteristics that may affect the validity of the self-report data; the need for approval or 
wanting to be liked (social desirability) may influence participants’ responses in a way that 
would allow them to be seen as desirable, ‘good’ participants. This may mean that 
participants may have been ‘faking good’ and underreported their substance use and cravings, 
including alcohol, and other aversive symptoms such as stress and anxiety.                                                                                                                                                                      
Confounding factors  
An important consideration is the impact of dual roles, that is, the author being the lead 
researcher, co-facilitator of the group, and an Intern Psychologist at the AOD service. This 
meant that some of participants in the groups were also seen by the author for individual 
sessions as an Intern Psychologist. Therefore, therapeutic alliances may have impacted 




participants’ attendance, motivation, and created potential biases like simulation which is 
when a participant wants to appear likeable by the facilitator (Van de Mortel, 2008 as cited in 
Thekiso et al., 2015). This particular issue was not measured, and it is recognised that this 
may have influenced the data.  
While the group was run by an experienced senior Clinical Psychologist and an Intern 
Psychologist, differences in experience and competence need to be considered. However, 
feedback data suggests that participants reported both facilitators to be ‘very competent’ with 
only one indicating ‘moderately competent’. Lack of competence ratings for research has 
been reported as a limitation in several studies and hence it is an important consideration for 
further research.  
Contamination of the ACT group treatment condition by concurrent therapies was 
considered one of the most important confounding factors for the results. It is difficult to 
separate out the effects of the ACT group with those that were receiving parallel individual 
treatment. Although the various individual treatments were accounted for in the initial 
questionnaire participants completed, it is difficult to characterise the specific content for each 
therapy or counselling provided. The follow-up questionnaire attempted to distinguish the 
direct impact of the ACT group on participants by asking if the ACT group was responsible 
for changes in overall satisfaction with life and their sense of happiness and wellbeing, for 
example. However, it remains a limitation of the current research and was stated as one of the 
common methodological limitations of the existing ACT research (Ost, 2008; 2014). One 
participant offered an insight into this via their follow-up questionnaire in which they stated:  
“I’m not entirely sure how much of it has been the ACT group and how much an 
influence of circumstance, and other influences, but I do think that I have been able to turn 




my life around and improve my circumstance dramatically since participating in the ACT 
group, and would credit that participation with being key to my success in recent months” 
       - Anonymised quote, ACT Group 
Attrition rates  
While the first group had 95% retention rate for the follow-up assessment phase, the other 
remaining groups halved in size by three months post-group. Holding the group during 
working hours meant several participants withdrew from the ACT group due to work 
commitments. Other attrition issues included several participants who struggled significantly 
with anxiety issues and therefore either did not attend the group at all or attended one or two 
sessions and withdrew. Therefore, these participants may have required further support prior 
to group to address anxiety in order to cope and engage with the group format of the ACT-
based treatment programme. Several ACT studies have found lower rates of attrition when 
comparing the transdiagnostic therapy to other treatments such as CBT, TAU, or control 
groups (Luoma et al., 2012).  
Group format 
The benefits of group treatment have been outlined as time and cost effective as well as 
offering a format for connection with others who are struggling with similar problems. 
Qualitative information obtained from the supplementary measures (session rating scales and 
group rating scales) showed that most participants found the group format to be welcoming 
and non-judgemental. The quotes below support the use of the group treatment programme 
for the current study.  
“I learnt that other people use/abuse substances for similar reasons as myself. 
Already I feel less isolated and less like these issues are due to some sort of personal failing.” 




“I really enjoyed today, it gave me a sense of belonging and confidence to speak in 
front of others and was very interesting to hear others opinions etc.” 
“I simply enjoy being a part of a group with no judgment and it feels like a positive 
step towards my and others recovery” 
- Anonymised quotes, ACT Group  
These quotes are in line with the benefits of ACT delivered in a group format previously 
described by Walser and Pistorello (2004), namely, support, validation, increased self-
awareness, and better understanding through different perspectives.  
Manualised approach  
Öst (2008; 2014) stated that adherence to a manual increases the validity and reliability of the 
treatment given and recommends that this method should be used in all studies to ensure 
group members receive the well-researched and supported material that is encapsulated in a 
manualised group programme. The current research project included developing a manual for 
an ACT-based group treatment programme specifically tailored for those that struggle with 
alcohol and other drug problems. This manual served as the base for all four groups from 
which data were collected and then examined in order to gain an idea of the effectiveness of 
group programmes utilising ACT for SUDs in NZ. The facilitator’s manual and the 
corresponding participant workbooks allowed each group to receive nearly identical 
therapeutic intervention content, and this was ensured via the treatment fidelity checklists. 
However, Öst (2008; 2014) still recommends that sessions should videotaped or audiotaped 
with a 20% sample randomly reviewed by an external assessor to assess treatment adherence 
and therapist competency and further research that could implement this if the resources are 
available is recommended.  




SECTION THREE: Future implications and recommendations 
While many of limitations outlined above were beyond the control and feasibility of the 
current research, Öst’s (2014) recommendations for future research are still applicable to the 
ever-growing body of empirical evidence investigating ACT, specifically with SUDs and 
coexisting problems. For further implementation of an ACT-based group treatment 
programme for coexisting SUDs and mental health problems in NZ, larger, more diverse 
samples are needed alongside waitlist controls, TAU comparisons, and more importantly 
active treatment comparisons (such as already established treatments). It will be important for 
future studies to make corrections to the Alpha level, particularly when making multiple 
comparisons with small sample sizes. Specific tailoring to the needs of New Zealanders who 
struggle with AOD problems is warranted which may incorporate Māori specific processes 
and language given the high prevalence of SUDs in this population. An ACT-based 
intervention offers a therapy that usually has stronger retention rates and has shown to be 
potentially effective for multiple comorbid conditions should be pursued within NZ.  
 Some ideas for change to the current study’s ACT-based group treatment programme 
include:  
1) only measure participants’ specific substances that they target for change as a result of 
attending group rather than measuring all substances for each participant,  
2) apply corrections for statistical significance testing such as adjusting the Alpha levels 
reported to address type one error,  
3) allocate more time to explain and prepare participants about the underlying processes 
of exposing themselves to unwanted psychological experiences they have previously 
avoided or suppressed, 




4) in order to address the tobacco use, breaks may be shorter, or the group could be held 
in a non-smoking environment that participants would not be able to leave the grounds 
within the break, and more specific content geared towards smoking cessation may be 
included,  
5) organise more routine follow-up with an AOD counsellor or mental health worker to 
remind participants of the skills learnt, specifically when stressful life events have 
occurred post-intervention.  
While these changes may produce improvements in outcomes from future studies, it may 
be that the rebound stress, anxiety, and external locus of control scores at follow-up are a 
normal part of the process. ACT is about sitting with uncomfortable internal states rather than 
removing oneself through avoidance strategies such as substance use. Through this real-world 
setting the ACT group showed what realistic changes can occur for New Zealanders 
struggling with an array of difficulties.  
The next logical step for ACT interventions for SUDs and comorbid diagnoses would 
involve a replication of the current study with the changes outlined above, as well as the 
inclusion of a waitlist group to control for the impact of concurrent therapies. This would 
allow for greater confidence in interpreting outcomes as a result of the ACT group 
programme itself rather than the influence of concurrent therapies. Other inclusions would be 
a measure of facilitator’s competencies with ACT model, incorporating process of change 
measures such as the AAQ, and reporting detailed demographic characteristics of the sample.  
 
  




SECTION FOUR: Concluding Statement 
Overall, evidence supporting the use of ACT with SUDs and co-occurring mental health 
problems is still emerging. SUDs are complex and rarely diagnosed in the absence of 
significant coexisting problems such as anxiety and depression. The current study applied a 
transdiagnostic approach for those struggling with AOD and comorbid mental health 
disorders. Although the outcomes are preliminary due to the small sample size, the data are 
certainly encouraging and suggest ACT is a promising alternative therapy for coexisting 
substance use and mental health disorders. This transdiagnostic approach to treating such 
comorbid and challenging problems is a significant advance in the way treating services begin 
to conceptualise problems outside of the medical model. Not only is ACT able to broadly treat 
underlying processes commonly found in several mental health disorders (including SUDs) 
and physical health conditions, but it also helps people in general to come in contact, or closer 
in contact, with their deeply held values, and forges a way towards making active changes in 
people’s behaviours to enable a more vital and meaningful life. The group format offered a 
comforting sense of connection and was a cost and time effective way to impart ACT-based 
skills. The current study supports the continued use and development of group-based 
treatment programmes with ACT and has shown its applicability for such formats. Further 
research is necessary to promote the continued and further use of ACT-based treatment 
programme for complex coexisting problems, and more extensive use of the manual for group 
therapy is likely to build on the evidence in support of ACT for the AOD population in New 
Zealand. This piece of research, albeit small scale, has illustrated the potential of ACT to 
make a difference in the lives of those affected.
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Appendix A. Information brochure for recruiting participants 
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This questionnaire measures a range of areas that can be affected by substance use in everyday 
life. Questions will range from alcohol and drug use, stress, anxiety, emotional management, 
feelings of control, influences from peers, and mindful awareness.  
Before you start, please fill out the following information about yourself: 
Code #: …………………………………….. Date:……………………………………. 
D.O.B. (dd/mm/yyyy):……………………... Ethnicity: ………………………………. 
Gender:  M / F / T 
Relationship status (e.g. single, defacto, married, 
etc):…..………………………...…............................ 












Have you attended any group treatment in the past?        Yes or No or 
Unsure 





Are you receiving any individual therapy while attending this group?     Yes or No or 
Unsure 





Acceptance and Commitment Therapy for 
Alcohol and Drug Populations 
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Alcohol Use Assessment 
Section A 
1. How often do you have a drink containing alcohol? (Please tick ONE circle) 
Never Monthly or less 
Two to four times 
per month 
Two to three 
times per week 
Four or more 
times a week 
     
 
2. How many drinks containing alcohol do you have on a typical day when drinking? 
 (Please tick ONE circle) 
1 or 2 3 or 4 5 or 6 7 to 9 10 or more 
     
 
 
3. How often do you have six or more drinks on one occasion? (Please tick ONE circle) 
Never Less than monthly Monthly Weekly Daily or almost daily 
     
Section B 
1. Think about your drinking over the PAST 4 WEEKS. On how many days did you have at 
least ONE drink in the past 4 weeks? 
 
 
“I had at least one drink on _____ days during the past 4 weeks” 
 
 
2. On how many of THESE days did you have 4 or more drinks in the course of the day? 
 
“I had at least 4 drinks on _____ days during the past 4 weeks” 
 
 
3. On how many of THESE days did you have 8 or more drinks in the course of the day? 
 
“I had at least 8 drinks on _____ days during the past 4 weeks” 
Drug Use Assessment 
 
In the past month how often have you used the following 
substances? 





































1. Tobacco products (cigarettes, chewing tobacco, cigars, etc.)      
2. Cannabis (marijuana, pot, grass, hash, etc.)      
3. Cocaine (coke, crack, etc.)      
4. Amphetamine-type stimulants (speed, meth, ecstasy, etc.)      
5. Inhalants (nitrous, glue, petrol, paint thinner, etc.)      
6. Sedatives and sleeping pills (diazepam, alprazolam, 
flunitrazepam, midazolam, etc.) 
     
7. Hallucinogens (LSD, acid, mushrooms, trips, ketamine, etc.)      
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8. Opioids (heroin, morphine, methadone, buprenorphine, codeine, 
etc.) 
     
9. Other – specify: 
_____________________________________________________
____ 
     
In the past month how often have you had a strong desire or 
urge to use the following substances? 





































1. Tobacco products (cigarettes, chewing tobacco, cigars, etc.)      
2. Cannabis (marijuana, pot, grass, hash, etc.)      
3. Cocaine (coke, crack, etc.)      
4. Amphetamine-type stimulants (speed, meth, ecstasy, etc.)      
5. Inhalants (nitrous, glue, petrol, paint thinner, etc.)      
6. Sedatives and sleeping pills (diazepam, alprazolam, 
flunitrazepam, midazolam, etc.) 
     
7. Hallucinogens (LSD, acid, mushrooms, trips, ketamine, etc.)      
8. Opioids (heroin, morphine, methadone, buprenorphine, codeine, 
etc.) 
     
9. Other – specify: 
_____________________________________________________
____ 
     
 
Stress Assessment 










   
   
   






























1. ...been upset because of something that happened unexpectedly?      
2. ...felt that you were unable to control the important things in your 
life? 
     
3. ...felt nervous and “stressed”?      
4. ...felt confident in your ability to handle your personal problems?      
5. ...felt that things were going your way?      
6. ...found that you could not cope with all the things that you had to 
do? 
     
7. ...been able to control irritations in your life?      
8. ...felt that you were on top of things?      
9. ...been angered because of things that happened that were 
outside of your control? 
     
10. ...felt difficulties were piling up so high that you could not 
overcome them? 
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1. Feeling nervous, anxious or on edge     
2. Not being able to stop or control worrying     
3. Worrying too much about different things     
4. Trouble relaxing     
5. Being so restless that it is hard to sit still     
6. Becoming easily annoyed or irritable     






Locus of Control Assessment 
 
For each of the statements below please tick the response that best 

























































1. My life is determined by my own actions.      
2. To a great extent, my life is controlled by accidental 
happenings. 
     
3. My life is chiefly controlled by powerful others.      
4. I am usually able to protect my personal interests.      
5. I feel like what happens in my life is mostly determined by 
powerful people. 
     
6. When I get what I want, it’s usually because I’m lucky.      
7. I can pretty much determine what will happen in my life.      
8. Often there is no chance of protecting my personal interest 
from bad luck. 
     
9. People like myself have very little chance of protecting our 
personal interests where they conflict with those of strong 
pressure groups. 









For each of the statements below please tick the response 


























































1. I try to think good thoughts no matter how badly I feel.       
2. People would be better off if they felt less and thought more.       
3. I don’t think it’s worth paying attention to your emotions or 
moods.  
     
4. I don’t usually care much about what I’m feeling.       
5. Sometimes I can’t tell what my feelings are.       
6. I am rarely confused about what my feelings are.       
7. Feelings give direction to life.       
8. Although I am sometimes sad, I have a mostly optimistic 
outlook.  
     
9. When I am upset I realize that the “good things in life” are 
illusions.  
     
10. I believe in acting from the heart.       
11. I can never tell how I feel.       
12. The best way for me to handle my feelings is to experience 
them to the fullest.  
     
13. When I become upset I remind myself of all the pleasures in 
life.  
     
14. My belief and opinions always seem to change depending on 
how I feel.  
     
15. I am often aware of my feelings on a matter.       
16. I am usually confused about how I feel.       
17. One should never be guided by emotions.       
18. I never give into my emotions.       
19. Although I am sometimes happy, I have a mostly pessimistic 
outlook.  
     
20. I feel at ease about my emotions.       
21. I pay a lot of attention to how I feel.       
22. I can’t make sense out of my feelings.       
23. I don’t pay much attention to my feelings.       
24. I often think about my feelings.       
25. I am usually very clear about my feelings.       
26. No matter how badly I feel, I try to think about pleasant 
things.  
     
27. Feelings are a weakness humans have.       
28. I usually know my feelings about a matter.       
29. It is usually a waste of time to think about your emotions.       
30. I almost always know exactly how I am feeling.       
Peer Influence Assessment 
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For each statement below, decide which sort of person you are most like — the one 
described on the right or the one described on the left. Then decide if that is “sort of true” or 















  Some people go along with their 




Other people refuse to go along with 
what their friends want to do, even 


















Some people go along with their 




Other people refuse to go along with 
what their friends want to do, even 




Some people think it’s more 
important to be an individual than 
to fit in with the crowd. 
BUT 
 
Other people think it is more 
important to fit in with the crowd 
than to stand out as an individual. 
  
  
For some people, it’s pretty easy 
for their friends to get them to 
change their mind. 
BUT 
 
For other people, it’s pretty hard for 




Some people would do something 
that they knew was wrong just to 
stay on their friends’ good side. 
BUT 
 
Other people would not do 
something they knew was wrong just 
to stay on their friends’ good side. 
  
  
Some people hide their true 
opinion from their friends if they 
think their friends will make fun of 
them because of it. 
BUT 
 
Other people will say their true 
opinion in front of their friends, even 
if they know their friends will make 
fun of them because of it. 
  
  
Some people will not break the law 




Other people would break the law if 




Some people change the way they 
act so much when they are with 
their friends that they wonder who 
they “really are”. 
BUT 
 
Other people act the same way when 
they are alone as they do when they 
are with their friends. 
  
  
Some people take more risks when 
they are with their friends than 
they do when they are alone. 
BUT 
 
Other people act just as risky when 




Some people say things they don’t 
really believe because they think it 




Other people would not say things 
they didn’t really believe just to get 
their friends to respect them more. 
  
  
Some people think it’s better to be 
an individual even if people will be 




Other people think it’s better to go 
along with the crowd than to make 
people angry at you. 
  
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Please indicate how frequently or infrequently you currently have each 
experience.  
Please answer according to what really reflects your experience rather than 










































































1. I could be experiencing some emotion and not be conscious of it until some 
time later.       
2. I break or spill things because of carelessness, not paying attention, or 
thinking of something else.       
3. I find it difficult to stay focused on what's happening in the present. 
       
4. I tend to walk quickly to get where I'm going without paying attention to 
what I experience along the way. 
 
      
5. I tend not to notice feelings of physical tension or discomfort until they 
really grab my attention. 
 
      
6. I forget a person's name almost as soon as I've been told it for the first 
time.       
7. It seems I am "running on automatic," without much awareness of what 
I'm doing. 
 
      
8. I rush through activities without being really attentive to them. 
       
9. I get so focused on the goal I want to achieve that I lose touch with what 
I'm doing right now to get there. 
 
      
10. I do jobs or tasks automatically, without being aware of what I'm doing. 
       
11. I find myself listening to someone with one ear, doing something else at 
the same time. 
 
      
12. I drive places on "automatic pilot" and then wonder why I went there. 
       
13. I find myself preoccupied with the future or the past. 
       
14. I find myself doing things without paying attention 
       
15. I snack without being aware that I'm eating. 
      
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The following are general questions about today’s sessions on ACT. Please indicate the 
extent to which you agree or disagree with each statement: 
 


















































Session Rating Scale 
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The following are general questions about ACT group programme as a whole. Please 
indicate the extent to which you agree or disagree with each statement: 
 






































The STYLE of the ACT group programme was appropriate (e.g. weekly sessions/ group 



















The FACILITATORS were a good fit for the ACT group programme (e.g. 


















Group Rating Scale 










































Thank you for your valuable feedback.  
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Appendix E. Follow-up Feedback Questionnaire 
 
ACT Group Participant Survey 
The following questions are to help us understand how well the ACT group meets the needs 
of the people who use its services. Please circle the answer below each question that best 
describes your experience.  
 
     
1. Around the time you first had 
contact with the ACT group, 
how would you have described 
your state of psychological 
wellbeing? 
Excellent Good Fair Poor 
2. Since then, has your state of 
psychological wellbeing 
improved?  
Yes – a lot 
Yes – 
somewhat 
No change No - worse 
3. If your psychological wellbeing 
has changed, would you say 
your contact with the ACT 
group had anything to do with 
the change?  
Yes – a lot Yes – a bit No 
Does not 
apply 
4. Around the time you first had 
contact with the ACT group, 
how would you have described 
your ability to carry out the 
everyday activities you wanted 
to do?  
Excellent Good Fair Poor 
5. Since then, has your ability to 
carry out everyday activities 
improved? 
Yes – a lot 
Yes – 
somewhat 
No change No - worse 
6. If your ability to carry out 
everyday activities has changed, 
would you say that the ACT 
group has had anything to do 
with the change? 
Yes – a lot Yes – a bit No 
Does not 
apply 
7. Overall, would you say that 
contact with the ACT group has 
helped you to cope or manage 
better in your life?  
Yes – a lot Yes – a bit No change 
No – worse 
now 
8. Overall, would you say that 
contact with the ACT group has 
helped to improve your sense of 
happiness and wellbeing?  
Yes – a lot Yes – a bit No change 
No – worse 
now 
9. Overall, would you say that 
contact with the ACT group has 
contributed to your satisfaction 
with life?  
Yes – a lot Yes – a bit No change 
No – worse 
now 
10.  Overall, how satisfied have you 
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facilitators have responded to 
assist you?  
11. In your opinion, how competent 
were the facilitator’s you have 







Not at all 
competent 
12. Overall, how satisfied do you 
feel with your contact with the 









13. Overall, since your contact with 
the ACT group, has it helped 
you to sit with your unwanted 
psychological experiences?   
Yes – a lot Yes – a bit No change 
No – worse 
now 
14. Overall, has the ACT helped 
you cope with problems related 
to addiction? 
Yes – a lot Yes – a bit No change 
No – worse 
now 
15. Overall, since your contact with 
the ACT group are you living 
more in line with your values?  
Yes – a lot Yes – a bit No change 
No – worse 
now 
16. Overall, since your contact with 
the ACT group has your 
commitment to carrying out 
your goals that are in line with 
your values improved? 
Yes – a lot Yes – a bit No change 
No – worse 
now 
 
























Thank you for your valuable feedback. 
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 Facilitators introduced each other and modelled to the group how it’s done. 
 
Group members got to know another group member and introduced the person sitting 
next to them.  
 Facilitators outlined limits of confidentiality (expectations and obligations). 
 Group expectations were collaboratively agreed upon.  
 Introduced ACT and mindfulness theories. 
 Completed a brief mindfulness exercise.  
 Group exercises demonstrating the concept of “control is the problem”  
- White bear exercise 
- Chinese finger trap 
 
Group discussion about the reasons for using substances (good and bad). 
 Outline the expectations for practicing skills outside of the group in the form of weekly 
challenges. 
 
Closing comments for the group and administer the session rating scale. 
  /10 Total 
  
Session 1 Checklist 
Treatment Fidelity 
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Confidentiality (what is said in the group stays in the group) 
 
Respect (no put downs and be nice) 
 
Trust (trust each other with vulnerable information about ourselves) 
 
Active listening/No interrupting (let people finish talking) 
 
Phones on silent or off 
 
Turn up for group sober and straight (if this is not possible at least 
appear sober and straight for the group) 
 
No invitations to group members to be involved in drug or alcohol 
use (no organising trips to the pub etc.) 
 
 
I ________________________ agree and commit to upholding the group 





ACT Group  
Agreement 
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Locality: Palmerston North Hospital Alcohol and Other Drug Service  
Address: Nikau House, Community Health Village, Palmerston North Hospital, Gate 13 (off Ruahine Street)  
Lead Researcher: Rachel Cotter 
 
You are invited to take part in a research study to examine the efficacy of Acceptance and Commitment Therapy 
(ACT) and its Application to Group Treatment Intervention in an Alcohol and Other Drug Community Sample.  
 
My name is Rachel Cotter and I am a doctoral student in the clinical psychology programme at Massey 
University. I am seeking volunteers to help me complete my doctorate research thesis by taking part in a ten 
week Acceptance and Commitment Therapy group treatment programme aimed at reducing substance cravings 
and their related symptoms (e.g. anxiety, stress, and depression). I am recruiting individuals who have a 
diagnosis of substance use disorder between the ages of 18 and 65 years old. I am conducting my research 
under the supervision of Doctor Shane Harvey (Massey University, Palmerston North), Senior Clinical 
Psychologist, Guy Breakwell (Alcohol and Other Drug Service, Palmerston North), and Doctor Simon Bennett 
(Massey University, Wellington). 
 
This study will involve up to 30 individuals (18-65 years old), who use alcohol and other drugs and have a 
diagnosis of substance use disorder.  Three groups of ten people will be formed in order to run a group therapy 
programme.  
Your participation is entirely voluntary. Whether or not you take part is your choice. If you do not wish to take 
part in this study you do not need to give a reason, and it will not affect your future health care in any way. If 
Acceptance and Commitment Therapy for 
Alcohol and Drug Populations 
PARTICIPANT INFORMATION SHEET 
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you do want to take part, but change your mind later, you can pull out of the study at any time. You may wish 
to talk to a friend, family or whānau member, or a healthcare provider before you make a decision.  
I will contact you by phone once you have had time to read and process this information sheet. During the 
phone call please feel free to ask any questions you may have about the study. If you agree to take part in this 
study, you will be asked to sign the Consent Form on the last page of this document. You will be given a copy 
of both the Participant Information Sheet and the Consent Form to keep.  
This document is 7 pages long, including the Consent Form. Please make sure you have read and understood 
all the pages.  
What is the purpose of the study? 
The aim of this study is to investigate the effectiveness of Acceptance and Commitment Therapy (ACT) to reduce 
substance use cravings and increase overall quality of life. ACT is a new therapy that has shown favourable 
results in the reduction of negative symptoms experienced for a number of problems including chronic pain 
and smoking cessation. Our intention is to develop and pilot an alternative treatment programme for alcohol 
and other drug issues.   
What will my participation in the study involve? 
Participation in this study will involve up to three hours of your time each week for ten weeks. The whole study 
will consist of 12 visits: a one on one initial interview, ten group sessions, and a follow-up session three month 
post treatment (see Table 1. below). There may be some simple homework activities for you to complete during 
the week to put into practice the skills that you learned during the session. You will be required to transport 
yourself to Palmerston North AOD Service to attend the group. Punctuality and respectful behaviour is expected 
as well as willingness to actively participant in group exercise and discussions. You will be required to complete 
a range of questionnaires at four assessment points (pre, during, post, and follow-up).  
Table 1. 
Summary Table for ACT group programme  
Session Timeline Tasks Assessment Points 
Initial Session - Participant information sheets 
explained 
- Consent form signed 
- Address any questions about 
study 
- Pre-group treatment 
assessment 
Group Sessions 1 -10 - Introduction to programme 
- Core principles of ACT  
- Group Discussions 
- Group Exercises  
- Individual homework  
- Relapse prevention 
- During treatment assessment 
(administered in session 5) 
- Post treatment assessment 
(administered in session 10) 
Follow-Up Session - Relapse prevention 
- Progress so far 
- Recap on skills learnt 
- Follow-up assessment 




Who can participate? 
If you are: 
 Between the ages of 18 and 65  
 Have a diagnosis of a substance use disorder 
 Not suffering from severe depression, suicidal ideation, or diagnosed with a personality disorder 
 Willing to take part in ten therapy sessions and two assessment sessions and maintain sobriety for 
these sessions (i.e. you will not attend group intoxicated or under the influence of drugs)  
What are the possible benefits and risks of this study? 
Research has shown ACT helps individuals cope effectively with a range of difficulties. We anticipate 
participants may benefit from taking part in this study by gaining skills to cope with a wide range of every day 
struggles associated with using substances.  
The potential risks of participating in this study are minimal. You may experience some discomfort in the 
group format when discussing substance use and related symptoms. However we will endeavour to ensure 
confidentiality is upheld. You do not have to share anything in the group that may make you feel 
uncomfortable.  
You will not be expected to pay any money to participate in this study. You will be gifted a $20 supermarket 
voucher at the completion of the ten therapy sessions. You will also be gifted with another $20 voucher 
(supermarket) at the completion of the three-month follow-up session.  
You have the right to access information collected about you as part of the study. Please contact the lead 
researcher if you would like to do so. You will be informed of any new information that becomes available 
during the study through assessment sessions or via telephone.  
Will my information remain confidential? 
The interview and questionnaires are anonymous, and files will be coded with anonymous identification 
numbers to ensure confidentiality to individuals. Only the lead researcher and three supervisors are able to 
directly access any written material.  
All material will be kept in a secure location and destroyed after ten years. No material that could personally 
identify you will be used in any reports of this study. The information collected will be used for the study and 
may be submitted for publication in an academic journal. Only collective data from the entire sample will be 
described.  
Please note that while confidentiality will be strongly encouraged within the group format by signing the 
consent form, we cannot guarantee complete confidentiality due to the nature of group work. 
Confidentiality may be broken at the discretion of the facilitators if there is any risk to yourself or others.  
If any risks arise, actions will be taken to ensure safety of all participants under the Palmerston North AOD 
Service procedures.  
What happens after the study? 






You can choose to be sent an information sheet with the results of the study when they are available. These 
results will be summarised and will be in the form of group averages, therefore no individual results will be 
identifiable.  
Thank you very much for your time and help in making this study possible. Please contact me if you have any 
queries about this study.  
Rachel Cotter, Doctoral Student 
Telephone:  
Email:   
Dr Shane Harvey 
Telephone: (06) 350 5196 
Email: S.T.Harvey@massey.ac.nz  
Guy Breakwell 
Telephone: (06) 350 9130  
Email: Guy.Breakwell@midcentraldhb.govt.nz  
Dr Simon Bennett 
Telephone: (04) 801 5799  
Email: S.T.Bennett@massey.ac.nz  
If you want to talk to someone who isn’t involved with the study, you can contact an independent health and 
disability advocate on: 
Phone:  0800 555 050 
Fax:  0800 2 SUPPORT (0800 2787 7678) 
Email:  advocacy@hdc.org.nz 
For Māori Heath support please contact : 
MidCentral Specialist Māori Mental Health 
 Phone: 06 350 9155 
               Freephone: 0800 00 78 78 
You can also contact the health and disability ethics committee (HDEC) that approved this study on: 
 Phone:  0800 4 ETHICS 
 Email:  hdecs@moh.govt.nz 
 
Contact Phone Number: 021 354 141 
Ethics Committee Reference Number: 15CEN134 







✓ I have read and I understand the participant information sheet 
 
✓ I have had the opportunity to discuss this study with the researcher, and I am satisfied with the 
information I have been given. I have a copy of this consent form and information sheet.  
 
✓ I have had sufficient time to decide whether or not to take part in this study. 
 
✓ I understand that taking part in this study is voluntary (my choice), and that I may withdraw from this 
study at any time, and this will in no way affect my continuing health care. 
 
✓ I consent to the research staff collecting and processing my information, including information about 
my health. 
 
✓ If I decide to withdraw from the study, I agree that the information collected about me up to the 
point when I withdraw may continue to be processed: (please tick one) 
 
YES  ☐ NO ☐ 
 
✓ I understand that the study will include a total of ten sessions and will take up to three hours each 
session and will take approximately 20 hours to complete over a ten week period.  
 
✓ I understand that my participation in this study is confidential and that a participant number (not my 
name) will be recorded next to any data collected from me over the course of this study. 
 
✓ I understand my responsibilities as a study participant:  
Acceptance and Commitment Therapy  
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- Being punctual  
- Willingness to actively participate in group exercises and discussions 
- Upholding respectful and appropriate behaviour (aggressive behaviour is not acceptable) 
- Upholding confidentiality of the individuals in the group (Do NOT discuss group members 
outside of this room) 
- Completing homework and questionnaires at given times 
 
✓ I wish to receive a copy of the results: (please tick one) 
 
YES ☐ NO ☐ 
 
✓ I understand that I can contact the researcher or the co-facilitator and supervisors if I have any 
questions about this study.  
 











This project has received ethical approval from the Health and Disability Ethics Committee, Reference 
Number: 15CEN134 
  APPENDICES 
Page 233 
Appendix I. Participant Feedback Summary – Anonymised copy 
 
 
Scores over 5 indicate increasing 
or higher risk drinking. At pre-
group assessment your score 
indicated increased risk drinking 
however at during and post-
group assessment points you 
reported no hazardous alcohol 
use.  
 
At pre-group assessment point 
you reported consuming more 
than 8 drinks on 21 days out of 
the last month. At during and 
post-group assessment you 
reported no alcohol use within 
the last month.  
 
At pre and during group 
assessment points you reported 
tobacco cravings once or twice 
in the last month. At pre-group 
assessment you reported once or 
twice sedative use in the last 
month. At during group 
assessment, you reported no 
sedative use but reported weekly 
sedative cravings. No use or 
urges to use tobacco or sedatives 
in post-group questionnaire. No 
other substance use or urges 
reported throughout group.  
 
At pre-group assessment your 
stress score fell within the 
moderate stress range. At during 
and post-group assessment your 
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At pre-group assessment your 
anxiety score fell within the 
moderate range. At during and 
post-group assessment your 
scores decreased to the mild 
anxiety range.  
 
At pre-group assessment point 
you reported that your belief that 
you have control over your life 
(internal) was the same as others 
having control over your life. 
Your during and post-group 
assessment points reflect that 
your internal control belief 
increased and your chance and 
others having control over your 
life decreased.  
 
Your total mood management 
scores increased throughout 
group and fell within the range 
that suggests you have a handle 
on emotions but could use more 
work.  
Attention: your self-perceived 
ability to attend to your 
mood/emotions increased 
throughout group and remained 
within the range of growing 
awareness.  
Clarity: your self-perceived 
ability to clearly discriminate 
between your mood/emotions 
varied throughout group but 
remained within the range of 
growing clarity.  
Repair: your self-perceived 
ability to regulate your 
emotions/moods slightly 
increased throughout group and 
fell within in the range of 







































Higher scores on this measure 
reflect higher resistance to peer 
influence. Your scores remained 
high with a slight decrease 
evident throughout group.  
 
Higher scores on this measure 
reflect more frequent mindful 
tendencies. Your scores slightly 
varied throughout group but 
remained at the lower end of 
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Appendix J. Ethical Approval  
 
 
Health and Disability Ethics Committees  
 Ministry of Health  
Freyberg Building  
20 Aitken Street  
PO Box 5013  
   Wellington  
6011  
  
 0800 4 ETHICS   
hdecs@moh.govt.nz  
  
05 November 2015  
   
Miss Rachel Cotter   
School of Psychology, T4 Building  
Massey University  
P.O. Box 756  
Wellington 6140  
  
Dear Miss Cotter   
 Re:  Ethics ref:  15/CEN/134  
  Study title:  Acceptance and Commitment Therapy (ACT) and its Application to  
Group Treatment with an Alcohol and Other Drug (AOD) Community Sample  
  
 I am pleased to advise that this application has been approved by the Central Health and 
Disability Ethics Committee.  This decision was made through the HDEC-Full Review 
pathway.  
  
Conditions of HDEC approval  
  
HDEC approval for this study is subject to the following conditions being met prior 
to the commencement of the study in New Zealand.  It is your responsibility, and 
that of the study’s sponsor, to ensure that these conditions are met.  No further 
review by the Central Health and Disability Ethics Committee is required.  
  
Standard conditions:  
  
1. Before the study commences at any locality in New Zealand, all relevant 
regulatory approvals must be obtained.  
  
  APPENDICES 
Page 237 
2. Before the study commences at any locality in New Zealand, it must be 
registered in a WHO-approved clinical trials registry (such as the Australia 
New Zealand Clinical Trials Registry, www.anzctr.org.au).  
  
3. Before the study commences at a given locality in New Zealand, it must 
be authorised by that locality in Online Forms.  Locality authorisation 
confirms that the locality is suitable for the safe and effective conduct of 
the study, and that local research governance issues have been addressed.  
    
  
After HDEC review   
  
Please refer to the Standard Operating Procedures for Health and Disability 
Ethics Committees (available on www.ethics.health.govt.nz) for HDEC 
requirements relating to amendments and other post-approval processes.    
  
Your next progress report is due by 04 November 2016.  
  
Participant access to ACC  
  
The Central Health and Disability Ethics Committee is satisfied that your study is 
not a clinical trial that is to be conducted principally for the benefit of the 
manufacturer or distributor of the medicine or item being trialled.  Participants 
injured as a result of treatment received as part of your study may therefore be 
eligible for publicly-funded compensation through the Accident Compensation 
Corporation (ACC).  
  
  
Please don’t hesitate to contact the HDEC secretariat for further information.  We 
wish you all the best for your study.  
  
Yours sincerely,  
  
Mrs Helen Walker  
Chairperson  
Central Health and Disability Ethics Committee  
  
  
Encl:  appendix A: documents submitted appendix B: 
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Appendix L. Table of means, standard error of means, and standard deviation for Paired Sample t-Tests 
Dependent variable 
n 
Pre versus Post 
(24) 
 Pre versus Follow-up 
(20) 







































































































































































































































































































Pre versus Mid 
(26) 
 Mid versus Post 
(24) 
 Mid versus Follow-up 
(20)  
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Note:  = mean, SD = standard deviation, SEM = standard error of the mean, § = an abbreviation of ‘subscale’, F/U = follow-up, AUDIT-C = Alcohol Use Disorder 
Identification Test – Consumption, ALC Section B = Alcohol Use Section B, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief 
Locus of Control Scale, TMMS = Trait Meta Mood Scale, MAAS = Mindfulness Attention Awareness Scale. Scores for Cocaine, inhalants, hallucinogens, and “other” on the 
WHO-ASSIST V3.0 (World Health Organisation – Alcohol, Smoking, and Substance Involvement Screening Test Version 3.0) were excluded from the analysis due to 
minimal or no endorsement. BLOCS scales for internal locus of control and external chance locus of control were also excluded. 
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Appendix M. Correlation Matrices Showing Associations Between Dependent Variables Across all Assessment Phases 
Pre-group treatment assessment phase 
N (39) AUDIT-C ALC  TOB CAN AMPH SED OPI PSS-10 GAD-7 BLOCS  
 
TMMS ATTN CLAR REP MAAS 
AUDIT-C 1               
ALC 0.662** 1              
TOB 0.000 -0.248 1             
CAN -0.033 -0.305 0.221 1            
AMPH -0.197 -0.260 -0.023 0.147 1           
SED 0.155 -0.078 0.176 0.079 0.567* 1          
OPI -0.279 -0.202 0.079 0.091 0.267 0.379* 1         
PSS-10  0.105 -0.040 0.332* 0.166 0.176 0.518** 0.222 1        
GAD-7  0.098 -0.112 0.097 0.148 0.377* 0.584** 0.286 0.752** 1       


































































MAAS  0.126 0.191 -0.067 -0.030 -0.307 -0.288 -0.116 -0.546** -0.534** -0.211 0.527** 0.310 0.392* 0.473** 1 
Note. AUDIT- C = Alcohol Use Disorder Identification Test-Consumption, ACL =Alcohol Use Section B, TOB = Tobacco total, CAN = Cannabis total, AMPH = 
Amphetamine total, SED = Sedative total, OPI = Opioid total, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief Locus of 
Control Scale, TMMS = Trait Meta Mood Scale, MAAS = Mindfulness Attention Awareness Scale. BLOCS scales for internal locus of control and external chance locus of 
control were also excluded. § = an abbreviation of ‘subscale’. **Correlation is significant at the 0.01 level (2-tailed) *Correlation is significant at the 0.05 level (2-tailed)   
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Mid-group treatment assessment phase 
N (26) AUDIT-
C 
ALC  TOB CAN AMPH SED OPI PSS-10 GAD-7 BLOCS TMMS ATTN CLAR REP MAAS 
AUDIT-C 1               
ALC 0.563** 1              
TOB 0.144 -0.171 1             
CAN -0.197 -0.284 0.220 1            
AMPH -0.362 -0.316 0.070 0.342 1           
SED -0.026 -0.186 0.004 -0.064 0.466* 1          
OPI -0.340 -0.277 0.209 0.114 0.508** 0.549** 1         
PSS-10  0.299 -0.092 0.262 0.178 0.300 0.369 0.102 1        
GAD-7  0.246 -0.098 0.183 0.013 0.366 0.393* 0.407* 0.624** 1       
































































MAAS -0.040 0.205 -0.150 -0.370 -0.231 -0.205 0.028 -0.703** -0.247 -0.404* 0.596** 0.454* 0.609** 0.383 1 
Note. AUDIT- C = Alcohol Use Disorder Identification Test-Consumption, ACL =Alcohol Use Section B, TOB = Tobacco total, CAN = Cannabis total, AMPH = 
Amphetamine total, SED = Sedative total, OPI = Opioid total, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief Locus of 
Control Scale, TMMS = Trait Meta Mood Scale, MAAS = Mindfulness Attention Awareness Scale. BLOCS scales for internal locus of control and external chance locus of 
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Post-group treatment assessment phase 
N (25) AUDIT-C ALC  TOB CAN AMPH SED OPI PSS-10 GAD-7 BLOCS TMMS ATTN CLAR REP MAAS 
AUDIT-C 1               
ALC 0.742** 1              
TOB 0.047 0.129 1             
CAN -0.182 0.082 0.477* 1            
AMPH -0.355 -0.246 0.128 0.396* 1           
SED -0.233 -0.196 0.072 -0.083 0.524** 1          
OPI -0.346 -0.219 0.163 0.067 0.503* 0.733** 1         
PSS-10  0.262 0.229 0.435* 0.250 0.227 0.090 0.110 1        
GAD-7  0.254 0.220 0.329 0.202 0.293 0.284 0.274 0.490* 1       


































































-0.042 -0.135 -0.042 0.092 -0.341 -0.350 -0.134 -0.389 -0.360 -0.646** 0.536** 0.292 0.604** 0.194 1 
Note. AUDIT- C = Alcohol Use Disorder Identification Test-Consumption, ACL =Alcohol Use Section B, TOB = Tobacco total, CAN = Cannabis total, AMPH = 
Amphetamine total, SED = Sedative total, OPI = Opioid total, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief Locus of 
Control Scale, TMMS = Trait Meta Mood Scale, MAAS = Mindfulness Attention Awareness Scale. BLOCS scales for internal locus of control and external chance locus of 
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Three-month follow-up group treatment assessment phase 
N (20) AUDIT-C ALC  TOB CAN AMPH SED OPI PSS-10 GAD-7 BLOCS TMMS ATTN CLAR REP MAAS 
AUDIT-C 1               
ALC 0.798** 1              
TOB 0.475* 0.334 1             
CAN 0.144 -0.080 0.288 1            
AMPH -0.273 -0.194 -0.163 0.229 1           
SED -0.294 0.008 0.015 -0.102 0.310 1          
OPI -0.339 -0.267 -0.217 -0.145 0.162 0.444* 1         
PSS-10  0.131 0.113 0.551* -0.070 0.168 0.515* 0.277 1        
GAD-7  -0.014 -0.001 .0155 -0.080 0.210 0.457* 0.416 0.737** 1       
































































-0.304 -0.326 -0.421 -0.225 -0.467* -0.391 -0.103 -0.557* -0.426 -0.599** 0.504* 0.245 0.487* 0.421 1 
Note. AUDIT- C = Alcohol Use Disorder Identification Test-Consumption, ACL =Alcohol Use Section B, TOB = Tobacco total, CAN = Cannabis total, AMPH = 
Amphetamine total, SED = Sedative total, OPI = Opioid total, PSS-10 = Perceived Stress Scale – 10, GAD-7 = General Anxiety Disorder – 7, BLOCS = Brief Locus of 
Control Scale, TMMS = Trait Meta Mood Scale, MAAS = Mindfulness Attention Awareness Scale. BLOCS scales for internal locus of control and external chance locus of 
control were also excluded. § = an abbreviation of ‘subscale’. **Correlation is significant at the 0.01 level (2-tailed) *Correlation is significant at the 0.05 level (2-tailed)
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Appendix N: Research Case Study  
 
A Preliminary Analysis of an Acceptance and Commitment Therapy Group 
Treatment Programme in a Real-World Alcohol and Other Drug Community Setting: 




Massey University  
Doctorate of Clinical Psychology Candidate 
 
 




This case study represents the research of Rachel Cotter throughout the DClinPsych 
programme and the resultant reflections of her internship in 2017. 
Research Supervisors: Dr Shane Harvey, PhD, Guy Breakwell, Senior Clinical 
Psychologist, and Dr Simon Bennett, PhD 
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Abstract 
This preliminary analysis examined a group therapy programme utilising Acceptance 
and Commitment Therapy (ACT) for people diagnosed with Substance Use Disorders 
(SUDs) and coexisting mental health problems. The group programme consisted of ten 
group sessions that ran for up to three hours on a weekly basis. A final sample total of 
eight participants were included in the study, who were clients of the Palmerston North 
Alcohol and Other Drug (AOD) Service. A repeated measures design was used to 
explore the effectiveness of the ACT group programme targeting alcohol, stress, 
anxiety, and mood. These were measured at pre and post-group assessment points using 
the AUDIT-C, PSS-10, GAD-7 and TMMS respectively. Retention rates were high 
with 95% of the ACT group completing post-group assessments. There were reductions 
in stress (PSS-10) and anxiety (GAD-7) and an improvement in mood management 
(TMMS) as well as a slight reduction in alcohol use (AUDIT-C) scores post-treatment. 
These results, although only small, demonstrate the promising therapeutic gains of ACT 
when applied to alcohol use and coexisting mental health problems within the context 
of an AOD population and within a group format. The limitations of this preliminary 
analysis are discussed and the benefits of this experience in relation to my development 
as a clinical psychology intern are reflected.  
Keywords: Acceptance and Commitment Therapy, Substance Use Disorders, Group 
Treatment Programme 
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A Preliminary Analysis of an Acceptance and Commitment Therapy Group 
Treatment Programme in a Real-World Alcohol and Other Drug Community 
Setting 
Substance Use Disorders (SUDs), commonly referred to as addictions, affect a broad 
range of people. An individual with a SUD often experiences mental health issues co-
morbidly, which make the treatment of these co-existing problems a complicated and 
complex challenge to those assigned to treat them. Not only does the individual suffer 
from the chronic enduring nature of these problems but the families and communities 
surrounding that individual are also affected. These rippling effects of addiction are 
an important rationale for investigating and examining potential alternative treatments 
for SUDs. 
The World Health Organisation (WHO, 2008) reported 125 million people 
worldwide suffer from some form of alcohol use disorder. The global prevalence rate 
for a drug use disorder was 11.8% with men being nearly seven times more likely 
than females to have an alcohol or drug use disorder (WHO, 2008). These findings 
were reflected in New Zealand (NZ) through the Te Rau Hinengaro Mental Health 
Survey where the lifetime prevalence for any SUD was 12.3% and the 12-month 
prevalence was 3.5%. Again, males were more likely to suffer from SUDs compared 
to females (5.0% and 2.2% respectively). Furthermore, out of the 12.3% of people 
diagnosed with a SUD, 40% also suffered from anxiety disorders and 29% suffered 
from any mood disorder (Oakley-Browne et al., 2006). Therefore, a transdiagnostic 
treatment that addresses both mental illness and addictive behaviours is another 
important rationale for implementing an intervention for comorbid problems rather 
than one that solely addresses one issue over the other.  
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A common aspect observed in SUDs and mental health problems is 
experiential avoidance. Experiential avoidance is a process that occurs when a person 
is unwilling to experience emotions, thoughts, memories, or bodily sensations and 
they take actions to avoid or alter the frequency of these experiences (Hayes, Wilson, 
Gifford, Follette, & Strosahl, 1996). The strategy used to control or suppress the 
aversive emotional states in this context is substance use (Hayes et al., 1996). An 
integrated approach to treating such dual diagnoses has been put forward as the gold 
standard. These treatment methods haven grown out of “third wave” therapies such as 
Cognitive Behavioural Therapy and more recently have expanded to include 
mindfulness, DBT, and ACT.  
ACT is a transdiagnostic therapy that has been specifically developed to 
reduce experiential avoidance. Therefore, this therapy was deemed an appropriate 
modality to apply a pilot group programme targeting SUDs and coexisting mental 
health problems. The aim of ACT is to increase a person’s psychological flexibility 
through behaviour change and mindfulness and acceptance processes and skills. There 
are six core processes listed in Table 1 on the following page and are commonly 
presented in a Hexaflex (see Figure 1). Each skill promotes psychological flexibility 
and represents opportunities for clinical intervention (Ciarrochi, 2012; Hayes et al., 
1999; Hayes, Luoma, Bond, Masuda, & Lillis, 2006; Hayes et al., 2004). 
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Table 1.  
Six Core Principles of Acceptance and Commitment Therapy.  
Core Principle Description 
Present moment 
awareness 
Mindfulness component of therapy involves the person gaining 
awareness of the present moment that is often occupied by 
thoughts about the past or future. 
Values Clarification of a person’s values is essential in identifying goals 
to work towards. This step provides the reason to deal with 
discomfort and to engage in important areas of life.  
Committed Action Identifying and taking action about what matters in the person’s 
life while facing uncomfortable feelings and thoughts. This assists 
people to actualize their valued goals.  
Self as context Addresses core beliefs the client has about themselves and the 
world. This step aims to free the person of beliefs about roles, 
ways of being, and who they are. 
Defusion A skill to change a person’s relationship with unhelpful thoughts 
that lead to engagement in behaviour that is not in line with their 
valued goals. This process provides a platform for people to 
practise letting go of the unhelpful thoughts. 
Acceptance Hold the thought that arises and allow them to be there rather than 
trying to ignore the thought that is likely to make it stronger. 
Attempts to avoid thoughts typically lead to actions that are out of 
line with the person’s values.  
Note: Adapted from Hayes et al., 2004 and Hayes et al., 2006.  
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Figure 1. The Hexaflex Diagram adapted from various sources.  
Previous research utilising ACT with a number of different populations 
including SUDs have shown promising results; those pertaining to SUDs will be 
briefly outlined. A full analysis of ACT’s efficacy applied to various health problems 
is beyond the scope of this case study, however key meta-analysis and review articles 
demonstrating ACT’s efficacy across mental health and physical disorders include A-
Tjak et al. (2015) and Öst (2014) amongst others. With a focus on SUDs literature, 
the research is strengthening scientific evidence for ACT’s effectiveness in treating 
people who struggle with SUDs. To date, there have been several case studies 
examining alcohol dependence (Heffner, Eifert, Parker, Hernandez, & Sperry, 2003), 
cananbis use (Twohig, Shoenberger, & Hayes, 2007), and comorbid alcohol and 
mood disorders (Thekiso et al., 2015). While it is important for case studies and pilot 
studies to be conducted in the early stages of the development of a new therapy, there 
are several limitations of such research. These studies all show the potential of ACT 
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to treat SUDs; however, the major limitation of this study design is the 
generalisability of the results. Even though their results cannot be generalised to 
larger populations they are crucial to the development of empirical evidence of ACT 
and all support the further investigation of ACT applied to SUDs.   
Numerous Randomised Controlled Trials (RCTs) are being conducted and 
published with promising results dating back to the early 2000s that support the 
exploratory case studies findings. Studies focusing on nicotine have demonstrated the 
long term effectiveness of ACT for smoking cessation in comparison to medication as 
well as other TAU options including CBT and suppression based strategies (Gifford 
et al., 2004; Gifford et al., 2011; Hernández-López, Luciano, Bricker, Roales-Nieto, 
& Montesinos, 2009; Litvin, Kovacs, Hayes, & Brandon, 2012; Brown et al., 2013; 
Russell, 2013). Studies that applied ACT for people struggling with comorbid alcohol 
and depressive disorders compared to TAU showed positive shifts in participants’ 
mood and experiential avoidance (Petersen & Zettle, 2009; Thekiso et al., 2015). 
Hayes et al.  (2004) and Stotts et al. (2012) focused on methadone treatment 
programmes incorporating ACT principles to support dose reduction, both showing 
successful detoxification of methadone by the end of treatment. Smout et al. (2010) 
compared the effectiveness of ACT vs CBT to treat methamphetamine use and found 
ACT to be equivalent to CBT (Smout et al., 2010). Other aspects of SUDs include 
shame and stigma; one study demonstrated ACT’s ability to decrease substance use as 
well as reduce individuals’ experience of shame associated with substance use. ACT 
was also compared to CBT within the context of female inmates with polysubstance 
use disorders in three studies that demonstrated again ACT can perform as well as 
CBT and should be considered an alternative treatment for SUDs (Luoma, 
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Kohlenberg, Hayes, & Fletcher, 2012, González-Menéndez, Fernández, Rodríguez, & 
Villagrá, 2014; Lanza, García, Lamelas, & González-Menéndez, 2014).  
A meta-analysis specifically investigating ACT’s effectiveness in treating 
SUDs has now been published (Lee et al., 2015). This initial meta-analysis examined 
the aggregated effect sizes of ACT compared to other treatments (including CBT, 12 
step facilitation, pharmacotherapy, and TAU). This study supported ACT as a 
promising alternative for treatment of SUDs. More specifically the authors found a 
significant small effect size (g = .29) for ACT compared to control conditions at post-
treatment. However, it is acknowledged that more studies are needed to make it an 
empirically supported treatment option, particularly studies that address the 
limitations in the previous research. The purpose of the present study, therefore, was 
to add to this research by conducting a preliminary analysis to test the hypothesis that 
a manualised ACT group treatment programme for people struggling with SUDs and 
mental health problems such as stress, anxiety, and mood would improve their overall 
wellbeing from pre to post and a three-month follow-up. It was hypothesised that 
alcohol use, stress, and anxiety levels would decrease whilst mood management 
would improve from pre, post, and follow-up assessment points.  
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Methodology 
Study Design and Setting 
A repeated measures design was used to test the hypothesis outlined above. This study 
was conducted in the Alcohol and Other Drug Service, Palmerston North, NZ and was 
approved by the Health and Disability Committees of NZ (HDEC).  
Participants 
Ten clients who met the study criteria and gave written informed consent were 
recruited for the ACT group treatment programme for SUDs on a voluntary basis. 
Each client was interviewed for intake purposes using a semi structured clinical 
interview. The research study was embedded within the AOD service thereby 
participants were clients who already met referral requirements for the service (i.e. 
significant alcohol and drug problems). Inclusion criteria included a) between the 
ages of 18-66; b) be able to commit to 10 weekly sessions up to two hours duration; 
and c) have a nominated case manager at the AOD or Community Mental Health 
services. Exclusion criteria included a) suffering from severe or active depression, 
suicidal ideation/behaviour, PTSD, or psychotic symptoms; b) those in active 
withdrawal phases or active hazardous substance use; and c) case by case 
consideration of personality disorders/factors that would significantly derail group 
processes, methadone maintenance programme users, and those with current legal 
court issues. The latter were based on the severity of the behaviours. Given the real 
world setting of the study the criteria for participation served as a guideline and as a 
result no participants that were referred were excluded from the study.  
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One participant withdrew prior to the group commencing due to other 
commitments. One further participant withdrew by session four due to obtaining 
employment. Therefore, a total of eight individuals completed the first ACT group 
treatment programme. Of these participants five were male and three were female. 
Ages ranged between 29 and 66 years old with the average being 47 years of age (SD 
= 14.23). All participants lived within the MidCentral District Health Board (DHB) 
area and were NZ citizens except for one participant who identified as Australian. 
Most participants were unemployed and single. The complexity of the presentations 
varied however most participants had more than one substance use problem and 
comorbid mental health issue. 
Measures 
To provide evidence for evaluating the programme treatment effectiveness 
quantitatively the study used brief psychometric measures to examine participants’ 
alcohol use and related symptoms such as stress, anxiety, and mood commonly 
observed in substance use disorders. The measures are already used by a larger study 
of ACT group-based programme for the NZ army through Massey University. The 
measures were selected based on the research questions which arose from the 
literature review and to provide outcome data suitable for the programme evaluation 
purpose. The protocol of measures included Alcohol Use Disorder Identification Test-
Consumption (AUDIT-C), Perceived Stress Scale – 10 (PSS-10), Generalised Anxiety 
Disorder – 7 (GAD-7), and the Trait Meta Mood Scale (TMMS).  
Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). The 
AUDIT-C (World Health Organisation) is designed to briefly measure quantity and 
frequency of alcohol consumption on a typical day as well as binge drinking patterns. 
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It involves three items scored from 0 to 4 with a possible total score of 12. Higher 
scores indicate heavy/hazardous drinking and possible alcohol abuse and dependence. 
The AUDIT-C psychometric properties are similar to the full 10-item AUDIT which 
has good reliability and validity (Meneses-Gaya et al., 2010).  
Perceived Stress Scale-10 (PSS-10). The PSS-10 is a 10-item scale that 
assesses the degree general life situations are perceived as stressful. Each item is 
scored on a 5-point Likert scale and has shown good psychometric properties in a 
range of populations (Cohen, Kamarck, & Mermelstein, 1983).  
Generalised Anxiety Disorder Screen (GAD-7). The GAD-7 assesses 
general anxiety using a 7-item scale with a possible score of 0-3 for each item. The 
GAD-7 has good psychometric properties across a range of reliability and validity 
(Spitzer, Kroenke, Williams, & Lowe, 2006).  
Trait Meta-Mood Scale (TMMS). The TMMS is a 30-item self-administered 
questionnaire that comprises a 5-point Likert scale with three sub scales (attention, 
clarity, and repair). The TMMS has adequate psychometric properties (Palmer et al., 
2003). 
Procedures 
The sample for the ACT group was drawn from adults referred to the AOD service in 
Palmerston North. The facilitators of the group managed the recruitment process for 
selection and participation in collaboration with case managers working within the 
AOD service. Each potential participant was screened for exclusion and inclusion 
criteria before receiving a copy of the information sheet and informed consent. 
Informed consent involved participants agreeing to attend ten weekly group therapy 
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sessions based on ACT applied to SUDs, completing psychometric inventories at pre-
determined assessment points, and agreeing to attend a three-month follow-up 
assessment point for a subsequent analysis in the completion of the thesis. The 
measures were collected by the two group facilitators at the pre-treatment interview 
and at the completion of the therapy programme. Brief measures are practical, 
reliable, and valid for initial assessment and appraisal of treatment efficacy in clinical 
settings (Campbell and Hemsley 2009). 
Data Analysis 
Due to data regarding the results of ACT interventions for both SUDs and mental 
health problems treatment outcomes not being found in the available literature at the 
time of writing, a proper calculation of the sample size to obtain the generally 
accepted statistical power of 0.8 could not be achieved a priori. Consistent with the 
idea that this was an exploration study, the research used the data elicited from the 
participants that could be enrolled within the existing resources, a principle described 
in Haynes (2012) as using “the patients I can get” (pg. 139, 2012). This study was 
therefore limited with a sample size of eight.  
Quantitative data were analysed using the Statistical Package for the Social 
Sciences software (SPSS; version 20.0 for Windows, IBM Corp., Armonk, NY). Data 
was coded and entered into the SPSS database. Demographic variables of age, sex, 
levels of education, marital status, and ethnicity were also included. Age was 
measured on a continuous scale. Preliminary checks were conducted to ensure there 
were no violations of the assumptions of the statistical analyses used. A Wilcoxon 
signed-rank test was chosen to compare pre and post measures from the same 
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participants for alcohol use whereas Paired sample t-tests were used for stress, 
anxiety, and total mood management as the data appeared to be normally distributed.  
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Initial findings 
The first ACT group had a 95% retention rate post treatment. Table 2 below outlines 
means for each measure including the standard deviation and standard error of the 
mean pre and post-group using the final sample size of eight (excluding the two 
participants who withdrew and did not complete the post-group assessment phase).  
Table 2.  
Dependent Variable Sample Means, Standard Deviation (SD), and Standard Errors of 
the Mean (SEM) for ACT group treatment programme at pre and post assessment 
phases.  
Measure Pre-group 
(N = 8) 
Post-group 
(N = 8) 
Values M SEM SD M SEM SD 
AUDIT-C (Alcohol) 6.8 1.3 3.9 6.5 1.1 3.0 
PSS-10 (Stress) 23.4 1.6 5.5 18.6 1.1 3.2 
GAD-7 (Anxiety) 11.1 2.0 5.6 7.8 0.8 2.1 
TMMS (Total mood management) 97.9 3.3 10.6 110.1 3.8 10.9 
 
Wilcoxon Ranged Signs Test results demonstrated that a 10-week ACT group 
treatment programme for SUDs and mental health problems did not elicit a 
statistically significant change in alcohol use (Z = - 0.43, p = 0.67), see Figure 2 
below.  
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Figure 2. Alcohol use (AUDIT-C) pre and post-group mean scores demonstrating a 
slight decrease in scores and reduced error bars at completion of the ACT group 
treatment programme. 
Paired sample t-test results for stress and total mood management revealed 
statistically significant results. There was a significant decrease in stress scores (see 
Figure 3) by post-group (t (7) = 2.67, p = 0.01) and a significant increase in total 
mood management scores (see Figure 4) by post-group (t (7) = -3.28, p = 0.03). 
However, there was no statistically significant decrease observed in anxiety scores (t 
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Figure 3. Total average scores pre and post for stress (PSS-10). 
 
Figure 4. Total average scores pre and post for anxiety (GAD-7). 
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Figure 5. Average total scores for mood management (TMMS) at pre and post 
assessment points. 
This study, conducted in a real-world AOD setting, provides a preliminary 
analysis on the effectiveness of an ACT-based group treatment programme with 
people who struggle from both SUDs and mental health problems (with a focus on 
stress, anxiety, and mood). The initial findings support the hypothesis to the extent 
that initial trends in the results demonstrate reduction in alcohol consumption and 
anxiety. The significant results found for stress and mood management were as 
predicted and support the idea that a manualised ACT group treatment programme 
provides added benefits to people with SUDs and coexisting problems. The initial 
results also support the use of group as an acceptable format of delivery for 
participants targeted specifically for AOD problems and commonly comorbid mental 
health disorders. This is consistent with the literature that shows ACT is as effective 
as established psychological interventions for treating anxiety and depression (A-Tjak 
et al., 2015) as well as stress (Öst, 2014). The findings are also in line with Lee et al 
2015’s study where their initial meta-analysis for ACT applied to SUDs reported the 
  APPENDICES 
Page 276 
promising future of utilising such a transdiagnostic approach to treating such complex 
problems.  
Heffner et al. (2003), Petersen and Zettle (2009), and Thekiso et al. (2015) 
examined ACT applied to alcohol use. These studies all found reductions in both 
alcohol use and longer periods of sobriety reported at follow-up points. Although the 
results of the present study for alcohol use did not elicit a significant reduction by 
post-group assessment, a meta-analysis found that ACT treatments were more likely 
to show significant results at extended follow-up assessment points. This indicates 
that ACT may have increased effectiveness at follow-up compared to post-group 
assessment points. This finding may then be applied to the current results, in that, 
through further practise of psychological flexibility via ACT-based skills learnt in 
group, a continued positive behaviour change and growth over time may occur at the 
follow-up assessment point with an increased likelihood for potentially statistically 
significant results (Lee et al., 2015). 
This study has some important limitations. Firstly, as this was a preliminary 
analysis of the first ACT group as part of the larger research thesis project, a small 
sample size was used thereby limiting generalisability. This is a common limitation of 
the literature involving ACT as it is a growing body of research. Secondly, the sample 
demographics do not accurately reflect NZ populations as all participants were of 
European descent (NZ and Australian) therefore important cultural differences could 
not be assessed. As well as ethnicity, participants varied in their problematic 
substance use therefore this case study was limited to alcohol which was not the drug 
of choice for several participants. Inclusion of other drug measures is recommended 
to further evaluate the efficacy of ACT for SUDs as previous research that examined 
methadone (Hayes et al., 2004; Stotts et al., 2012), methamphetamine (Smout et al., 
  APPENDICES 
Page 277 
2010), nicotine (Bricker et al., 2013; Brown et al., 2013; Gifford et al., 2004; Gifford 
et al., 2011; Hernandez-Lopez et al., 2009; Litvin et al., 2012; Russell, 2013) and 
cannabis (Twohig et al., 2007) all showed promising results. The lack of a 
comparison group also limits the strength of evaluation of an ACT-based group 
treatment programme.  
This study also had important strengths; first the ACT intervention was 
delivered by a trained senior clinical psychologist and an intern psychologist who had 
developed the manual protocol specifically for this treatment population. Several 
reviews of ACT recommend group treatment is facilitated by two or more 
psychologists (Öst, 2014). Of note, this group had a 95% retention rate from pre to 
post, which may be a reflection of the engagement of the facilitators as well as the use 
of a transdiagnostic therapy, ACT. ACT can be conceptualised as a gentler or more 
realistic approach to managing aversive internal psychological experiences (Hayes et 
al., 2004) as the therapy works towards focusing on a person’s values and actions 
rather than focussing on their unhelpful or dysfunctional thoughts. Overall, the results 
of this preliminary analysis add to the developing literature that suggests more 
transdiagnostic approaches such as ACT in a group format may be better suited to 
working with such complex cases and can lead to sustainable improvements in 
coexisting problems in NZ, Aotearoa. However, further studies utilising randomised 
trials with larger groups of coexisting problems are required to confirm these 
promising results, yet the positive trend of the current study should support such 
endeavours.  
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Reflections 
My research involves clinical practice that can be directly applied to working 
with clients as a clinical psychology intern. I have been able to transfer my knowledge 
of ACT from group therapy and incorporate it into individual therapy sessions where 
appropriate. Taking such an integrated approach when working with complex 
comorbid problems such as SUDs and mental health problems has been recommended 
as the most effective way to elicit motivation and observe positive behaviour change. 
A core aspect of ACT includes mindfulness skills and I have found this incredibly 
helpful when working with clients who are anxious and depressed. A core part of 
working with anxiety is teaching clients calming and grounding techniques therefore 
mindfulness skills are a key component that I can now bring to session with 
individuals. Through the ACT group I have over ten mindfulness exercises that I can 
rely on and are now in my repertoire. Another core skill in ACT is the values work. 
This has also been a great tool to apply to individual sessions and help people clarify 
what they hold as deeply important to them. This has been helpful for many of my 
AOD clients who had lost touch with their values. Being a co-facilitator of the group 
therapy programme has been a welcome additional skill to acquire during my clinical 
training. Co-facilitating with an experienced senior clinical psychologist as a mentor 
has also influenced and improved my skills and knowledge base by observing how he 
interacts with clients or deals with difficult questions.   
On a personal note because I had developed this group programme and 
devoted a lot of time into this research I found myself being anxious and worried if 
the group participants did not like the session material or if they did not show up, 
particularly after the first session. I found that in the first initial sessions my anxiety 
levels were elevated, and I stumbled on my words trying to explain concepts of the 
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therapy and how the group would be run. Talking in front of groups is not my strong 
point as I feel that I can present as overtly nervous. I was glad when this feeling 
subsided as the group sessions progressed and my nerves settled.  
By the end of the group handing out certificates for those that completed the 
programme was a highlight for me. I was so proud of all the participants for their 
honesty and commitment to the group programme. One participant has completely 
counted off the methadone programme and another had maintained abstinence from 
alcohol. To hear their gratitude made me feel positive and hopeful about future groups 
helping more people in similar ways. One participant wrote a glowing review of the 
group to the MidCentral DHB AOD Service in the hopes of further groups like these 
running (see Appendix O). Another side to this was my own doubts about how much I 
had actually helped these people and wondering if it was more like a ceiling or 
Hawthorne effect (as my imposter syndrome kicked in at this point).  
While this case study reflects on the first group I have since completed a 
second group in 2016 as well as run two further groups during my internship year. 
This will add to the strength of the results presented in the final thesis. I am very 
hopeful about the future of ACT treating complex comorbid problems in NZ.   
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